FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Ota, H
   Ito-Matsuoka, Y
   Matsui, Y
AF Ota, Hiromitsu
   Ito-Matsuoka, Yumi
   Matsui, Yasuhisa
TI Identification of the X-linked germ cell specific miRNAs (XmiRs) and
   their functions
SO PLOS ONE
LA English
DT Article
ID SPERMATOGONIAL STEM-CELLS; BETA-CATENIN; SELF-RENEWAL; MICRORNAS;
   DIFFERENTIATION; PROLIFERATION; MECHANISMS; EXPRESSION; EFFICIENT; RNA
AB MicroRNAs (miRNAs) play a critical role in multiple aspects of biology. Dicer, an RNase III endonuclease, is essential for the biogenesis of miRNAs, and the germ cell-specific Dicer1 knockout mouse shows severe defects in gametogenesis. How miRNAs regulate germ cell development is still not fully understood. In this study, we identified germ cell-specific miRNAs (miR-741-3p, miR-871-3p, miR-880-3p) by analyzing published RNA-seq data of mouse. These miRNA genes are contiguously located on the X chromosome near other miRNA genes. We named them X chromosome-linked miRNAs (XmiRs). To elucidate the functions of XmiRs, we generated knockout mice of these miRNA genes using the CRISPR/Cas9-mediated genome editing system. Although no histological abnormalities were observed in testes of F0 mice in which each miRNA gene was disrupted, a deletion covering miR-871 and miR-880 or covering all XmiRs (Delta XmiRs) resulted in arrested spermatogenesis in meiosis in a few seminiferous tubules, indicating their redundant functions in spermatogenesis. Among candidate targets of XmiRs, we found increased expression of a gene encoding a WNT receptor, FZD4, in Delta XmiRs testis compared with that in wildtype testis. miR-871-3p and miR-880-3p repressed the expression of Fzd4 via the 3'-untranslated region of its mRNA. In addition, downstream genes of the WNT/beta-catenin pathway were upregulated in Delta XmiRs testis. We also found that miR-871, miR-880, and Fzd4 were expressed in spermatogonia, spermatocytes and spermatids, and overexpression of miR-871 and miR-880 in germ stem cells in culture repressed their increase in number and Fzd4 expression. Previous studies indicated that the WNT/beta-catenin pathway enhances and represses proliferation and differentiation of spermatogonia, respectively, and our results consistently showed that stable beta-catenin enhanced GSC number. In addition, stable beta-catenin partially rescued reduced GSC number by overexpression of miR-871 and miR-880. The results together suggest that miR-871 and miR-880 cooperatively regulate the WNT/beta-catenin pathway during testicular germ cell development.
C1 [Ota, Hiromitsu; Ito-Matsuoka, Yumi; Matsui, Yasuhisa] Tohoku Univ, Cell Resource Ctr Biomed Res, Inst Dev Aging & Canc, Sendai, Miyagi, Japan.
   [Ota, Hiromitsu; Matsui, Yasuhisa] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Chuo Ku, Tokyo, Japan.
   [Matsui, Yasuhisa] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan.
RP Matsui, Y (reprint author), Tohoku Univ, Cell Resource Ctr Biomed Res, Inst Dev Aging & Canc, Sendai, Miyagi, Japan.; Matsui, Y (reprint author), Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Chuo Ku, Tokyo, Japan.; Matsui, Y (reprint author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan.
EM yasuhisa.matsui.d3@tohoku.ac.jp
OI Matsui, Yasuhisa/0000-0001-7026-6355
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [JP16K20908]; KAKENHI in the Innovative Areas, "Mechanisms regulating
   gamete formation in animals" from MEXT [16H06530]; AMED-CREST from the
   Japan Agency for Medical Research and Development [JP17gm0510017h]
FX H.O. was supported by a Grant-in-Aid (KAKENHI) for Young Scientists (B)
   (grant #JP16K20908) from the Ministry of Education, Culture, Sports,
   Science and Technology of Japan
   (http://www.mext.go.jp/en/index.htm).Y.M.was supported by KAKENHI in the
   Innovative Areas, "Mechanisms regulating gamete formation in animals"
   (grant #16H06530) from MEXT, and by AMED-CREST (grant #JP17gm0510017h)
   from the Japan Agency for Medical Research and
   Development8https://www.amed.go.jp/en/index.html).The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129
   Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0
   Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102
   Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366
   Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1
   Chang YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028039
   Chen J, 2017, NUCLEIC ACIDS RES, V45, P4142, DOI 10.1093/nar/gkw1287
   Chuma S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0338
   Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367
   Cui N, 2016, J CELL MOL MED, V20, P1503, DOI 10.1111/jcmm.12838
   de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347
   Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412
   Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
   Forte E, 2015, J VIROL, V89, P2333, DOI 10.1128/JVI.03317-14
   Garcia-Lopez J, 2015, RNA, V21, P946, DOI 10.1261/rna.048215.114
   GINSBURG M, 1990, DEVELOPMENT, V110, P521
   Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758
   Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200
   Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107
   Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043
   Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315
   He ZP, 2013, STEM CELLS, V31, P2205, DOI 10.1002/stem.1474
   Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006
   Huszar JM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103747
   Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501
   Ishiguro K, 2011, EMBO REP, V12, P267, DOI 10.1038/embor.2011.2
   Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718
   Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI [10.1095/biolreprod.103.017012, 10.1095/biloreprod.103.017012]
   Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243
   Kerr GE, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.112.105809
   Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001
   Kumar M, 2016, ONCOTARGET, V7, P85709, DOI 10.18632/oncotarget.13920
   LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137
   Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684
   Liang XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033861
   Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2
   Liu DK, 2012, BIOCHEM BIOPH RES CO, V422, P114, DOI 10.1016/j.bbrc.2012.04.118
   MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016
   Marco A, 2013, NUCLEIC ACIDS RES, V41, P7745, DOI 10.1093/nar/gkt534
   McLaren A, 1984, Symp Soc Exp Biol, V38, P7
   Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112
   Miyoshi H, 1998, J VIROL, V72, P8150
   Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9
   Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743
   Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108
   O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677
   Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393
   Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198
   Povinelli BJ, 2014, STEM CELLS, V32, P105, DOI 10.1002/stem.1513
   REDDI PP, 1995, BIOL REPROD, V53, P873, DOI 10.1095/biolreprod53.4.873
   Reza AMT, 2019, BIOL REV, V94, P415, DOI 10.1111/brv.12459
   Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815
   Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241
   Rossitto M, 2015, SEMIN CELL DEV BIOL, V45, P84, DOI 10.1016/j.semcdb.2015.09.014
   Royo H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005461
   Soma K, 2006, GENE EXPR PATTERNS, V6, P325, DOI 10.1016/j.modgep.2005.06.013
   Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338
   Sosa E, 2015, DEVELOPMENT, V142, P3791, DOI 10.1242/dev.127191
   Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803
   Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200
   Takase HM, 2016, P NATL ACAD SCI USA, V113, pE1489, DOI 10.1073/pnas.1601461113
   Tong MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096313
   Nguyen TA, 2015, CELL, V161, P1374, DOI 10.1016/j.cell.2015.05.010
   Wang YR, 2016, MOL BIOL EVOL, V33, P2232, DOI 10.1093/molbev/msw089
   Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622
   Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070
   Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104
   Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053
   Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046
   Yang QE, 2013, DEVELOPMENT, V140, P280, DOI 10.1242/dev.087403
   Yasue A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05705
   Yeh JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040002
   Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903
   Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316
   Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675
   Yu M, 2014, J CELL BIOCHEM, V115, P232, DOI 10.1002/jcb.24655
   Zhang XX, 2010, NUCLEIC ACIDS RES, V38, P7689, DOI 10.1093/nar/gkq645
   Zhao BT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-488
NR 81
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 1
PY 2019
VL 14
IS 2
AR e0211739
DI 10.1371/journal.pone.0211739
PG 26
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HK2LM
UT WOS:000457742900045
PM 30707741
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Sillivan, SE
   Jones, ME
   Jamieson, S
   Rumbaugh, G
   Miller, CA
AF Sillivan, Stephanie E.
   Jones, Meghan E.
   Jamieson, Sarah
   Rumbaugh, Gavin
   Miller, Courtney A.
TI Bioinformatic analysis of long-lasting transcriptional and translational
   changes in the basolateral amygdala following acute stress
SO PLOS ONE
LA English
DT Article
ID ANXIETY-LIKE BEHAVIOR; SYNAPTIC PLASTICITY; GENE-EXPRESSION; MICRORNA;
   MEMORY; MIRBASE; DISORDERS; NETWORKS; SYSTEM; RATS
AB Stress profoundly impacts the brain and increases the risk of developing a psychiatric disorder. The brain's response to stress is mediated by a number of pathways that affect gene expression and protein function throughout the cell. Understanding how stress achieves such dramatic effects on the brain requires an understanding of the brain's stress response pathways. The majority of studies focused on molecular changes have employed repeated or chronic stress paradigms to assess the long-term consequences of stress and have not taken an integrative genomic and/or proteomic approach. Here, we determined the lasting impact of a single stressful event (restraint) on the broad molecular profile of the basolateral amygdala complex (BLC), a key brain region mediating emotion, memory and stress. Molecular profiling performed thirty days post-restraint consisted of small RNA sequencing, RNA sequencing and quantitative mass spectrometry and identified long-lasting changes in microRNA (miRNA), messenger RNA (mRNA) and proteins. Alignment of the three datasets further delineated the regulation of stress-specific pathways which were validated by qPCR and Western Blot analysis. From this analysis, mir-29a-5p was identified as a putative regulator of stress-induced adaptations in the BLC. Further, a number of predicted mir-29a-5p targets are regulated at the mRNA and protein level. The concerted and long-lasting disruption of multiple molecular pathways in the amygdala by a single stress event is expected to be sufficient to alter behavioral responses to a wide array of future experiences, including exposure to additional stressors.
C1 [Sillivan, Stephanie E.; Jones, Meghan E.; Jamieson, Sarah; Miller, Courtney A.] Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA.
   [Sillivan, Stephanie E.; Jones, Meghan E.; Jamieson, Sarah; Rumbaugh, Gavin; Miller, Courtney A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.
   [Sillivan, Stephanie E.] Temple Univ, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA.
RP Miller, CA (reprint author), Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA.; Miller, CA (reprint author), Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.
EM cmiller@scripps.edu
FU National Institute of Mental Health [MH105400]; National Institute on
   Drug Abuse [DA041469]
FX This work was funded by grants from the National Institute of Mental
   Health (MH105400 to CAM) and the National Institute on Drug Abuse
   (DA041469 to SS). The funding agencies had no role in study design, data
   collection and analysis, decision to publish or preparation of the
   manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Babaev O, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0063-8
   Bagot RC, 2016, NEURON, V90, P969, DOI 10.1016/j.neuron.2016.04.015
   Balakathiresan NS, 2014, J PSYCHIATR RES, V57, P65, DOI 10.1016/j.jpsychires.2014.05.020
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099
   Bi J, 2007, P NATL ACAD SCI USA, V104, P13810, DOI 10.1073/pnas.0703805104
   Cathomas F, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12475
   Cohen JL, 2017, BEHAV BRAIN RES, V319, P110, DOI 10.1016/j.bbr.2016.11.015
   Daskalakis NP, 2018, BIOL PSYCHIAT, V83, P849, DOI 10.1016/j.biopsych.2018.01.009
   Duval ER, 2015, THER CLIN RISK MANAG, V11, P115, DOI 10.2147/TCRM.S48528
   Filatova EV, 2014, DOKL BIOCHEM BIOPHYS, V456, P116, DOI 10.1134/S1607672914030107
   Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688
   Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004
   Geisler S, 2014, J CELL SCI, V127, P3280, DOI 10.1242/jcs.146035
   Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023
   Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Griggs EM, 2013, J NEUROSCI, V33, P1734, DOI 10.1523/JNEUROSCI.2873-12.2013
   Haramati S, 2011, J NEUROSCI, V31, P14191, DOI 10.1523/JNEUROSCI.1673-11.2011
   Jarome TJ, 2013, NEUROBIOL LEARN MEM, V105, P107, DOI 10.1016/j.nlm.2013.03.009
   Kall L, 2008, BIOINFORMATICS, V24, pI42, DOI 10.1093/bioinformatics/btn294
   Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848
   Korn CW, 2017, BIOL PSYCHIAT, V82, P522, DOI 10.1016/j.biopsych.2017.01.018
   Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loewy R. L., 2018, SCHIZOPHR RES
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mannironi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073385
   Maren S, 2016, NEUROPSYCHOPHARMACOL, V41, P58, DOI 10.1038/npp.2015.180
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006
   McEwen BS, 2015, NAT NEUROSCI, V18, P1353, DOI 10.1038/nn.4086
   Mifsud KR, 2017, NEUROENDOCRINOLOGY, V104, P157, DOI 10.1159/000445875
   Moreira PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163245
   Novais A, 2017, NEUROBIOL STRESS, V6, P44, DOI 10.1016/j.ynstr.2016.11.004
   Okkels N, 2017, SCHIZOPHRENIA BULL, V43, P180, DOI 10.1093/schbul/sbw082
   Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P282, DOI 10.1001/archpsyc.62.3.282
   Pfau ML, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00144
   Ranjbar H, 2017, CLIN EXP PHARMACOL P, V44, P470, DOI 10.1111/1440-1681.12727
   Rinaldi A, 2010, BEHAV BRAIN RES, V208, P265, DOI 10.1016/j.bbr.2009.11.012
   Rumbaugh G, 2015, NEUROPSYCHOPHARMACOL, V40, P2307, DOI 10.1038/npp.2015.93
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sharanova NE, 2016, B EXP BIOL MED+, V161, P355, DOI 10.1007/s10517-016-3413-3
   Sillivan SE, 2017, BIOL PSYCHIAT, V82, P924, DOI 10.1016/j.biopsych.2017.06.030
   Sousa N, 2016, MOL PSYCHIATR, V21, P302, DOI 10.1038/mp.2015.196
   Sun JD, 2015, CELL REP, V12, P449, DOI 10.1016/j.celrep.2015.06.023
   Syed S. A., 2017, EARLY LIFE STRESS MO, V1
   Vaisvaser S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146236
   Van't Veer A, 2013, PSYCHOPHARMACOLOGY, V229, P435, DOI 10.1007/s00213-013-3195-5
   Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403
   Vyas S, 2016, NEURAL PLAST, DOI 10.1155/2016/6391686
   Windischberger C, 2010, NEUROIMAGE, V49, P1161, DOI 10.1016/j.neuroimage.2009.10.013
   Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033
   Zhou M, 2018, NEUROSCIENCE, V376, P24, DOI 10.1016/j.neuroscience.2018.02.010
NR 55
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 10
PY 2019
VL 14
IS 1
AR e0209846
DI 10.1371/journal.pone.0209846
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HH1ME
UT WOS:000455483000036
PM 30629705
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Takashima, Y
   Kawaguchi, A
   Iwadate, Y
   Hondoh, H
   Fukai, J
   Kajiwara, K
   Hayano, A
   Yamanaka, R
AF Takashima, Yasuo
   Kawaguchi, Atsushi
   Iwadate, Yasuo
   Hondoh, Hiroaki
   Fukai, Junya
   Kajiwara, Koji
   Hayano, Azusa
   Yamanaka, Ryuya
TI MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a
   promising prognostic marker in primary central nervous system lymphoma
SO PLOS ONE
LA English
DT Article
ID GENE-EXPRESSION; PRIMARY CNS; RNA INTERFERENCE; RISK SCORE; BIOMARKERS;
   SERUM
AB MicroRNAs (miRNAs) are small RNA molecules that inhibit gene function by suppressing translation of target genes. However, in primary central nervous system lymphoma (PCNSL), the biological significance of miRNAs is largely unknown, although some miRNAs are known to be prognosis markers. Here, we analyzed 847 miRNAs expressed in 27 PCNSL specimens using microarray profiling and surveyed miRNA signature for prognostic prediction. Of these, 16 miRNAs were expressed in 27 PCNSL specimens at a frequency of 48%. Their variable importance measured by Random forest model revealed miR-192, miR-486, miR-28, miR-52, miR-181b, miR-194, miR-197, miR-93, miR-708, and let-7g as having positive effects; miR-29b-2*, miR-126, and miR-182 as having negative effects; and miR-18a*, miR-425, and miR-30d as neutral. After principal component analysis, the prediction formula for prognosis, consisting of the expression values of the above-mentioned miRNAs, clearly divided Kaplan-Meier survival curves by the calculated Z-score (HR = 6.4566, P = 0.0067). The 16 miRNAs were enriched by gene ontology terms including angiogenesis, cell migration and proliferation, and apoptosis, in addition to signaling pathways including TGF-beta/SMAD, Notch, TNF, and MAPKinase. Their target genes included BCL2-related genes, HMGA2 oncogene, and LIN28B cancer stem cell marker. Furthermore, three miRNAs including miR-181b, miR-30d, and miR-93, selected from the 16 miRNAs, also showed comparable results for survival (HR = 8.9342, P = 0.0007), suggestive of a miRNA signature for prognostic prediction in PCNSL. These results indicate that this miRNA signature is useful for prognostic prediction in PCNSL and would help us understand target pathways for therapies in PCNSL.
C1 [Takashima, Yasuo; Hayano, Azusa; Yamanaka, Ryuya] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Lab Mol Target Therapy Canc, Kyoto, Japan.
   [Kawaguchi, Atsushi] Saga Univ, Ctr Comprehens Community Med, Fac Med, Saga, Japan.
   [Iwadate, Yasuo] Chiba Univ, Grad Sch Med Sci, Dept Neurosurg, Chiba, Japan.
   [Hondoh, Hiroaki] Toyama Prefectural Cent Hosp, Dept Neurosurg, Toyama, Japan.
   [Fukai, Junya] Wakayama Med Univ, Dept Neurol Surg, Sch Med, Wakayama, Japan.
   [Kajiwara, Koji] Yamaguchi Univ, Grad Sch Med Sci, Dept Neurosurg, Ube, Yamaguchi, Japan.
RP Yamanaka, R (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Lab Mol Target Therapy Canc, Kyoto, Japan.
EM ryaman@koto.kpu-m.ac.jp
OI Yamanaka, Ryuya/0000-0003-2941-7996; Takashima,
   Yasuo/0000-0001-8876-6673
FU MEXT KAKENHI [16H05441, 18K09001]
FX The study was supported the MEXT KAKENHI Grant Numbers 16H05441 and
   18K09001. There was no additional external funding received for this
   study.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Ahmadvand M, 2018, LEUKEMIA RES, V70, P45, DOI 10.1016/j.leukres.2018.05.006
   Anfossi S, 2018, ADV EXP MED BIOL, V1056, P87, DOI 10.1007/978-3-319-74470-4_6
   Baraniskin A, 2018, J NEURO-ONCOL, V137, P463, DOI 10.1007/s11060-018-2749-0
   Baraniskin A, 2012, J NEURO-ONCOL, V109, P239, DOI 10.1007/s11060-012-0908-2
   Baraniskin A, 2011, BLOOD, V117, P3140, DOI 10.1182/blood-2010-09-308684
   Fang C, 2012, ANN HEMATOL, V91, P553, DOI 10.1007/s00277-011-1350-9
   Fischer L, 2011, NEURO-ONCOLOGY, V13, P1090, DOI 10.1093/neuonc/nor107
   Giza DE, 2015, ADV EXP MED BIOL, V889, P23, DOI 10.1007/978-3-319-23730-5_2
   Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169
   Iwadate Y, 2014, J NEURO-ONCOL, V117, P261, DOI 10.1007/s11060-014-1379-4
   Jorgensen LK, 2015, DAN MED J, V62
   Kanayama T, 2016, PRIMARY CENTRAL NERV, P81
   Kawaguchi A, 2016, PRIMARY CENTRAL NERV, P67
   Kawaguchi A, 2013, CANCER SCI, V104, P1205, DOI 10.1111/cas.12214
   Kawaguchi A, 2012, CLIN CANCER RES, V18, P5672, DOI 10.1158/1078-0432.CCR-12-0596
   Khare D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187722
   Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x
   Leivonen SK, 2017, BLOOD CANCER J, V7, DOI 10.1038/s41408-017-0033-8
   Lim EL, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0568-y
   Lopez-Santillan Maria, 2018, Oncotarget, V9, P22850, DOI 10.18632/oncotarget.25230
   Louis DN, 2016, WHO CLASSIFICATION T
   Meng YY, 2018, GENE, V642, P205, DOI 10.1016/j.gene.2017.11.022
   Montesinos-Rongen M, 2008, LEUKEMIA, V22, P400, DOI 10.1038/sj.leu.2405019
   Moss EG, 2001, CURR BIOL, V11, pR772, DOI 10.1016/S0960-9822(01)00467-5
   Pillar N, 2017, ONCOTARGET, V8, P86020, DOI 10.18632/oncotarget.20902
   Rao P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00039
   Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9
   Roehle A, 2008, BRIT J HAEMATOL, V142, P732, DOI 10.1111/j.1365-2141.2008.07237.x
   Roth P, 2015, EUR J CANCER, V51, P382, DOI 10.1016/j.ejca.2014.10.028
   Royer-Perron L, 2017, CURR OPIN NEUROL, V30, P669, DOI 10.1097/WCO.0000000000000492
   Rubenstein JL, 2006, BLOOD, V107, P3716, DOI 10.1182/blood-2005-03-0897
   Shalaby T, 2015, INT J MOL SCI, V16, P29103, DOI 10.3390/ijms161226150
   Sugita Y, 2016, PRIMARY CENTRAL NERV, P9
   Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X
   Takashima Yasuo, 2018, Oncotarget, V9, P27471, DOI 10.18632/oncotarget.25463
   Takashima Yasuo, 2018, Oncotarget, V9, P19065, DOI 10.18632/oncotarget.24897
   Takashima Y, 2016, HEPATOLOGY, V64, P245, DOI 10.1002/hep.28548
   Thyagarajan A, 2018, J PHARMACOL EXP THER, V364, P1, DOI 10.1124/jpet.117.242636
   Tun HW, 2008, BLOOD, V111, P3200, DOI 10.1182/blood-2007-10-119099
   Ultimo S, 2018, J CELL PHYSIOL, V233, P5642, DOI 10.1002/jcp.26290
   Wei D, 2015, MOL NEUROBIOL, V51, P1452, DOI 10.1007/s12035-014-8822-6
   Weiss B, 1999, CELL MOL LIFE SCI, V55, P334, DOI 10.1007/s000180050296
   Yamanaka R, 2016, PRIMARY CENTRAL NERV, P175
   Zheng B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00936
NR 45
TC 1
Z9 1
U1 4
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 7
PY 2019
VL 14
IS 1
AR e0210400
DI 10.1371/journal.pone.0210400
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HG5UW
UT WOS:000455045900073
PM 30615673
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Gondaliya, P
   Dasare, A
   Srivastava, A
   Kalia, K
AF Gondaliya, Piyush
   Dasare, Aishwarya
   Srivastava, Akshay
   Kalia, Kiran
TI miR29b regulates aberrant methylation in In-Vitro diabetic nephropathy
   model of renal proximal tubular cells
SO PLOS ONE
LA English
DT Article
ID MICRORNA TARGET PREDICTION; PATHOGENETIC MECHANISMS; DNA METHYLATION;
   EXPRESSION; INJURY
AB The role of DNA methylation has not been enough explored in pathophysiology of diabetic nephropathy (DN). However, according to recent reports it has been inferred that hypermethylation could be one of the principle cause associated with the enhancement of DN. An interrelationship between miR29b and DNA methylation has been studied via in-silico analysis. We have validated that miR29b prominently targets DNA methyl transferase (DNMT), specifically DNMT1, DNMT3A and DNMT3B. We have developed in vitro DN model using renal proximal tubule epithelial cells (RPTECs), contributed to a significant alleviation in RNA and protein expression levels of DNMT3A, DNMT3B and DNMT1. The developed model has also demonstrated downregulation in expression of miR29b. Our studies have also suggested that miR29b targets DNMT1 via targeting its transcription factor SP1. In addition to this, downregulation of a specific biomarker for kidney injury, tubular kidney injury molecule-1 (KIM-1) and fibrosis causing glycoprotein i.e. fibronectin, was also demonstrated. Hence, the developed model revealed that hypermethylation is a key factor incorporated in DN, and miR29b could effectively ameliorate defensive actions in DN pathogenesis.
C1 [Gondaliya, Piyush; Dasare, Aishwarya; Kalia, Kiran] Natl Inst Pharmaceut Educ & Res Ahmedabad, Dept Biotechnol, Ahmadabad, Gujarat, India.
   [Srivastava, Akshay] Natl Inst Pharmaceut Educ & Res Ahmedabad, Dept Med Devices, Ahmadabad, Gujarat, India.
RP Kalia, K (reprint author), Natl Inst Pharmaceut Educ & Res Ahmedabad, Dept Biotechnol, Ahmadabad, Gujarat, India.; Srivastava, A (reprint author), Natl Inst Pharmaceut Educ & Res Ahmedabad, Dept Med Devices, Ahmadabad, Gujarat, India.
EM akshay.srivastava@niperahm.ac.in; director@niperahm.ac.in
FU National Institute of Pharmaceutical Education and Research, Department
   of Pharmaceutics, Ministry of Chemicals and Fertilizers, Government of
   India
FX The authors have received funding from National Institute of
   Pharmaceutical Education and Research, Department of Pharmaceutics,
   Ministry of Chemicals and Fertilizers, Government of India. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Bansal A, 2017, PEDIATR DIABETES, V18, P167, DOI 10.1111/pedi.12521
   Bell CG, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-33
   Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193
   Chen HY, 2014, MOL THER, V22, P842, DOI 10.1038/mt.2013.235
   Chung ACK, 2010, J AM SOC NEPHROL, V21, P249, DOI 10.1681/ASN.2009010018
   Dooley J, 2016, DIABETES, V65, P53, DOI 10.2337/db15-0770
   Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894
   Eisenreich A, 2016, J HYPERTENS, V34, P323, DOI 10.1097/HJH.0000000000000799
   Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104
   Fujita H, 2009, J AM SOC NEPHROL, V20, P1303, DOI 10.1681/ASN.2008080844
   Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589
   Hollenberg NK, 2004, KIDNEY INT, V65, P1435, DOI 10.1111/j.1523-1755.2004.00524.x
   Hsu YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30575
   Ilyas Z, 2017, REV ENDOCR METAB DIS, P1, DOI [10.1007/s11154-017-9419-y, DOI 10.1007/S11154-017-9419-Y]
   Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150
   Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243
   Lu ZY, 2017, J DIABETES RES, DOI 10.1155/2017/7805058
   Maghbooli Z, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-69
   Marumo T, 2015, J AM SOC NEPHROL
   Massart J, 2017, DIABETES
   Pan JL, 2014, INT J MOL MED, V34, P1381, DOI 10.3892/ijmm.2014.1935
   Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308
   Reddy MA, 2013, SEMIN NEPHROL, V33, P341, DOI 10.1016/j.semnephrol.2013.05.006
   Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970
   Serban AI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152376
   Stenvinkel P, 2009, J RENAL NUTR, V19, P82, DOI 10.1053/j.jrn.2008.10.022
   van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175
   Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055
   Watanabe J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150897
   Wing MR, 2014, NEPHROL DIAL TRANSPL, V29, P864, DOI 10.1093/ndt/gft537
   Wing MR, 2014, NEPHROL DIAL TRANSPL
   Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104
   Wu H, 2014, J DIABETES RES, DOI 10.1155/2014/920134
   Wu R, 2018, METABOLISM, V83, P18, DOI 10.1016/j.metabol.2018.01.002
   Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148
   Zheng J, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160611
   Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033766
   Zhou L, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0710-y
NR 39
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 29
PY 2018
VL 13
IS 11
AR e0208044
DI 10.1371/journal.pone.0208044
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HC4HL
UT WOS:000451763800083
PM 30496316
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Li, N
   Zhang, Y
   Li, HP
   Han, L
   Yan, XM
   Li, HB
   Du, W
   Zhang, JS
   Yu, QL
AF Li, Na
   Zhang, Yang
   Li, Hai-Peng
   Han, Ling
   Yan, Xiang-Min
   Li, Hong-Bo
   Du, Wei
   Zhang, Jin-Shan
   Yu, Qun-Li
TI Differential expression of mRNA-miRNAs related to intramuscular fat
   content in the longissimus dorsi in Xinjiang brown cattle
SO PLOS ONE
LA English
DT Article
ID ADIPOCYTE DIFFERENTIATION; MEAT QUALITY; PREADIPOCYTE PROLIFERATION;
   ADIPOSE-TISSUES; PPAR-GAMMA; MICRORNAS; TARGET; IDENTIFICATION;
   METABOLISM; PATTERNS
AB In this study, we examined the role of mRNAs and miRNAs in variations in intramuscular fat content in the longissimus dorsi muscle in Xinjiang brown cattle. Two groups of Xinjiang brown cattle with extremely different intramuscular fat content in the longissimus dorsi were selected for combined of miRNA and mRNA analysis using an RNA-Seq. In total, 296 mRNAs and 362 miRNAs were significantly differentially expressed, including 155 newly predicted miRNAs, 275 significantly upregulated genes, 252 significantly upregulated miRNAs, 21 significantly downregulated genes and 110 significantly downregulated miRNAs. The combined miRNA and mRNA analysis identified 96 differentially expressed miRNAs and 27 differentially expressed mRNAs. In all, 47 upregulated miRNAs had a regulatory effect on 14 differentially downregulated target genes, and 49 downregulated miRNAs had a regulatory effect on 13 upregulated target genes. To verify the sequencing results, 10 differentially expressed genes (DEGs) and 10 differentially expressed miRNAs were selected for qRT-PCR. The qRT-PCR results confirmed the sequencing results. The results of this study shed light on the molecular regulation of bovine adipose tissue, which might help with the development of new strategies for improving meat quality and animal productivity in beef cattle to provide healthier meat products for consumers.
C1 [Li, Na; Han, Ling; Yu, Qun-Li] Gansu Agr Univ, Dept Food Sci & Engn, Lanzhou, Gansu, Peoples R China.
   [Li, Na; Zhang, Yang; Yan, Xiang-Min; Li, Hong-Bo; Du, Wei; Zhang, Jin-Shan] Xinjiang Acad Anim Sci, Dept Res Livestock, Urumqi, Xinjiang, Peoples R China.
   [Li, Hai-Peng] Chinese Acad Agr Sci, Dept Anim Sci, Beijing, Peoples R China.
RP Yu, QL (reprint author), Gansu Agr Univ, Dept Food Sci & Engn, Lanzhou, Gansu, Peoples R China.
EM yuqunli@gsau.edu.cn
FU National Beef Cattle Industrial Technology System [CARS-37]; Key
   Research of Autonomous Region and Plan Projects [2017B01001]; National
   Nature Science Foundation [31460647]
FX This work was supported by the National Beef Cattle Industrial
   Technology System (CARS-37), Key Research of Autonomous Region and Plan
   Projects (2017B01001) and the National Nature Science Foundation
   (31460647).
CR Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102
   Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Bahar B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060011
   Bartel DP, 2007, CELL, V131, P11, DOI 10.1016/S0092-8674(04)00045-5
   Boque N, 2013, MOL NUTR FOOD RES, V57, P1473, DOI 10.1002/mnfr.201200686
   Cheng DF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09245
   Crea F, 2014, ONCOTARGET, V5, P764, DOI 10.18632/oncotarget.1769
   Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265
   Du JJ, 2018, GENE, V668, P1, DOI 10.1016/j.gene.2018.05.036
   Fan YY, 2012, GENET MOL RES, V11, P3781, DOI 10.4238/2012.August.17.4
   Franck N, 2011, J CLIN ENDOCR METAB, V96, pE413, DOI 10.1210/jc.2009-2534
   Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436
   Gerst F, 2017, DIABETOLOGIA, V60, P2240, DOI 10.1007/s00125-017-4385-1
   Giroud M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28613
   Grindflek E, 2004, ANIM GENET, V35, P238, DOI 10.1111/j.1365-2052.2004.01126.x
   Han DX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194300
   Han DX, 2017, ONCOTARGET, V8, P36553, DOI 10.18632/oncotarget.16615
   He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167
   Healy NA, 2011, CANCER RES, V71, DOI 10.1158/0008-5472.SABCS11-P3-03-05
   Jiang J, 2018, HUM CELL, V31, P282, DOI 10.1007/s13577-018-0210-5
   Jin WW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-29
   Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06
   Kim YJ, 2015, MOL BIOL REP, V42, P617, DOI 10.1007/s11033-014-3807-0
   Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lee HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028033
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Li HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071568
   Li HL, 2011, MOL BIOL REP, V38, P4045, DOI 10.1007/s11033-010-0523-2
   Li N, 2016, INT J CLIN EXP MED, V9, P5912
   Liao CH, 2018, OBES RES CLIN PRACT, V12, P570, DOI 10.1016/j.orcp.2018.06.005
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Lin XZ, 2013, GENE, V521, P15, DOI 10.1016/j.gene.2013.03.050
   Ling HY, 2011, CLIN EXP PHARMACOL P, V38, P239, DOI 10.1111/j.1440-1681.2011.05493.x
   Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101
   Liu SY, 2016, FEBS LETT, V590, P1417, DOI 10.1002/1873-3468.12169
   Martinez-Perez B, 2016, TRANSL RES, V178, P1, DOI 10.1016/j.trsl.2016.06.012
   Miao XY, 2015, MOL CELL ENDOCRINOL, V402, P32, DOI 10.1016/j.mce.2014.12.023
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Palacios-Ortega S, 2015, CELL PHYSIOL BIOCHEM, V36, P1499, DOI 10.1159/000430314
   Romao J. M. H ML, 2014, EFFECT AGE BOVINE SU
   Ryu J, 2012, MOL BIOL REP, V39, P1441, DOI 10.1007/s11033-011-0880-5
   Shen LY, 2018, BIOMED PHARMACOTHER, V103, P1538, DOI 10.1016/j.biopha.2018.04.170
   Shen LY, 2016, MEAT SCI, V116, P201, DOI 10.1016/j.meatsci.2016.02.023
   Shi XE, 2014, INT J MOL SCI, V15, P8526, DOI 10.3390/ijms15058526
   Suzuki R, 2005, J BIOL CHEM, V280, P3331, DOI [10.1074/jbc.M506902200, 10.1074/jbc.M410955200]
   t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705
   Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299
   Yang J H-l S C-C, 2014, MOL CELL BIOCHEM, V395, P155, DOI [10.1007/s11010-014-2121-4, DOI 10.1007/S11010-014-2121-4]
   Yang S, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0869-2
   Ye F, 2014, MITOCHONDRION, V17, P157, DOI 10.1016/j.mito.2014.05.004
NR 53
TC 1
Z9 1
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 9
PY 2018
VL 13
IS 11
AR e0206757
DI 10.1371/journal.pone.0206757
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GZ8VH
UT WOS:000449772600025
PM 30412616
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Hanif, Q
   Farooq, M
   Amin, I
   Mansoor, S
   Zhang, Y
   Khan, QM
AF Hanif, Quratulain
   Farooq, Muhammad
   Amin, Imran
   Mansoor, Shahid
   Zhang, Yi
   Khan, Qaiser Mahmood
TI In silico identification of conserved miRNAs and their selective target
   gene prediction in indicine (Bos indicus) cattle
SO PLOS ONE
LA English
DT Article
ID DIFFERENTIALLY EXPRESSED MICRORNAS; COMPUTATIONAL IDENTIFICATION;
   BIOINFORMATICS ANALYSIS; HOLSTEIN CATTLE; HEAT; STRESS; BIOGENESIS;
   DIVERSITY; EVOLUTION; SEQUENCE
AB The modern cattle was domesticated from aurochs, sharing its physiological traits into two subspecies Bos taurus and Bos indicus. MicroRNAs (miRNAs) are a class of non-coding short RNAs of similar to 22nt which have a key role in the regulation of many cellular and physiological processes in the animal. The current study was aimed to predict and annotate the potential mutations in indicine miRNAs throughout the genome using de novo and homology-based in silico approaches. Genome-wide mapping was performed in available indicine assembly by the homology-based approach and 768 miRNAs were recovered out of 808 reported taurine miRNAs belonging to 521 unique mature miRNA families. While 42 precursors were dropped due to lack of secondary miRNA structure, increasing stringency or decreasing similarity between the two genomes' miRNA. Increasing tendency of miRNAs incidence was observed on chr5, chr7, chr8, chr12 and chr21 with 19 polycistronic miRNA within 1-kilobase distance throughout the indicine genome. Notably, 12 miRNAs showed copy number variation. Eighteen miRNAs showed a mutation in their mature sequences in which eight were found in their seed region. Whilst in de novo based approach, 12 novel potential miRNAs on Y chromosome in indicine cattle along with a new miRNA (bind-miR-1264) on chrX were found. The final data set is annotated and explains the impending target genes that are responsible for enhanced immunity, heat tolerance and disease tolerance regulation in indicine. The study conforms to better understanding and perceptive approach towards indicine genome.
C1 [Hanif, Quratulain; Zhang, Yi] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Minist Agr,Key Lab Anim Genet & Breeding & Reprod, Beijing, Peoples R China.
   [Hanif, Quratulain; Farooq, Muhammad; Amin, Imran; Mansoor, Shahid] NIBGE, Bioinformat & Computat Biol Lab, Faisalabad, Pakistan.
   [Hanif, Quratulain] Pakistan Inst Engn & Appl Sci, Islamabad, Pakistan.
   [Khan, Qaiser Mahmood] NIBGE, Environm Toxicol Lab, Faisalabad, Pakistan.
RP Zhang, Y (reprint author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Minist Agr,Key Lab Anim Genet & Breeding & Reprod, Beijing, Peoples R China.; Khan, QM (reprint author), NIBGE, Environm Toxicol Lab, Faisalabad, Pakistan.
EM yizhang@cau.edu.cn; qk_5@yahoo.com
OI Mansoor, Shahid/0000-0001-7418-1826; Farooq,
   Muhammad/0000-0003-0704-3372
FU National Institute for Biotechnology and Genetic Engineering (NIBGE);
   Program for Changjiang Scholars and Innovative Research in University
   [IRT1191]; ICARDA project [1198]
FX The current study was supported by an agricultural project, ICARDA
   project #1198 and initiated by National Institute for Biotechnology and
   Genetic Engineering (NIBGE). Yi Zhang was supported by the Program for
   Changjiang Scholars and Innovative Research in University (IRT1191).
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   [Anonymous], 2005, PLOS COMPUT BIOL, V1, pe13
   [Anonymous], 2009, PROTEIN NETWORKS PAT, P123
   Bahbahani H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11729
   Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079
   Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995
   Bitetti A, 2018, NAT STRUCT MOL BIOL, V25, P244, DOI 10.1038/s41594-018-0032-x
   Braud M, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00003
   Canavez FC, 2012, J HERED
   Chaves-Olarte E, 2002, CELL MICROBIOL, V4, P663, DOI 10.1046/j.1462-5822.2002.00221.x
   Cui M, 2014, BIOCHEM BIOPH RES CO, V444, P270, DOI 10.1016/j.bbrc.2014.01.051
   Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250
   Das K, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00079
   Devi Karam Jayanandi, 2018, Indian Journal of Plant Physiology, V23, P179, DOI 10.1007/s40502-018-0353-0
   Elsik CG, 2015, NUCLEIC ACIDS RES
   Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641
   Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244
   Hou L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193371
   Hu Yang, 2018, CELL STRESS CHAPERON, P1, DOI [DOI 10.1007/S12192-017-0806-9, 10.1080/21582041.2018.1448941]
   Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016
   Hussain K, 2018, GENE, V653, P57, DOI 10.1016/j.gene.2018.02.017
   Islam MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058902
   Ji K, 2018, GENE
   Keel BN, 2017, ANIM GENET, V48, P141, DOI 10.1111/age.12519
   Khan MS, 2008, PAK VET J, V28, P95
   Krishnan Remya, 2015, Syst Synth Biol, V9, P11, DOI 10.1007/s11693-014-9159-1
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054
   Lan W, 2018, METHODS MOL BIOL, V1754, P205, DOI 10.1007/978-1-4939-7717-8_12
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Lawless N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00611
   Li AL, 2007, CELL RES, V17, P212, DOI 10.1038/sj.cr.7310113
   Li ZX, 2014, ANIM GENET, V45, P20, DOI 10.1111/age.12096
   Liu YX, 2010, GENET MOL RES, V9, P891, DOI 10.4238/vol9-2gmr769
   Liu YX, 2011, AGR SCI CHINA, V10, P1336, DOI 10.1016/S1671-2927(11)60126-0
   Lukaszewicz A, 2015, ANIM BIOTECHNOL, V26, P276, DOI 10.1080/10495398.2015.1014491
   Mahjoub N, 2015, J VIROL, V89, P428, DOI 10.1128/JVI.02181-14
   Malas TB, 2012, OPEN BIOL J, V5, DOI DOI 10.2174/1874196701205010023
   Manku HK, 2017, COMPUT BIOL CHEM, V70, P96, DOI 10.1016/j.compbiolchem.2017.08.005
   Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x
   Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666
   Naeem A, 2012, J DAIRY SCI, V95, P6397, DOI 10.3168/jds.2011-5173
   Nayee N, 2018, J ANIMAL BREEDING GE
   Norden GA, 2018, J ANIM SCI, V96, P253
   Pande HO, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0410-3
   Park SM, 2008, CYTOKINE GROWTH F R, V19, P303, DOI 10.1016/j.cytogfr.2008.04.011
   Pitt D, 2018, EVOLUTIONARY APPL
   Place RF, 2014, CELL STRESS CHAPERON, V19, P159, DOI 10.1007/s12192-013-0456-5
   Pryce JE, 2018, J DAIRY SCI, V101, P3702, DOI 10.3168/jds.2017-13377
   Qiao Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-544
   QIBIN L, 2008, MIREAP MICRORNA DISC
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798
   Reyes-Herrera PH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-454
   Sahoo S, 2018, GENE REP, V11, P213, DOI 10.1016/j.genrep.2018.03.020
   Samad AFA, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1164-8
   Sartori R, 2011, REPROD DOMESTIC RUMI, VVII, P357
   Sasazaki S, 2010, ANIM SCI J
   Sengar GS, 2018, CELL STRESS CHAPERON, P1, DOI [10.1007/s12192-017-0806-9, DOI 10.1007/S12192-017-0806-9]
   Sengar GS, 2018, CELL STRESS CHAPERON, V23, P155, DOI 10.1007/s12192-017-0833-6
   Shukla V, 2017, BRIEF FUNCT GENOMICS, V16, P249, DOI 10.1093/bfgp/elw042
   Silva CF, 2013, THERIOGENOLOGY, V79, P351, DOI 10.1016/j.theriogenology.2012.10.003
   Singh J, 2008, INSECT MOL BIOL, V17, P427, DOI 10.1111/j.1365-2583.2008.00816.x
   Syed MA, 2010, AM J RESP CRIT CARE, V181
   Szweykowska-Kulinska Z, 2018, MOL PLANT, V11, P1006, DOI 10.1016/j.molp.2018.06.010
   Vejnar CE, 2012, NUCLEIC ACIDS RES, V40, P11673, DOI 10.1093/nar/gks901
   Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046
   Wang F, 2015, CURR OPIN PLANT BIOL, V27, P118, DOI 10.1016/j.pbi.2015.06.012
   Wang H, 2018, REPROD DOMESTIC ANIM
   Wang HY, 2015, GENE, V559, P119, DOI 10.1016/j.gene.2015.01.021
   Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595
   Wang ZM, 2012, MOL PLANT, V5, P889, DOI 10.1093/mp/ssr094
   Wu XM, 2014, CENT EUR J BIOL, V9, P841, DOI 10.2478/s11535-014-0308-z
   Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107
   Yang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039015
   Yin ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035765
   Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260
   Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7
   Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302
   Zheng CY, 2018, THAI J VET MED, V48, P37
   Zheng Y, 2014, CELL STRESS CHAPERON, V19, P973, DOI 10.1007/s12192-014-0521-8
   Zhou R, 2011, CELL MOL IMMUNOL, V8, P371, DOI 10.1038/cmi.2011.19
   Zorc Minja, 2015, J Genomics, V3, P51, DOI 10.7150/jgen.11246
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 85
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 26
PY 2018
VL 13
IS 10
AR e0206154
DI 10.1371/journal.pone.0206154
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GY3KA
UT WOS:000448448700028
PM 30365525
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Sticht, C
   De La Torre, C
   Parveen, A
   Gretz, N
AF Sticht, Carsten
   De La Torre, Carolina
   Parveen, Alisha
   Gretz, Norbert
TI miRWalk: An online resource for prediction of microRNA binding sites
SO PLOS ONE
LA English
DT Article
ID TARGET INTERACTIONS
AB miRWalk is an open-source platform providing an intuitive interface that generates predicted and validated miRNA-binding sites of known genes of human, mouse, rat, dog and cow. The core of miRWalk is the miRNA target site prediction with the random-forest-based approach software TarPmiR searching the complete transcript sequence including the 5'-UTR, CDS and 3'-UTR. Moreover, it integrates results other databases with predicted and validated miRNA-target interactions. The focus is set on a modular design and extensibility as well as a fast update cycle. The database is available using Python, MySQL and HTML/Javascript Database URL: http://mirwalk.umm.uni-heidelberg.de.
C1 [Sticht, Carsten; De La Torre, Carolina; Parveen, Alisha; Gretz, Norbert] Heidelberg Univ, Med Res Ctr, Med Fac Mannheim, Mannheim, Germany.
RP Sticht, C (reprint author), Heidelberg Univ, Med Res Ctr, Med Fac Mannheim, Mannheim, Germany.
EM carsten.sticht@medma.uni-heidelberg.de
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Bandyopadhyay S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08004
   Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067
   Ding J, 2016, BIOINFORMATICS, V32, P2768, DOI 10.1093/bioinformatics/btw318
   Dweep H, 2014, METHODS MOL BIOL, V1182, P289, DOI 10.1007/978-1-4939-1062-5_25
   Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29
   Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130
   Xu J, 2013, GENOME RES, V23, P1810, DOI 10.1101/gr.148916.112
NR 8
TC 7
Z9 7
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 18
PY 2018
VL 13
IS 10
AR e0206239
DI 10.1371/journal.pone.0206239
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GX4KR
UT WOS:000447701300101
PM 30335862
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Vestergaard, AL
   Bang-Berthelsen, CH
   Floyel, T
   Stahl, JL
   Christen, L
   Sotudeh, FT
   Horskjaer, PD
   Frederiksen, KS
   Kofod, FG
   Bruun, C
   Berchtold, LA
   Storling, J
   Regazzi, R
   Kaur, S
   Pociot, F
   Mandrup-Poulsen, T
AF Vestergaard, Anna Lindelov
   Bang-Berthelsen, Claus Heiner
   Floyel, Tina
   Stahl, Jonathan Lucien
   Christen, Lisa
   Sotudeh, Farzaneh Taheri
   Horskjaer, Peter de Hemmer
   Frederiksen, Klaus Stensgaard
   Kofod, Frida Greek
   Bruun, Christine
   Berchtold, Lukas Adrian
   Storling, Joachim
   Regazzi, Romano
   Kaur, Simranjeet
   Pociot, Flemming
   Mandrup-Poulsen, Thomas
TI MicroRNAs and histone deacetylase inhibition-mediated protection against
   inflammatory beta-cell damage
SO PLOS ONE
LA English
DT Article
ID KAPPA-B ACTIVATION; PROINFLAMMATORY CYTOKINES; EXPRESSION CONTRIBUTE;
   INTERFERON-GAMMA; NITRIC-OXIDE; IN-VITRO; APOPTOSIS; TYPE-1;
   DYSFUNCTION; MIR-146A
AB Inflammatory beta-cell failure contributes to type 1 and type 2 diabetes pathogenesis. Pro-inflammatory cytokines cause beta-cell dysfunction and apoptosis, and lysine deacetylase inhibitors (KDACi) prevent beta-cell failure in vitro and in vivo, in part by reducing NF-kappa B transcriptional activity. We investigated the hypothesis that the protective effect of KDACi involves transcriptional regulation of microRNAs (miRs), potential new targets in diabetes treatment. Insulin-producing INS1 cells were cultured with or without the broad-spectrum KDACi Givinostat, prior to exposure to the pro-inflammatory cytokines IL-1 beta and IFN-gamma for 6 h or 24 h, and miR expression was profiled with miR array. Thirteen miRs (miR-7a-2-3p, miR-29c-3p, miR-96-5p, miR-101a-3p, miR-140-5p, miR-146a-5p, miR-146b-5p, miR-340-5p, miR-384-5p, miR-455-5p, miR-466b-2-3p, miR-652-5p, and miR-3584-5p) were regulated by both cytokines and Givinostat, and nine were examined by qRT-PCR. miR-146a-5p was strongly regulated by cytokines and KDACi and was analyzed further. miR-146a-5p expression was induced by cytokines in rat and human islets. Cytokine-induced miR-146a5p expression was specific for INS1 and beta-TC3 cells, whereas alpha-TC1 cells exhibited a higher basal expression. Transfection of INS1 cells with miR-146a-5p reduced cytokine signaling, including the activity of NF-kappa B and iNOS promoters, as well as NO production and protein levels of iNOS and its own direct targets TNF receptor associated factor 6 (TRAF6) and interleukin-1 receptor-associated kinase 1 (IRAK1). miR-146a-5p was elevated in the pancreas of diabetes-prone BB-DP rats at diabetes onset, suggesting that miR-146a-5p could play a role in type 1 diabetes development. The miR array of cytokine-exposed INS1 cells rescued by KDACi revealed several other miRs potentially involved in cytokine-induced beta-cell apoptosis, demonstrating the strength of this approach.
C1 [Vestergaard, Anna Lindelov; Stahl, Jonathan Lucien; Christen, Lisa; Sotudeh, Farzaneh Taheri; Horskjaer, Peter de Hemmer; Mandrup-Poulsen, Thomas] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.
   [Bang-Berthelsen, Claus Heiner; Floyel, Tina; Frederiksen, Klaus Stensgaard; Storling, Joachim; Pociot, Flemming] Herlev & Gentofte Hosp, Dept Pediat, Ctr Noncoding RNA Technol & Hlth, Herlev, Denmark.
   [Floyel, Tina; Kofod, Frida Greek; Storling, Joachim; Kaur, Simranjeet; Pociot, Flemming] Steno Diabet Ctr Copenhagen, Gentofte, Denmark.
   [Frederiksen, Klaus Stensgaard] Novo Nordisk, Dept GLP 1 & T2D Biol, Malov, Denmark.
   [Bruun, Christine; Berchtold, Lukas Adrian] Hagedorn Res Inst, Gentofte, Denmark.
   [Berchtold, Lukas Adrian] Univ Hosp Herlev, Dept Pediat, Copenhagen Diabet Res Ctr, Herlev, Denmark.
   [Regazzi, Romano] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland.
RP Mandrup-Poulsen, T (reprint author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.; Pociot, F (reprint author), Herlev & Gentofte Hosp, Dept Pediat, Ctr Noncoding RNA Technol & Hlth, Herlev, Denmark.; Pociot, F (reprint author), Steno Diabet Ctr Copenhagen, Gentofte, Denmark.
EM flemming.pociot@regionh.dk; tmpo@sund.ku.dk
RI Kaur, Simranjeet/K-2487-2019
OI Kaur, Simranjeet/0000-0003-0490-1028; Rose, Peter
   Horskjaer/0000-0002-8664-8662
FU Independent Research Fund Denmark; Novo Nordisk Foundation; Danish
   Diabetes Association; DesireAe and Niels Yde Foundation; A.P. Moller
   Foundation; Poul and Erna Sehested Hansen Foundation; Sven Hansen and
   wife Ina Hansen Foundation; Danish Strategic Research Council, Center
   for non-coding RNA in Technology and Health; commercial company Novo
   Nordisk A/S; Novo Nordisk A/S
FX This work was supported by the Independent Research Fund Denmark (ALV,
   TMP;
   https://ufm.dk/en/research-and-innovation/councils-and-commissions/indep
   endent-research-fund-Denmark), the Novo Nordisk Foundation (ALV, TMP;
   http://novonordiskfonden.dk/en), the Danish Diabetes Association (FP;
   https://diabetes.dk/diabetesforeningen/inenglish/the-danish-diabetes-ass
   ociation.aspx), the DesireAe and Niels Yde Foundation (ALV, TMP), the
   A.P. Moller Foundation (ALV, TMP, CHBB; https://www.apmollerfonde.dk/),
   Novo Nordisk A/S (KSF), the Poul and Erna Sehested Hansen Foundation
   (CHBB, ALV), the Sven Hansen and wife Ina Hansen Foundation (ALV), and
   the Danish Strategic Research Council (FP;
   https://ufm.dk/en/research-and-innovation/councils-and-commissions/the-d
   anish-council-for-research-and-innovation-policy/the-danish-council-for-
   research-policy) by funding the Center for non-coding RNA in Technology
   and Health. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. The
   commercial company Novo Nordisk A/S provided support in the form of
   salaries for authors [ALV, KSF], but did not have any additional role in
   the study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The specific roles of these authors are
   articulated in the 'author contributions' section.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Berchtold LA, 2016, ADV CLIN CHEM, V75, P99, DOI 10.1016/bs.acc.2016.02.001
   Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406
   Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07
   Chakraborty C, 2017, MOL THER-NUCL ACIDS, V8, P132, DOI 10.1016/j.omtn.2017.06.005
   Choi SW, 2014, LANCET ONCOL, V15, P87, DOI 10.1016/S1470-2045(13)70512-6
   Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258
   Chou DHC, 2012, CHEM BIOL, V19, P669, DOI 10.1016/j.chembiol.2012.05.010
   Christensen DP, 2014, P NATL ACAD SCI USA, V111, P1055, DOI 10.1073/pnas.1320850111
   Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488
   Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925
   Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y
   Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21
   Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021
   Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171
   Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
   Fred RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010843
   Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006
   Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178
   Hansen JB, 2012, CELL METAB, V16, P449, DOI 10.1016/j.cmet.2012.09.001
   Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219
   Hendgen-Cotta UB, 2017, FREE RADICAL RES, V51, P91, DOI 10.1080/10715762.2017.1282158
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Jiang MH, 2012, AGING CELL, V11, P29, DOI 10.1111/j.1474-9726.2011.00757.x
   Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998
   Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354
   Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160
   Larsen L, 2007, DIABETOLOGIA, V50, P779, DOI 10.1007/s00125-006-0562-3
   Lewis EC, 2011, MOL MED, V17, P369, DOI 10.2119/molmed.2010.00152
   Lindholm MW, 2012, MOL THER, V20, P376, DOI 10.1038/mt.2011.260
   Liu Da Zhi, 2015, J Neuromuscul Dis, V2, P387
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lovis P, 2008, DIABETES, V57, P2728, DOI 10.2337/db07-1252
   Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012
   Lundh M, 2012, DIABETOLOGIA, V55, P2421, DOI 10.1007/s00125-012-2615-0
   Lundh M, 2010, DIABETOLOGIA, V53, P2569, DOI 10.1007/s00125-010-1892-8
   Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271
   MANDRUPPOULSEN T, 1987, J IMMUNOL, V139, P4077
   MANDRUPPOULSEN T, 1986, DIABETOLOGIA, V29, P63, DOI 10.1007/BF02427283
   Mokhtari D, 2008, DIABETES, V57, P1896, DOI 10.2337/db07-1670
   Nesca V, 2013, DIABETOLOGIA, V56, P2203, DOI 10.1007/s00125-013-2993-y
   Nielsen K, 1999, DIABETES, V48, P2324, DOI 10.2337/diabetes.48.12.2324
   Olsen CA, 2014, CHEMMEDCHEM, V9, P434, DOI 10.1002/cmdc.201300421
   Osmai M, 2016, DIABETES-METAB RES, V32, P334, DOI 10.1002/dmrr.2719
   Perry MM, 2009, FEBS LETT, V583, P3349, DOI 10.1016/j.febslet.2009.09.038
   Perske C, 2010, AM J PATHOL, V177, P2046, DOI 10.2353/ajpath.2010.091111
   Roggli E, 2012, DIABETES, V61, P1742, DOI 10.2337/db11-1086
   Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881
   Roos J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38339
   Saba R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00578
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270
   Sparre T, 2003, AUTOIMMUNITY, V36, P99, DOI 10.1080/01891693031000079248
   Strandell E, 1995, IMMUNOL LETT, V48, P145, DOI 10.1016/0165-2478(95)02459-X
   Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103
   Vojinovic J, 2011, MOL MED, V17, P397, DOI 10.2119/molmed.2011.00030
   Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200
   Wang JH, 2013, OSTEOARTHR CARTILAGE, V21, P1987, DOI 10.1016/j.joca.2013.09.008
   Yang ML, 2015, J DIABETES, V7, P158, DOI 10.1111/1753-0407.12163
   Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2
NR 60
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 27
PY 2018
VL 13
IS 9
AR e0203713
DI 10.1371/journal.pone.0203713
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GV2HB
UT WOS:000445907400015
PM 30260972
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Wommack, JC
   Trzeciakowski, JP
   Miranda, RC
   Stowe, RP
   Ruiz, RJ
AF Wommack, Joel C.
   Trzeciakowski, Jerome P.
   Miranda, Rajesh C.
   Stowe, Raymond P.
   Ruiz, R. Jeanne
TI Micro RNA clusters in maternal plasma are associated with preterm birth
   and infant outcomes
SO PLOS ONE
LA English
DT Article
ID PREGNANCY-ASSOCIATED MICRORNAS; IDENTIFICATION; CIRCULATION
AB The current study examined micro RNA (miRNAs) clusters from the maternal plasma to determine their association with preterm birth (PTB) and infant birth outcomes. A subsample of 42 participants who spontaneously delivered either preterm (<= 37 weeks) or term was selected from a parent sample of 515 pregnant Mexican American women. Plasma samples and prenatal data were collected at a single mid-gestation time point (22-24 weeks' gestation) and birth outcomes were obtained from medical records after delivery. Circulating miRNAs were analyzed by qPCR. When miRNAs were grouped according to chromosomal cluster rather than expression level, individual miRNAs correlated strongly with other individual miRNAs within their respective genomic locus. miRNAs from the c19mc cluster negatively correlated with c14mc miRNAs, and this relationship was more pronounced in PTB. Clusters c14mc was negatively associated with length of gestation; while the c19mc was positively associated with length of gestation and infant head circumference. Together, these findings suggest that groups of miRNAs from common chromosomal clusters, rather than individual miRNAs, operate as co-regulated groups of signaling molecules to coordinate length of gestation and infant outcomes. From this evidence, differences in cluster-wide expression of miRNAs are involved in spontaneous PTB.
C1 [Wommack, Joel C.; Stowe, Raymond P.; Ruiz, R. Jeanne] Microgen Labs, La Marque, TX 77568 USA.
   [Trzeciakowski, Jerome P.; Miranda, Rajesh C.] Texas A&M Univ, Coll Med, Bryan, TX USA.
RP Wommack, JC (reprint author), Microgen Labs, La Marque, TX 77568 USA.
EM jwommack@microgenlabs.com
OI Miranda, Rajesh/0000-0002-8359-892X
FU NIH [R01NR0107891]; Microgen Labs LLC
FX This work was supported by an NIH grant (R01NR0107891) awarded to R.J.
   Ruiz. Microgen Labs LLC provided funding in the form of salaries for
   author [RS] but did not have any additional role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript. The specific role of this author is articulated in the
   'author contributions' section.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567
   [Anonymous], MIRNA TARG GEN PATHW
   Ashton D, 2006, ETHNIC DIS, V16, P58
   Balaraman S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165081
   Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235
   Behrman R., 2007, PRETERM BIRTH CAUSES
   Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590
   Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205
   Elovitz MA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.023
   Gardiner E, 2012, MOL PSYCHIATR, V17, P827, DOI 10.1038/mp.2011.78
   Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675
   Hromadnikova I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171756
   Hromadnikova I, 2012, J MOL DIAGN, V14, P160, DOI 10.1016/j.jmoldx.2011.11.003
   JENNRICH RI, 1970, J AM STAT ASSOC, V65, P904, DOI 10.2307/2284596
   Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006
   Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027
   Lin S, 2010, COMPUT BIOL CHEM, V34, P232, DOI 10.1016/j.compbiolchem.2010.08.001
   Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660
   Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125
   Morales-Prieto DM, 2014, PLACENTA, V35, pS39, DOI 10.1016/j.placenta.2013.11.017
   Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001
   Prieto DMM, 2011, J REPROD IMMUNOL, V88, P106, DOI 10.1016/j.jri.2011.01.004
   Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816
   Ruiz RJ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0640-y
   Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304
   Tsochandaridis M, 2015, BIOMED RES INT, V2015, P2949
   Williams KC, 2012, P NATL ACAD SCI USA, V109, P7529, DOI 10.1073/pnas.1200650109
   Yang SP, 2015, MOL MED REP, V12, P1145, DOI 10.3892/mmr.2015.3490
   Zhu XM, 2009, AM J OBSTET GYNECOL, V6, pe1
NR 30
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 27
PY 2018
VL 13
IS 6
AR e0199029
DI 10.1371/journal.pone.0199029
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GK9FZ
UT WOS:000436549200035
PM 29949620
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Iwama, H
   Kato, K
   Imachi, H
   Murao, K
   Masaki, T
AF Iwama, Hisakazu
   Kato, Kiyohito
   Imachi, Hitomi
   Murao, Koji
   Masaki, Tsutomu
TI Human microRNAs preferentially target genes with intermediate levels of
   expression and its formation by mammalian evolution
SO PLOS ONE
LA English
DT Article
ID ANIMAL MICRORNAS; RECOGNITION; IMPACT; ATLAS; BIRTH
AB MicroRNAs (miRNAs) are short, endogenous RNAs that post-transcriptionally repress mRNAs. Over the course of evolution, many new miRNAs are known to have emerged and added to the existing miRNA repertoires of drosophilids and vertebrates. Despite the large number of miRNAs in existence, the complementary pairing of only similar to 7 bases between miRNAs and mRNAs is sufficient to induce repression. Thus, miRNA targeting is so widespread that genes coexpressed with a miRNA have evolved to avoid sites that are targeted by the miRNA. Besides this avoidance, little is known about the preferential modes of miRNA targeting. Therefore, to elucidate miRNA targeting preference and avoidance, we evaluated the bias of the number of miRNA targeting occurrences in relation to expression intensities of miRNAs and their coexpressed target mRNAs by surveying transcriptome data from human organs. We found that miRNAs preferentially target genes with intermediate levels of expression, while avoiding highly expressed ones, and that older miRNAs have greater targeting specificity, suggesting that specificity increases during the course of evolution.
C1 [Iwama, Hisakazu] Kagawa Univ, Life Sci Res Ctr, Miki, Kagawa, Japan.
   [Kato, Kiyohito; Masaki, Tsutomu] Kagawa Univ, Dept Gastroenterol & Neurol, Fac Med, Miki, Kagawa, Japan.
   [Imachi, Hitomi; Murao, Koji] Kagawa Univ, Dept Endocrinol & Metab, Fac Med, Miki, Kagawa, Japan.
RP Iwama, H (reprint author), Kagawa Univ, Life Sci Res Ctr, Miki, Kagawa, Japan.
EM iwama@med.kagawa-u.ac.jp
FU JSPS KAKENHI from the Japan Society for the Promotion of Science (JSPS)
   [26440197]
FX This work was supported by JSPS KAKENHI (grant number: 26440197) from
   the Japan Society for the Promotion of Science (JSPS) to H. Iwama. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.; This work was
   supported by JSPS KAKENHI (grant number: 26440197) from the Japan
   Society for the Promotion of Science (JSPS).
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914
   de Rie D, 2017, NAT BIOTECHNOL, V35, P872, DOI 10.1038/nbt.3947
   Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158
   Fromm B, 2015, ANNU REV GENET, V49, P213, DOI 10.1146/annurev-genet-120213-092023
   Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105
   Iwama H, 2013, MOL BIOL EVOL, V30, P613, DOI 10.1093/molbev/mss262
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053
   Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73
   Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116
   McJunkin K, 2017, GENE DEV, V31, P422, DOI 10.1101/gad.290155.116
   Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112
   Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]
   Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036
   Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157
NR 26
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 24
PY 2018
VL 13
IS 5
AR e0198142
DI 10.1371/journal.pone.0198142
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GH0HY
UT WOS:000433084300129
PM 29795674
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Puertas, RD
   Jalabert, A
   Meugnier, E
   Euthine, V
   Chevalier, P
   Rome, S
AF Puertas, Rosa Donate
   Jalabert, Audrey
   Meugnier, Emmanuelle
   Euthine, Vanessa
   Chevalier, Philippe
   Rome, Sophie
TI Analysis of the microRNA signature in left atrium from patients with
   valvular heart disease reveals their implications in atrial fibrillation
SO PLOS ONE
LA English
DT Article
ID OXIDATIVE STRESS; EXPRESSION PROFILES; DNA METHYLATION; MIRNAS;
   HYPERMETHYLATION; IDENTIFICATION; CONTRIBUTES; ACTIVATION; MUTATIONS;
   PROMOTES
AB Background
   Among the potential factors which may contribute to the development and perpetuation of atrial fibrillation, dysregulation of miRNAs has been suggested. Thus in this study, we have quantified the basal expressions of 662 mature human miRNAs in left atrium (LA) from patients undergoing cardiac surgery for valve repair, suffering or not from atrial fibrillation (AF) by using TaqMan (R) Low Density arrays (v2.0).
   Results
   Among the 299 miRNAs expressed in all patients, 42 miRNAs had altered basal expressions in patients with AF. Binding-site predictions with Targetscan (conserved sites among species) indicated that the up- and down-regulated miRNAs controlled respectively 3,310 and 5,868 genes. To identify the most relevant cellular functions under the control of the altered miRNAs, we focused on the 100 most targeted genes of each list and identified 5 functional protein-protein networks among these genes. Up-regulated networks were involved in synchronisation of circadian rythmicity and in the control of the AKT/PKC signaling pathway (i.e., proliferation/adhesion). Down-regulated networks were the IGF-1 pathway and TGF-beta signaling pathway and a network involved in RNA-mediated gene silencing, suggesting for the first time that alteration of miRNAs in AF would also perturbate the whole miRNA machinery. Then we crossed the list of miRNA predicted genes, and the list of mRNAs altered in similar patients suffering from AF and we found that respectively 44.5% and 55% of the up- and down-regulated mRNA are predicted to be conserved targets of the altered miRNAs (at least one binding site in 3'-UTR). As they were involved in the same biological processes mentioned above, these data demonstrated that a great part of the transcriptional defects previously published in LA from AF patients are likely due to defects at the post-transcriptional level and involved the miRNAs.
   Conclusions
   Our stringent analysis permitted us to identify highly targeted protein-protein networks under the control of miRNAs in LA and, among them, to highlight those specifically affected in AF patients with altered miRNA signature. Further studies are now required to determine whether alterations of miRNA levels in AF pathology are causal or represent an adaptation to prevent cardiac electrical and structural remodeling.
C1 [Puertas, Rosa Donate; Chevalier, Philippe] Univ Lyon, Inst NeuroMyoGene INMG, UMR CNRS 5310, INSERM U1217, Lyon, France.
   [Jalabert, Audrey; Meugnier, Emmanuelle; Euthine, Vanessa; Rome, Sophie] Univ Lyon, Lyon Sud Fac Med, CarMeN Lab, UMR INSERM 1060,INRA 1397,INSA, Pierre Benite, France.
   [Chevalier, Philippe] Hosp Civils Lyon, Louis Pradel Cardiol Hosp, Rhythmol Unit, Bron, France.
RP Chevalier, P (reprint author), Univ Lyon, Inst NeuroMyoGene INMG, UMR CNRS 5310, INSERM U1217, Lyon, France.; Rome, S (reprint author), Univ Lyon, Lyon Sud Fac Med, CarMeN Lab, UMR INSERM 1060,INRA 1397,INSA, Pierre Benite, France.; Chevalier, P (reprint author), Hosp Civils Lyon, Louis Pradel Cardiol Hosp, Rhythmol Unit, Bron, France.
EM philippe.chevalier@chu-lyon.fr; srome@univ-lyon1.fr
OI ROME, SOPHIE/0000-0003-3986-5936
FU Fondation pour la Recherche Medicale grant [DRM20101220456]
FX This work was supported by Fondation pour la Recherche Medicale grant
   number DRM20101220456 (awarded to SR);
   https://wwwfrn.org/chercheurs/accueil. The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Akerman AW, 2013, HEART RHYTHM, V10, P1010, DOI 10.1016/j.hrthm.2013.03.021
   Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905
   Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82
   Bocchi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017750
   Caglayan AO, 2010, INTERACT CARDIOV TH, V11, P779, DOI 10.1510/icvts.2010.245910
   Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Castoldi G, 2012, J CELL PHYSIOL, V227, P850, DOI 10.1002/jcp.22939
   Christophersen IE, 2016, J HUM GENET, V61, P61, DOI 10.1038/jhg.2015.44
   Cooley N, 2012, PHYSIOL GENOMICS, V44, P211, DOI 10.1152/physiolgenomics.00111.2011
   Cui HW, 2016, FAM CANCER, V15, P317, DOI 10.1007/s10689-015-9846-4
   Dawson K, 2013, CIRCULATION, V127, P1466, DOI 10.1161/CIRCULATIONAHA.112.001207
   Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748
   Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033
   Puertas RD, 2017, TRANSL RES, V184, P57, DOI 10.1016/j.trsl.2017.03.004
   Duron E, 2014, J GERONTOL A-BIOL, V69, P1025, DOI 10.1093/gerona/glt206
   Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022
   Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399
   Guazzi M, 2009, HEART, V95, P102, DOI 10.1136/hrt.2007.135277
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   Gutierrez A, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0735-8
   Harada M, 2012, CIRCULATION, V126, P2051, DOI 10.1161/CIRCULATIONAHA.112.121830
   He XX, 2015, MOL BIOSYST, V11, P532, DOI 10.1039/c4mb00563e
   Higashi Y, 2010, TRENDS ENDOCRIN MET, V21, P245, DOI 10.1016/j.tem.2009.12.005
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Hu YF, 2015, NAT REV CARDIOL, V12, P230, DOI 10.1038/nrcardio.2015.2
   Husse B, 2005, BIOCHEM BIOPH RES CO, V334, P1260, DOI 10.1016/j.bbrc.2005.06.206
   Ivanovska I, 2008, CELL CYCLE, V7, P3137, DOI 10.4161/cc.7.20.6923
   Iwakawa HO, 2015, TRENDS CELL BIOL, V25, P651, DOI 10.1016/j.tcb.2015.07.011
   Kakkar AK, 2012, AM HEART J, V163, P13, DOI 10.1016/j.ahj.2011.09.011
   Kao YH, 2013, CLIN EXP PHARMACOL P, V40, P379, DOI 10.1111/1440-1681.12089
   Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866
   Kim NH, 2005, INT HEART J, V46, P383, DOI 10.1536/ihj.46.383
   Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512
   Kirchhof P, 2016, EUROPACE, V18, DOI 10.1093/europace/euw295
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Kuehn Heidi, 2008, Curr Protoc Bioinformatics, VChapter 7, DOI 10.1002/0471250953.bi0712s22
   Lao Kaiqin, 2007, Biotechnology Journal, V2, P33, DOI 10.1002/biot.200600119
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Li HL, 2012, MOL MED REP, V5, P1457, DOI 10.3892/mmr.2012.831
   Lin HH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40377
   Ling TY, 2013, HEART RHYTHM, V10, P1001, DOI 10.1016/j.hrthm.2013.03.005
   Liu H, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-90
   Liu H, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-10
   Liu ZD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050367
   Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533
   Lozano-Velasco E, 2015, MOL CELL BIOL, V35, P2892, DOI 10.1128/MCB.00536-15
   Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544
   Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967
   Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105
   Luo XB, 2013, J CLIN INVEST, V123, P1939, DOI 10.1172/JCI62185
   Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388
   Nattel S, 2014, J AM COLL CARDIOL, V63, P2335, DOI 10.1016/j.jacc.2014.02.555
   Orenes-Pinero E, 2015, ARCH CARDIOL MEX, V85, P225, DOI 10.1016/j.acmx.2015.01.005
   Orenes-Pinero E, 2013, INT J CARDIOL, V167, P1651, DOI 10.1016/j.ijcard.2012.09.120
   Perez-Serra A, 2017, CURR OPIN CARDIOL
   Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007
   Poudel P, 2015, CARDIOLOGY, V131, P58, DOI 10.1159/000375403
   Pregi N, 2017, MOL CELL BIOCHEM, V425, P9, DOI 10.1007/s11010-016-2858-z
   Reamon-Buettner SM, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040907
   Reamon-Buettner SM, 2004, J MED GENET, V41, P684, DOI 10.1136/jmg.2003.017483
   Reamon-Buettner SM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-38
   Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500
   Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030
   Sago N, 2004, BIOCHEM BIOPH RES CO, V319, P50, DOI 10.1016/j.bbrc.2004.04.151
   Sajjad A, 2014, BBA-MOL CELL RES, V1843, P2556, DOI 10.1016/j.bbamcr.2014.06.019
   Sandesara PB, 2017, HEART RHYTHM
   Schaaf M, 2017, EUR HEART J-CARD IMG, V18, P46, DOI 10.1093/ehjci/jew028
   Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130
   Sharma D, 2011, CARDIOLOGY, V120, P111, DOI 10.1159/000334434
   Sheward WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009783
   Shi KH, 2013, CELL SIGNAL, V25, P2079, DOI 10.1016/j.cellsig.2013.06.009
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Takeda N, 2011, J CARDIOL, V57, P249, DOI 10.1016/j.jjcc.2011.02.006
   Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511
   Viskin S, 1999, EUR HEART J, V20, P1429, DOI 10.1053/euhj.1999.1632
   Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403
   Wakili R, 2012, HERZ, V37, P166, DOI 10.1007/s00059-012-3594-0
   Wang F, 2017, ONCOL LETT, V13, P1048, DOI 10.3892/ol.2017.5593
   Wang JG, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0085-2
   Wang T, 2016, MOL MED REP, V13, P4535, DOI 10.3892/mmr.2016.5106
   Wang ZG, 2011, CARDIOVASC RES, V89, P710, DOI 10.1093/cvr/cvq350
   Xiao JJ, 2011, PHYSIOL GENOMICS, V43, P655, DOI 10.1152/physiolgenomics.00139.2010
   Xu GJ, 2013, CHINESE MED J-PEKING, V126, P1458, DOI 10.3760/cma.j.issn.0366-6999.20121233
   Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569
   Zhang DL, 2014, CIRCULATION, V129, P346, DOI 10.1161/CIRCULATIONAHA.113.005300
NR 87
TC 3
Z9 3
U1 2
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 3
PY 2018
VL 13
IS 5
AR e0196666
DI 10.1371/journal.pone.0196666
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GE6AF
UT WOS:000431305100049
PM 29723239
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Marco, A
AF Marco, Antonio
TI SeedVicious: Analysis of microRNA target and near-target sites
SO PLOS ONE
LA English
DT Article
ID SELECTION; FAMILY
AB Here I describe seedVicious, a versatile microRNA target site prediction software that can be easily fitted into annotation pipelines and run over custom datasets. SeedVicious finds microRNA canonical sites plus other, less efficient, target sites. Among other novel features, seedVicious can compute evolutionary gains/losses of target sites using maximum parsimony, and also detect near-target sites, which have one nucleotide different from a canonical site. Near-target sites are important to study population variation in microRNA regulation. Some analyses suggest that near-target sites may also be functional sites, although there is no conclusive evidence for that, and they may actually be target alleles segregating in a population. SeedVicious does not aim to outperform but to complement existing microRNA prediction tools. For instance, the precision of TargetScan is almost doubled (from 11% to similar to 20%) when we filter predictions by the distance between target sites using this program. Interestingly, two adjacent canonical target sites are more likely to be present in bona fide target transcripts than pairs of target sites at slightly longer distances. The software is written in Perl and runs on 64-bit Unix computers (Linux and MacOS X). Users with no computing experience can also run the program in a dedicated web-server by uploading custom data, or browse pre-computed predictions. SeedVicious and its associated web-server and database (SeedBank) are distributed under the GPL/GNU license.
C1 [Marco, Antonio] Univ Essex, Sch Biol Sci, Colchester, Essex, England.
RP Marco, A (reprint author), Univ Essex, Sch Biol Sci, Colchester, Essex, England.
EM amarco.bio@gmail.com
RI Marco, Antonio/N-1594-2019
OI Marco, Antonio/0000-0002-8603-7503
FU Wellcome Trust [200585/Z/16/Z]
FX This work was supported by a grant from the Wellcome Trust to Antonio
   Marco [grant number 200585/Z/16/Z]; funders website:
   https://wellcome.ac.uk/. The funder had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.; This software would not have been made publicly available
   without the encouragement and support of my colleagues, in particular
   Mohab Helmy and Sam Griffiths-Jones. I am also grateful to M. Helmy and
   Andrea Hatlen for discussion, to Roman Cheplyaka for feedback on the
   program, to Stuart Newman for his invaluable help setting up the
   web-server, and to the various anonymous reviewers (some more anonymous
   than others) for helpful comments and suggestions. This work was
   supported by the Wellcome Trust [grant number 200585/Z/16/Z].
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Chandradoss SD, 2015, CELL, V162, P96, DOI 10.1016/j.cell.2015.06.032
   Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910
   Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258
   Clifton BD, 2017, MOL BIOL EVOL, V34, P51, DOI 10.1093/molbev/msw212
   Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a
   Denzler R, 2016, MOL CELL, V64, P565, DOI 10.1016/j.molcel.2016.09.027
   Felsenstein J., 2005, PHYLIP PHYLOGENY INF
   Felsenstein J, 2003, INFERRING PHYLOGENIE
   He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379
   Hofacker Ivo L, 2009, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1202s26
   Jan C. H., 2010, Nature (London), V469, P97, DOI 10.1038/nature09616
   Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103
   Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030
   Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181
   Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295
   Marco A, 2015, G3-GENES GENOM GENET, V5, P2199, DOI 10.1534/g3.115.019497
   Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393
   Pinzon N, 2016, GENOME RES
   Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104
   Zhang CL, 2013, NUCLEIC ACIDS RES, V41, P6793, DOI 10.1093/nar/gkt421
NR 23
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 17
PY 2018
VL 13
IS 4
AR e0195532
DI 10.1371/journal.pone.0195532
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GD1LV
UT WOS:000430262300021
PM 29664927
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Chauhan, R
   Datzkiw, D
   Shrivastav, SV
   Shrivastav, A
AF Chauhan, Ranjit
   Datzkiw, David
   Shrivastav, Shailly Varma
   Shrivastav, Anuraag
TI In silico identification of microRNAs predicted to regulate
   N-myristoyltransferase and Methionine Aminopeptidase 2 functions in
   cancer and infectious diseases
SO PLOS ONE
LA English
DT Article
ID BREAST-CANCER; CELL-PROLIFERATION; HEPATOCELLULAR-CARCINOMA;
   TRANSCRIPTION FACTORS; POTENTIAL BIOMARKERS; DOWN-REGULATION; T-CELLS;
   EXPRESSION; INVASION; MIRNA
AB Protein myristoylation is a key protein modification carried out by N-Myristoyltransferase (NMT) after Methionine aminopeptidase 2 (MetAP2) removes methionine from the amino-terminus of the target protein. Protein myristoylation by NMT augments several signaling pathways involved in a myriad of cellular processes, including developmental pathways and pathways that when dysregulated lead to cancer or immune dysfunction. The emerging evidence pointing to NMT-mediated myristoylation as a major cellular regulator underscores the importance of understanding the framework of this type of signaling event. Various studies have investigated the role that myristoylation plays in signaling dysfunction by examining differential gene or protein expression between normal and diseased states, such as cancers or following HIV-1 infection, however no study exists that addresses the role of microRNAs (miRNAs) in the regulation of myristoylation. By performing a large scale bioinformatics and functional analysis of the miRNAs that target key genes involved in myristoylation (NMT1, NMT2, MetAP2), we have narrowed down a list of promising candidates for further analysis. Our condensed panel of miRNAs identifies 35 miRNAs linked to cancer, 21 miRNAs linked to developmental and immune signaling pathways, and 14 miRNAs linked to infectious disease (primarily HIV). The miRNAs panel that was analyzed revealed several NMT-targeting mRNAs (messenger RNA) that are implicated in diseases associated with NMT signaling alteration, providing a link between the realms of miRNA and myristoylation signaling. These findings verify miRNA as an additional facet of myristoylation signaling that must be considered to gain a full perspective. This study provides the groundwork for future studies concerning NMT-transcript-binding miRNAs, and will potentially lead to the development of new diagnostic/prognostic biomarkers and therapeutic targets for several important diseases.
C1 [Chauhan, Ranjit; Datzkiw, David; Shrivastav, Shailly Varma; Shrivastav, Anuraag] Univ Winnipeg, Dept Biol, Winnipeg, MB, Canada.
   [Shrivastav, Anuraag] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada.
   [Shrivastav, Anuraag] CancerCare Manitoba, Res Inst Oncol & Hematol, Winnipeg, MB, Canada.
   [Chauhan, Ranjit] Mem Univ, Div Biomed Sci, Mol Virol & Hepatol Res Grp, Hlth Sci Ctr, St John, NF, Canada.
RP Shrivastav, A (reprint author), Univ Winnipeg, Dept Biol, Winnipeg, MB, Canada.; Shrivastav, A (reprint author), Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada.; Shrivastav, A (reprint author), CancerCare Manitoba, Res Inst Oncol & Hematol, Winnipeg, MB, Canada.
EM a.shrivastav@uwinnipeg.ca
FU University of Winnipeg; Prostate Cancer Fight Foundation; CIHR; QE2;
   Manitoba Medical Service Foundation; CFI
FX AS acknowledges the funding from The University of Winnipeg and the
   Prostate Cancer Fight Foundation. DD acknowledges financial support from
   CIHR and QE2. SV acknowledges funding support from Manitoba Medical
   Service Foundation. RC's position as an RA at the University of Winnipeg
   was supported by CFI.
CR Adoro S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8562
   Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Andrews K, 2017, FUNCTIONAL VALIDATIO
   Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024
   Appert-Collin A, 2015, FRONT PHARMACOL, V6, DOI [10.3339/fphar.2015.00283, 10.3389/fphar.2015.00283]
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Avraham R, 2012, BIOCHEM SOC T, V40, P26, DOI 10.1042/BST20110623
   Bai RP, 2015, INT J CANCER, V137, P2310, DOI 10.1002/ijc.29607
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   BAUMGART M, 2017, MIRNA CATALOGUE NCRN, V0018
   Bibby BAS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134180
   Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1174
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Catalanotto C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101712
   Chauhan Ranjit, 2016, Biomark Cancer, V8, P37, DOI 10.4137/BIC.S34413
   Chen B, 2016, TUMOR BIOL, V37, P2765, DOI 10.1007/s13277-015-4046-2
   CHEN DR, 2013, INT J DISTRIB SENS N, V2013, P7, DOI DOI 10.1371/J0URNAL.P0NE.0080625
   Chen JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080266
   Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990
   Chen QY, 2016, TUMOR BIOL, V37, P521, DOI 10.1007/s13277-015-3675-9
   Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020
   Chiang K, 2013, VIROLOGY, V438, P1, DOI 10.1016/j.virol.2012.12.016
   Cui LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027071
   Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112
   Dhayat SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140066
   Diaz G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1971-9
   Dix A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00270
   Dong YJ, 2013, MOL CANCER RES, V11, P1051, DOI 10.1158/1541-7786.MCR-13-0061
   Donzelli S, 2016, METHODS MOL BIOL, V1379, P13, DOI 10.1007/978-1-4939-3191-0_2
   Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798
   Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037
   Durojaiye V, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-187
   EI-Guendy NM, 2016, HEPAT MON, V16
   Emmrich S, 2016, ONCOGENE, V35, P1822, DOI 10.1038/onc.2015.247
   Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004
   Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103
   Fang L, 2012, RADIOL ONCOL, V46, P233, DOI 10.2478/v10019-012-0025-z
   Fang YT, 2015, CELL PHYSIOL BIOCHEM, V35, P227, DOI 10.1159/000369690
   Fang ZX, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0198-6
   Favreau AJ, 2012, LEUKEMIA RES, V36, P334, DOI 10.1016/j.leukres.2011.09.027
   Fisher K, 2015, WORLD J GASTROENTERO, V21, P12274, DOI 10.3748/wjg.v21.i43.12274
   Flores O, 2014, NUCLEIC ACIDS RES, V42, P4629, DOI 10.1093/nar/gkt1393
   Floyd DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096239
   Formosa A, 2014, ONCOGENE, V33, P5173, DOI 10.1038/onc.2013.451
   Garzia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004998
   Giang DG, 1998, J BIOL CHEM, V273, P6595, DOI 10.1074/jbc.273.12.6595
   Gigante M, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0841-9
   Gonzalez-Martin A, 2016, NAT IMMUNOL, V17, P433, DOI 10.1038/ni.3385
   Greco D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021646
   Greenberg DS, 2014, CURR PHARM DESIGN, V20, P6022, DOI 10.2174/1381612820666140314151924
   Guerra-Assuncao JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-218
   Guglielmelli P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140445
   Guo WJ, 2015, HEPATOLOGY, V62, P1132, DOI 10.1002/hep.27929
   Han YM, 2013, EPIGENOMICS-UK, V5, P439, DOI [10.2217/EPI.13.37, 10.2217/epi.13.37]
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183
   Hoque MO, 2010, J THORAC ONCOL, V5, P1887, DOI 10.1097/JTO.0b013e3181f77a53
   Hoy AM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002701
   Hu J, 2016, CURR MOL MED, V16, P70, DOI 10.2174/1566524016666151222144656
   Hu XM, 2016, HEPATOL RES, V46, P804, DOI 10.1111/hepr.12618
   Hui ABY, 2013, CLIN CANCER RES, V19, P2154, DOI 10.1158/1078-0432.CCR-12-3572
   Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010
   Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868
   Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114
   Jaeger A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4070-2
   Jebbawi F, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0218-x
   Jeker LT, 2013, IMMUNOL REV, V253, P65, DOI 10.1111/imr.12061
   Jha A, 2015, NUCLEIC ACIDS RES, V43, P8713, DOI 10.1093/nar/gkv871
   Jha A, 2011, J BIOSCIENCES, V36, P621, DOI 10.1007/s12038-011-9109-y
   Jones DZ, 2016, FASEB J S, V30, P9366
   Jun H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12226
   Kasai M, 2011, BREEDING SCI, V61, P468, DOI 10.1270/jsbbs.61.468
   Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111
   Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302
   Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518
   Kong XJ, 2015, AM J CANCER RES, V5, P1795
   Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558
   Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021
   Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541
   Kurzynska-Kokorniak A, 2015, NUCLEIC ACIDS RES, V43, P4365, DOI 10.1093/nar/gkv328
   Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07
   Li WL, 2014, CELL PHYSIOL BIOCHEM, V34, P1466, DOI 10.1159/000366351
   Li X, 2016, VIRUSES, V8
   Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607
   Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284
   Liu CL, 2013, BLOOD, V122, P2083, DOI 10.1182/blood-2012-08-447375
   Liu H, 2016, J CHEM-NY, DOI 10.1155/2016/2862567
   Liu SG, 2013, ONCOL LETT, V5, P1639, DOI 10.3892/ol.2013.1251
   Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573
   Lu YC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02058-8
   Luo SY, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0063-7
   Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062880
   Maccani A, 2014, APPL MICROBIOL BIOT, V98, P7535, DOI 10.1007/s00253-014-5911-4
   Martin HC, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r51
   Mathieu J, 2013, ADV EXP MED BIOL, V786, P329, DOI 10.1007/978-94-007-6621-1_18
   Mei LL, 2017, CANCER BIOMARK, V19, P1, DOI 10.3233/CBM-160240
   Meng DL, 2016, INT J BIOCHEM CELL B, V73, P30, DOI 10.1016/j.biocel.2016.01.018
   Min S, 2012, GENES IMMUN, V13, P621, DOI 10.1038/gene.2012.45
   Mulrane L, 2012, CLIN CANCER RES, V18, P6702, DOI 10.1158/1078-0432.CCR-12-1420
   Nadal E, 2015, SCI REP-UK, V5, DOI 10.1038/srep12464
   Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509
   Nygren MK, 2014, BRIT J CANCER, V110, P2072, DOI 10.1038/bjc.2014.113
   O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677
   Orr-Burks NL, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.23
   Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309
   Pashkovskiy PP, 2013, BIOCHEMISTRY-MOSCOW+, V78, P627, DOI 10.1134/S0006297913060084
   Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002
   Pers YM, 2013, NAT REV RHEUMATOL, V9, P76, DOI 10.1038/nrrheum.2012.236
   Pertea M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-206
   Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007
   Ramalinga M, 2015, ONCOTARGET, V6, P34446, DOI 10.18632/oncotarget.5920
   Rampoldi F, 2015, J IMMUNOL, V195, P4228, DOI 10.4049/jimmunol.1500622
   Rau CS, 2015, J BIOMEDICAL SCI, V22, P1
   Riffo-Campos A. L, 2016, INT J MOL SCI, V17
   Roderburg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032999
   Saini S, 2012, CANCER RES, V72, P3618, DOI 10.1158/0008-5472.CAN-12-0540
   Sannigrahi MK, 2017, CLIN CANCER RES, V23, P3884, DOI 10.1158/1078-0432.CCR-16-2936
   Santhakumar D, 2010, P NATL ACAD SCI USA, V107, P13830, DOI 10.1073/pnas.1008861107
   Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136
   Schmitt MJ, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-41
   Schramedei K, 2011, ONCOGENE, V30, P2975, DOI 10.1038/onc.2011.15
   Selvakumar P, 2007, INT J MOL MED, V19, P823
   Shrestha S, 2014, CANCER MED-US, V3, P878, DOI 10.1002/cam4.246
   Shrivastav A, 2008, J IMMUNOL, V180, P1019, DOI 10.4049/jimmunol.180.2.1019
   Shrivastav A, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-58
   Shrivastav A, 2009, J PATHOL, V218, P391, DOI 10.1002/path.2550
   Smigielska-Czepiel K, 2014, GENES IMMUN, V15, P115, DOI 10.1038/gene.2013.69
   Squillace N, 2014, J ANTIMICROB CHEMOTH, V69, P3067, DOI 10.1093/jac/dku264
   Srivastava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076994
   Stern DF, 2000, BREAST CANCER RES, V2, P176, DOI 10.1186/bcr51
   Thinon E, 2016, ACS CHEM BIOL, V11, P2165, DOI 10.1021/acschembio.6b00371
   TOWLER DA, 1987, J BIOL CHEM, V262, P1030
   Tu L, 2016, HSA MIR 376C 3P REGU, V2016
   Turner M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-169
   Utikal J, 2015, SEMIN CANCER BIOL, V35, P200, DOI 10.1016/j.semcancer.2015.07.001
   Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806
   Varshney A, 2017, HEPATOLOGY
   Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403
   Wan TMH, 2014, DIS MARKERS, DOI 10.1155/2014/919283
   Wang S., 2014, DIS MARKERS, V2014, DOI DOI 10.1155/2014/401986
   Wang XS, 2016, BIOCHEM BIOPH RES CO, V470, P620, DOI 10.1016/j.bbrc.2016.01.095
   Wang YX, 2015, INT J CLIN EXP PATHO, V8, P786
   Wang-Renault SF, 2018, ANN RHEUM DIS, V77, P133, DOI 10.1136/annrheumdis-2017-211417
   Wei Jun-Qiang, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P291
   Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001
   Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104
   Wu CX, 2017, SHOCK, V47, P520, DOI 10.1097/SHK.0000000000000766
   Wu DY, 2015, MOL MED REP, V11, P1469, DOI 10.3892/mmr.2014.2792
   Wu DY, 2014, ONCOL LETT, V7, P1219, DOI 10.3892/ol.2014.1875
   Wu J, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0128280
   Xiao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032201
   Xie H, 2016, STEM CELLS INT, DOI 10.1155/2016/6493241
   Xie J, 2014, WORLD J GASTROENTERO, V20, P17439, DOI 10.3748/wjg.v20.i46.17439
   Xing TJ, 2014, INT J CLIN EXP MED, V7, P4924
   Xing TJ, 2014, INT J MOL SCI, V15, P14411, DOI 10.3390/ijms150814411
   Yang SH, 2005, J BIOL CHEM, V280, P18990, DOI 10.1074/jbc.M412917200
   Yen YC, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-6
   Yu GD, 2017, LIFE SCI, V175, P47, DOI [10.1016/j.ifs.2017.03.010, 10.1016/j.lfs.2017.03.010]
   Yu T, 2016, SCI REPORTS, V6, P30923
   Yu X, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2015.43
   Zekri ARN, 2016, TUMOR BIOL, V37, P12273, DOI 10.1007/s13277-016-5097-8
   Zeng JS, 2017, INT J BIOCH CELL BIO
   Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008
   Zhang L, 2015, BREAST CANCER RES TR, V154, P423, DOI 10.1007/s10549-015-3591-0
   Zhang WP, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0113-6
   Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055733
   Zhang YD, 2016, BIOCHEM BIOPH RES CO, V476, P607, DOI 10.1016/j.bbrc.2016.06.006
   Zhang YP, 2015, INT J CLIN EXP PATHO, V8, P15677
   Zhou JJ, 2015, CANCER LETT, V356, P669, DOI 10.1016/j.canlet.2014.10.014
   Zhou L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-677
   Zhou Xiaofeng, 2012, Microrna, V1, P1
   Zhu MJ, 2014, FEBS J, V281, P3766, DOI 10.1111/febs.12902
   Zhuang M, 2014, BIOCHEM BIOPH RES CO, V448, P315, DOI 10.1016/j.bbrc.2013.12.126
NR 175
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 26
PY 2018
VL 13
IS 3
AR e0194612
DI 10.1371/journal.pone.0194612
PG 32
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GA5DH
UT WOS:000428351800038
PM 29579063
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Hou, L
   Ji, ZB
   Wang, GZ
   Wang, J
   Chao, TL
   Wang, JM
AF Hou, Lei
   Ji, Zhibin
   Wang, Guizhi
   Wang, Jin
   Chao, Tianle
   Wang, Jianmin
TI W Identification and characterization of microRNAs in the intestinal
   tissues of sheep (Ovis aries)
SO PLOS ONE
LA English
DT Article
ID GENOME-WIDE ANALYSIS; TAIL HAN SHEEP; MESSENGER-RNAS; KAZAKH SHEEP;
   BIOINFORMATICS; PATHWAY; DORSET; GENES; OVARY
AB Sheep are small ruminants, and their long intestines exhibit high digestive and absorptive capacity in many different rearing conditions; however, the genetic bases of this characteristic remains unclear. MicroRNAs (miRNAs) play a major role in maintaining both intestinal morphological structure as well as in regulating the physiological functions of this organ. However, no study has reported on the miRNA expression profile in the intestinal tissues of sheep. Here, we analyzed and identified the miRNA expression profile of three different intestinal tissues (i.e., duodenum, cecum, and colon) of sheep (Ovis aries) using high-throughput sequencing and bioinformatic methods. In total, 106 known miRNAs were identified, 458 conserved miRNAs were detected, 192 unannotated novel miRNAs were predicted, and 195 differentially expressed miRNAs were found between the different tissues. Additionally, 3,437 candidate target genes were predicted, and 17 non-redundant significantly enriched GO terms were identified using enrichment analysis. A total of 99 candidate target genes were found to significantly enriched in 4 KEGG biological pathways. A combined regulatory network was constructed based on 92 metabolism-related candidate target genes and 65 differentially expressed miRNAs, among which 7 miRNAs were identified as hub miRNAs. Via these mechanisms, miRNAs may play a role in maintaining intestinal homeostasis and metabolism. This study helps to further explain the mechanisms that underlie differences in tissue morphology and function in three intestinal segments of sheep.
C1 [Hou, Lei; Ji, Zhibin; Wang, Guizhi; Wang, Jin; Chao, Tianle; Wang, Jianmin] Shandong Agr Univ, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China.
RP Chao, TL; Wang, JM (reprint author), Shandong Agr Univ, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China.
EM 2398901017@qq.com; wangjm@sdau.edu.cn
FU Funds of Shandong "Double Tops" Program [SYL2017YSTD12]; Shandong
   Provincial Modern Agriculture Industry Technology System
   [SDAIT-0901101]; National Key Technology Support Program [2015BAD03B05];
   Study on Super-high Reproductive New Breed and Supporting technological
   system of Small-Tailed Han Sheep [SDLZ2015131x]
FX This work was financially supported by the Funds of Shandong "Double
   Tops" Program (No. SYL2017YSTD12), Shandong Provincial Modern
   Agriculture Industry Technology System (no. SDAIT-0901101), National Key
   Technology Support Program (2015BAD03B05) and Study on Super-high
   Reproductive New Breed and Supporting technological system of
   Small-Tailed Han Sheep (no. SDLZ2015131x). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Bai J W, 2016, EUROPEAN REV MED PHA, V20
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Carrigan C T, 2016, GROWTH HORM IGF RES, V32, P14
   Chang WH, 2015, J VET MED SCI, V77, P1617, DOI 10.1292/jvms.15-0289
   Consortium T G O, 2007, NUCL ACIDS RES S1, V36, P391
   Coutinho LL, 2007, PHYSIOL GENOMICS, V29, P35, DOI 10.1152/physiolgenomics.00081.2006
   DEGREGORIO RM, 1982, J ANIM SCI, V54, P855
   FAICHNEY GJ, 1969, AUST J AGR RES, V20, P491, DOI 10.1071/AR9690491
   Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782
   HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629
   Jiang S, 2016, PARASITE, V23, DOI 10.1051/parasite/2016023
   John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Kim H, 2017, ONCOTARGET, V8, P8484, DOI 10.18632/oncotarget.14298
   Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181
   Lagana A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143313
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   LEWIS SM, 1985, APPL ENVIRON MICROB, V50, P356
   Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336
   Liang GX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092592
   Liao YL, 2013, GENES NUTR, V8, P69, DOI 10.1007/s12263-012-0297-3
   Liu G. Z., 2013, PLOS ONE, V8
   Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58
   McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040
   Meale SJ, 2014, J ANIM SCI, V92, P3328, DOI [10.2527/jas.2014-7710, 10.2527/jas2014-7710]
   Miao XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18470
   Miao XY, 2015, GENE, V562, P188, DOI 10.1016/j.gene.2015.02.070
   Miao XY, 2015, MOL CELL ENDOCRINOL, V402, P32, DOI 10.1016/j.mce.2014.12.023
   Morozzi G, 2017, CELL DEATH DIFFERENT
   Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063
   Qin YT, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007027
   Runtsch MC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00347
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sharbati J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12681
   Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275
   Sun HY, 2017, CELL BIOL INT, V41, P739, DOI 10.1002/cbin.10768
   Sun ZW, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0178-y
   Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937
   Tang XiaoHui, 2012, Journal of Agricultural Biotechnology, V20, P1178
   Tao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079343
   Tsukerman P, 2012, CANCER RES, V72, P5463, DOI 10.1158/0008-5472.CAN-11-2671
   Vienberg S, 2016, ACTA PHYSL
   Wang CN, 2017, BIOL PHARM BULL, V40, P465, DOI 10.1248/bpb.b16-00898
   Wang J., 2017, SCI REP, V7
   Wang J, 2017, ASIAN AUSTRAL J ANIM, V30, P100, DOI 10.5713/ajas.16.0166
   Wang L, 2014, N-S ARCH PHARMACOL, V387, P197, DOI 10.1007/s00210-013-0929-1
   Wong LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08574-x
   Yang H, 2016, ANIM REPROD SCI, V175, P18, DOI 10.1016/j.anireprosci.2016.10.004
   Ye DM, 2011, GASTROENTEROLOGY, V141, P1323, DOI 10.1053/j.gastro.2011.07.005
   Yu J, 2011, FUNCT INTEGR GENOMIC, V11, P203, DOI 10.1007/s10142-010-0198-8
   Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089817
   Zhang S, 2013, J NANOMATER, V8, P2013, DOI DOI 10.1371/J0URNAL.P0NE.0071913
   Zhou G, 2017, BIOMED RES INT, V2017
   Zhou GW, 2016, SCI REP-UK, V6, DOI 10.1038/srep35971
NR 58
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 28
PY 2018
VL 13
IS 2
AR e0193371
DI 10.1371/journal.pone.0193371
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FX7ND
UT WOS:000426276000068
PM 29489866
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Zhao, L
   Wu, S
   Huang, EY
   Gnatenko, D
   Bahou, WF
   Zhu, W
AF Zhao, Lu
   Wu, Song
   Huang, Erya
   Gnatenko, Dimitri
   Bahou, Wadie F.
   Zhu, Wei
TI Integrated micro/messenger RNA regulatory networks in essential
   thrombocytosis
SO PLOS ONE
LA English
DT Article
ID MATRIX METALLOPROTEINASE-1; MICRORNA; EXPRESSION; INFLAMMATION;
   MECHANISMS
AB Essential thrombocytosis (ET) is a chronic myeloproliferative disorder with an unregulated surplus of platelets. Complications of ET include stroke, heart attack, and formation of blood clots. Although platelet-enhancing mutations have been identified in ET cohorts, genetic networks causally implicated in thrombotic risk remain unestablished. In this study, we aim to identify novel ET-related miRNA-mRNA regulatory networks through comparisons of transcriptomes between healthy controls and ET patients. Four network discovery algorithms have been employed, including (a) Pearson correlation network, (b) sparse supervised canonical correlation analysis (sSCCA), (c) sparse partial correlation network analysis (SPACE), and, (d) (sparse) Bayesian network analysis-all through a combined data-driven and knowledge-based analysis. The result predicts a close relationship between an 8-miRNA set (miR-9, miR-490-5p, miR-490-3p, miR-182, miR-34a, miR-196b, miR-34b*, miR-181a-2*) and a 9-mRNA set (CAV2, LAPTM4B, TIMP1, PKIG, WASF1, MMP1, ERVH-4, NME4, HSD17B12). The majority of the identified variables have been linked to hematologic functions by a number of studies. Furthermore, it is observed that the selected mRNAs are highly relevant to ET disease, and provide an initial framework for dissecting both platelet-enhancing and functional consequences of dysregulated platelet production.
C1 [Zhao, Lu; Wu, Song; Huang, Erya; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.
   [Gnatenko, Dimitri; Bahou, Wadie F.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.
RP Zhao, L (reprint author), SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.
EM luzhao1986@gmail.com
FU National Institutes of Health [HL091939, CA205172, RR03211201A1];
   NIH/NHLBI DNA Resequencing and Genotyping Service [G175]
FX Study Design is supported by HL091939 https://www.nih.gov/ National
   Institutes of Health WB. Data Collection is supported Subcontract G175
   from https://www.nhlbi.nih.gov/research/resources/genetics-genomics/rsg
   NIH/NHLBI DNA Resequencing and Genotyping Service, WB. Modeling and data
   analysis is supported by HL091939 https://www.nih.gov/ National
   Institutes of Health WZ. Modeling and data analysis is also supported by
   CA205172 https://www.nih.gov/ National Institutes of Health SW. Data
   collection is also supported by RR03211201A1 https://www.nih.gov/
   National Institutes of Health DG.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Andonovska B, 2008, VOJNOSANIT PREGL, V65, P882, DOI 10.2298/VSP0812882A
   Bahou WF, 2013, HEMATOL ONCOL CLIN N, V27, P443, DOI 10.1016/j.hoc.2013.03.002
   Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928
   Brassart B, 2001, J BIOL CHEM, V276, P5222, DOI 10.1074/jbc.M003642200
   Bruchova H, 2008, HAEMATOL-HEMATOL J, V93, P1009, DOI 10.3324/haematol.12706
   Cathcart J, 2015, GENES DIS, V2, P26, DOI 10.1016/j.gendis.2014.12.002
   Chu G, 2001, SIGNIFICANCE ANAL MI
   Edelstein LC, 2011, BLOOD, V117, P5289, DOI 10.1182/blood-2011-01-292011
   Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
   Fu WJJ, 1998, J COMPUT GRAPH STAT, V7, P397, DOI 10.2307/1390712
   Gabor B, 2009, BIOINFORMATICS, V25, P1063, DOI 10.1093/bioinformatics/btp018
   Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006
   Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108
   Girardot M, 2010, BLOOD, V116, P437, DOI 10.1182/blood-2008-06-165985
   Gnatenko DV, 2010, BLOOD, V115, P7, DOI 10.1182/blood-2009-05-224477
   Gnatenko DV, 2005, THROMB HAEMOSTASIS, V94, P412, DOI 10.1160/TH05-01-0037
   Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797
   Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   He Y, 2009, ZHONGHUA XUE YE XUE, V5
   Herouy Y, 2001, J DERMATOL SCI, V25, P198, DOI 10.1016/S0923-1811(00)00128-6
   Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955
   Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002
   Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130
   Jayaswal V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-138
   Karim SMM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2300-z
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Li XJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.270
   Li XH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-44
   Lundberg P, 2014, BLOOD, V123, P2220, DOI 10.1182/blood-2013-11-537167
   Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685
   Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x
   Olga Troyanskaya MC, 2001, BIOINFORMATICS, V17, P6
   Parkhomenko E, 2007, BMC P
   Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126
   Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509
   Schulze H, 2004, SEMIN THROMB HEMOST, V30, P389, DOI 10.1055/s-2004-833474
   Schwertz H, 2010, BLOOD, V115, P3801, DOI 10.1182/blood-2009-08-239558
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Le TD, 2013, BIOINFORMATICS, V29, P765, DOI 10.1093/bioinformatics/btt048
   William J., 2000, BLOOD, V96, P8
   Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470
   Xiang J., 2013, ADV NEURAL INFORM PR, V26, P2418
   Xu X, 2012, BLOOD, V120, P3575, DOI 10.1182/blood-2012-02-411264
   Zhang BB, 2003, WORLD J GASTROENTERO, V9, P2490
NR 47
TC 1
Z9 1
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 8
PY 2018
VL 13
IS 2
AR e0191932
DI 10.1371/journal.pone.0191932
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FV4BG
UT WOS:000424517900032
PM 29420626
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Chadly, DM
   Best, J
   Ran, C
   Bruska, M
   Wozniak, W
   Kempisty, B
   Schwartz, M
   LaFleur, B
   Kerns, BJ
   Kessler, JA
   Matsuoka, AJ
AF Chadly, Duncan M.
   Best, Jennifer
   Ran, Cong
   Bruska, Malgorzata
   Wozniak, Witold
   Kempisty, Bartosz
   Schwartz, Mark
   LaFleur, Bonnie
   Kerns, B. J.
   Kessler, John A.
   Matsuoka, Akihiro J.
TI Developmental profiling of microRNAs in the human embryonic inner ear
SO PLOS ONE
LA English
DT Article
ID PARAFFIN-EMBEDDED TISSUES; PROGRESSIVE HEARING-LOSS; CARDIO-FACIAL
   SYNDROME; B-CELL LYMPHOMA; GENE-EXPRESSION; TARGETS; DIFFERENTIATION;
   NEURONS; MIR-96; MICE
AB Due to the extreme inaccessibility of fetal human inner ear tissue, defining of the microRNAs (miRNAs) that regulate development of the inner ear has relied on animal tissue. In the present study, we performed the first miRNA sequencing of otic precursors in human specimens. Using HTG miRNA Whole Transcriptome assays, we examined miRNA expression in the cochleovestibular ganglion (CVG), neural crest (NC), and otic vesicle (OV) from paraffin embedded (FFPE) human specimens in the Carnegie developmental stages 13-15. We found that in human embryonic tissues, there are different patterns of miRNA expression in the CVG, NC and OV. In particular, members of the miR-183 family (miR-96, miR-182, and miR-183) are differentially expressed in the CVG compared to NC and OV at Carnegie developmental stage 13. We further identified transcription factors that are differentially targeted in the CVG compared to the other tissues from stages 13-15, and we performed gene set enrichment analyses to determine differentially regulated pathways that are relevant to CVG development in humans. These findings not only provide insight into the mechanisms governing the development of the human inner ear, but also identify potential signaling pathways for promoting regeneration of the spiral ganglion and other components of the inner ear.
C1 [Chadly, Duncan M.; Best, Jennifer; Ran, Cong; Matsuoka, Akihiro J.] Northwestern Univ, Dept Otolaryngol & Head & Neck Surg, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Bruska, Malgorzata; Wozniak, Witold; Kempisty, Bartosz] Poznan Univ, Dept Anat, Poznan, Poland.
   [Schwartz, Mark; LaFleur, Bonnie; Kerns, B. J.] HTG Mol Diagnost Inc, Tucson, AZ USA.
   [Kessler, John A.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Matsuoka, Akihiro J.] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL 60208 USA.
   [Matsuoka, Akihiro J.] Northwestern Univ, Hugh Knowles Ctr Hearing Res, Evanston, IL 60208 USA.
RP Matsuoka, AJ (reprint author), Northwestern Univ, Dept Otolaryngol & Head & Neck Surg, Feinberg Sch Med, Chicago, IL 60611 USA.; Matsuoka, AJ (reprint author), Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL 60208 USA.; Matsuoka, AJ (reprint author), Northwestern Univ, Hugh Knowles Ctr Hearing Res, Evanston, IL 60208 USA.
EM amatsuoka@nm.org
OI Chadly, Duncan/0000-0002-8417-1522
FU Eleanor Wood-Price Grants Initiative: The Woman's Board of Northwestern
   Memorial Hospital; Department of Otolaryngology-Head and Neck Surgery,
   Feinberg School of Medicine, Northwestern University; Woman's Board of
   Northwestern Memorial Hospital
FX This work was supported by the Eleanor Wood-Price Grants Initiative: The
   Woman's Board of Northwestern Memorial Hospital [AJM] and the Department
   of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine,
   Northwestern University [AJM]. HTG Molecular Diagnostics, Inc. provided
   support in the form of salaries for authors MS, BL, and BJK. MS had a
   role in Methodology and Investigation (performed HTG Edgeseq miRNA whole
   transcriptome assay), BL had a role in Software (wrote initial R code
   for our differential expression analysis), and BJK had a role in Project
   Administration. The specific roles of these authors are also articulated
   in the 'author contributions' section.; Authors thank William E. Ditrick
   (Emily), Marleana Cross, and Cara Crosby (the Woman's Board of
   Northwestern Memorial Hospital) for their special guidance towards our
   funding source; Drs. Miho Tanaka-Matakatsu and Adam Piortowski for their
   work at the initial phase of this study; and Drs. Maki Motobu and Junko
   Motobu for an effort to establish a communication channel with our
   collaborating team at Poznan University.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Antoine MW, 2017, J NEUROSCI, V37, P5144, DOI 10.1523/JNEUROSCI.3545-16.2017
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bowl MR, 2015, GERONTOLOGY, V61, P149, DOI 10.1159/000368399
   Camarero G, 2001, J NEUROSCI, V21, P7630
   Chu YM, 2017, J DIGEST DIS, V18, P169, DOI 10.1111/1751-2980.12463
   Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27
   Csardi G., 2006, INTERJOURNAL, V2006, P1695, DOI DOI 10.1080/01621459.1951.10500769
   Davis B, 2017, J VET INTERN MED, V31, P854, DOI 10.1111/jvim.14686
   Digilio MC, 1999, BRIT J AUDIOL, V33, P329, DOI 10.3109/03005369909090116
   Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046
   Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97
   Fishilevich S, 2017, DATABASE, V2017, P1665
   Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Garcia-Garcia F, 2016, BIOINFORMATICS, V32, P2809, DOI 10.1093/bioinformatics/btw334
   Godard P, 2015, NUCLEIC ACIDS RES, V43, P3490, DOI 10.1093/nar/gkv249
   Goodrich L V, 2016, HDB AUDITORY RES, V52
   Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7
   Henshaw SK, 2009, MANAGEMENT UNINTENDE
   Herwig R, 2016, NAT PROTOC, V11, P1889, DOI 10.1038/nprot.2016.117
   Ivashchenko AT, 2015, RECENT ADV BIOMED CH, P102
   Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014
   Kersigo J, 2011, GENESIS, V49, P326, DOI 10.1002/dvg.20714
   Koehler KR, 2014, DEV AUDITORY VESTIBU, P213
   Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027
   Lassiter RNT, 2014, DEV BIOL, V389, P39, DOI 10.1016/j.ydbio.2013.11.025
   Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29
   Leon Y, 1999, HORM METAB RES, V31, P126, DOI 10.1055/s-2007-978709
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369
   Lin D, 1998, P 15 INT C MACH LEAR
   Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445
   Mahmoudian-sani MR, 2017, EUR ARCH OTO-RHINO-L, V274, P2373, DOI 10.1007/s00405-017-4470-6
   Matsuoka AJ, 2017, STEM CELL TRANSL MED, V6, P923, DOI 10.1002/sctm.16-0032
   Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355
   Meyers EA, 2017, COLD SPRING HARB PER, P1
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   O'Rahilly R, 2010, CELLS TISSUES ORGANS, V192, P73, DOI 10.1159/000289817
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Reyes MRT, 1999, INT J PEDIATR OTORHI, V47, P227, DOI 10.1016/S0165-5876(98)00180-3
   Rimsza LM, 2008, BLOOD, V112, P3425, DOI 10.1182/blood-2008-02-137372
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849
   Rudnicki A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-484
   Rudnicki A, 2012, EMBO MOL MED, V4, P849, DOI 10.1002/emmm.201100922
   Sacheli R, 2009, GENE EXPR PATTERNS, V9, P364, DOI 10.1016/j.gep.2009.01.003
   Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010
   Schlicker A, 2008, NUCLEIC ACIDS RES, V36, pD434, DOI 10.1093/nar/gkm806
   Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302
   Shearer AE, 2014, AM J HUM GENET, V95, P445, DOI 10.1016/j.ajhg.2014.09.001
   Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854
   Soukup GA, 2009, DEV BIOL, V328, P328, DOI 10.1016/j.ydbio.2009.01.037
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800
   Swillen A, 1999, GENET COUNSEL, V10, P79
   Tai YC, 2007, TIMECOURSE STAT ANAL
   Ushakov K, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00052
   Van den Ackerveken P, 2017, CELL DEATH DIFFER, V24, P2054, DOI 10.1038/cdd.2017.127
   Van Eynde C, 2016, J SPEECH LANG HEAR R, V59, P583, DOI 10.1044/2015_JSLHR-H-15-0098
   Vitelli F, 2003, HUM MOL GENET, V12, P2041, DOI 10.1093/hmg/ddg216
   Wang E, 2014, NONSMALL CELL LUNG C
   Wang JF, 2017, AM J PATHOL, V187, P1700, DOI 10.1016/j.ajpath.2017.04.009
   Wang XR, 2012, HEARING RES, V286, P55, DOI 10.1016/j.heares.2012.02.005
   Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006
   Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591
   Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002
NR 67
TC 5
Z9 5
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 26
PY 2018
VL 13
IS 1
AR e0191452
DI 10.1371/journal.pone.0191452
PG 27
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT8TF
UT WOS:000423425400013
PM 29373586
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Yang, VK
   Tai, AK
   Huh, TP
   Meola, DM
   Juhr, CM
   Robinson, NA
   Hoffman, AM
AF Yang, Vicky K.
   Tai, Albert K.
   Huh, Terry P.
   Meola, Dawn M.
   Juhr, Christine M.
   Robinson, Nicholas A.
   Hoffman, Andrew M.
TI Dysregulation of valvular interstitial cell let-7c, miR-17, miR-20a, and
   miR-30d in naturally occurring canine myxomatous mitral valve disease
SO PLOS ONE
LA English
DT Article
ID CARDIOMYOCYTE APOPTOSIS; EXPRESSION; DOGS; MANAGEMENT; FIBROSIS
AB Canine myxomatous mitral valve disease (MMVD) resembles the early stages of myxomatous pathology seen in human non-syndromic mitral valve prolapse, a common valvular heart disease in the adult human population. Canine MMVD is seen in older subjects, suggesting age-related epigenetic dysregulation leading to derangements in valvular cell populations and matrix synthesis or degradation. We hypothesized that valvular interstitial cells (VICs) undergo disease-relevant changes in miRNA expression. In primary VIC lines from diseased and control valves, miRNA expression was profiled using RT-qPCR and next generation sequencing. VICs from diseased valves showed phenotypic changes consistent with myofibroblastic differentiation (vimentin(low+), alpha-SMA(high+)), increases in senescence markers (p21, SA-beta-gal), and decreased cell viability and proliferation potential. RT-qPCR and miRNA sequencing analyses both showed significant (p<0.05) downregulation of let-7c, miR-17, miR-20a, and miR-30d in VICs from diseased valves compared to controls. Decreased let-7c, miR-17, and miR-20a may contribute to myofibroblastic differentiation in addition to cell senescence, and decreased miR-30d may disinhibit cell apoptosis. These data support the hypothesis that epigenetic dysregulation plays an important role in age-related canine MMVD.
C1 [Yang, Vicky K.; Huh, Terry P.; Meola, Dawn M.; Juhr, Christine M.; Hoffman, Andrew M.] Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA 01536 USA.
   [Tai, Albert K.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA.
   [Robinson, Nicholas A.] Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA USA.
RP Yang, VK (reprint author), Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA 01536 USA.
EM vicky.yang@tufts.edu
OI Yang, Vicky/0000-0002-1281-4250
FU Shipley Foundation
FX This work was supported by the Shipley Foundation to AMH. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Aupperle H, 2012, J VET CARDIOL, V14, P59, DOI 10.1016/j.jvc.2012.01.005
   Aupperle H, 2009, RES VET SCI, V87, P277, DOI 10.1016/j.rvsc.2009.01.009
   Barth PJ, 2005, PATHOL RES PRACT, V201, P301, DOI 10.1016/j.prp.2005.02.001
   Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.05.007
   Borgarelli M, 2012, J VET CARDIOL, V14, P93, DOI 10.1016/j.jvc.2012.01.011
   Brennan EP, 2013, J AM SOC NEPHROL, V24, P627, DOI 10.1681/ASN.2012060550
   Chen YW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060833
   Cole WG, BIOCH J, V2984, P415
   Correia ACP, 2016, J CELL SCI, V129, P569, DOI 10.1242/jcs.176248
   Dakhlallah D, 2013, AM J RESP CRIT CARE, V187, P397, DOI 10.1164/rccm.201205-0888OC
   Du WW, 2015, J CELL SCI, V128, P293, DOI 10.1242/jcs.158360
   Frank D, 2012, J MOL CELL CARDIOL, V52, P711, DOI 10.1016/j.yjmcc.2011.12.001
   Geirsson A, 2012, CIRCULATION, V126, pS189, DOI 10.1161/CIRCULATIONAHA.111.082610
   Georgakilas AG, 2017, TRENDS MOL MED
   Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110
   Guo YQ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003850
   Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x
   Hagler MA, 2013, CARDIOVASC RES, V99, P175, DOI 10.1093/cvr/cvt083
   Han RI, 2008, AM J VET RES, V69, P763, DOI 10.2460/ajvr.69.6.763
   HARPER JW, 1993, CELL, V75, P805
   Hulanicka M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0205-8
   IBM Corp, 2013, SPSS STAT WIND
   Jiang T, 2016, MOL CELLS, V39, P345, DOI 10.14348/molcells.2016.2336
   Khee SGS, 2014, OXID MED CELL LONGEV, DOI 10.1155/2014/725929
   Lu CC, 2015, VET J, V204, P23, DOI 10.1016/j.tvjl.2015.02.021
   Melman YF, 2015, CIRCULATION, V131, P2202, DOI 10.1161/CIRCULATIONAHA.114.013220
   Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]
   Murray MJ, 2015, CANCER EPIDEM BIOMAR, V24, P350, DOI 10.1158/1055-9965.EPI-14-0669
   Oyama MA, 2006, AM J VET RES, V67, P1307, DOI 10.2460/ajvr.67.8.1307
   Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372
   Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Wang XH, 2015, INT J CARDIOL, V187, P365, DOI 10.1016/j.ijcard.2015.03.195
   Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104
   Xie H, 2016, ONCOTARGET, V7, P51473, DOI 10.18632/oncotarget.10444
   Yang VK, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1350088
NR 38
TC 1
Z9 1
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 9
PY 2018
VL 13
IS 1
AR e0188617
DI 10.1371/journal.pone.0188617
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS3CC
UT WOS:000419655900001
PM 29315310
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Freire, PP
   Cury, SS
   de Oliveira, G
   Fernandez, GJ
   Moraes, LN
   Duran, BOD
   Ferreira, JH
   Fuziwara, CS
   Kimura, ET
   Dal-Pai-Silva, M
   Carvalho, RF
AF Freire, Paula Paccielli
   Cury, Sarah Santiloni
   de Oliveira, Grasieli
   Fernandez, Geysson Javier
   Moraes, Leonardo Nazario
   da Silva Duran, Bruno Oliveira
   Ferreira, Juarez Henrique
   Fuziwara, Cesar Seigi
   Kimura, Edna Teruko
   Dal-Pai-Silva, Maeli
   Carvalho, Robson Francisco
TI Osteoglycin inhibition by microRNA miR-155 impairs myogenesis
SO PLOS ONE
LA English
DT Article
ID SKELETAL-MUSCLE; GENE-EXPRESSION; CELL-DIFFERENTIATION; MOUSE; MIMECAN;
   IDENTIFICATION; PROLIFERATION; HYPERTROPHY; MIGRATION; ATROPHY
AB Skeletal myogenesis is a regulated process in which mononucleated cells, the myoblasts, undergo proliferation and differentiation. Upon differentiation, the cells align with each other, and subsequently fuse to form terminally differentiated multinucleated myotubes. Previous reports have identified the protein osteoglycin (Ogn) as an important component of the skeletal muscle secretome, which is expressed differentially during muscle development. However, the posttranscriptional regulation of Ogn by microRNAs during myogenesis is unknown. Bioinformatic analysis showed that miR-155 potentially targeted the Ogn transcript at the 3'-untranslated region (3' UTR). In this study, we tested the hypothesis that miR-155 inhibits the expression of the Ogn to regulate skeletal myogenesis. C2C12 myoblast cells were cultured and miR-155 overexpression or Ogn knockdown was induced by transfection with miR-155 mimic, siRNA-Ogn, and negative controls with lipofectamine for 15 hours. Near confluence (80-90%), myoblasts were induced to differentiate myotubes in a differentiation medium. Luciferase assay was used to confirm the interaction between miR-155 and Ogn 3' UTR. RT-qPCR and Western blot analyses were used to confirm that the differential expression of miR-155 correlates with the differential expression of myogenic molecular markers (Myh2, MyoD, and MyoG) and inhibits Ogn protein and gene expression in myoblasts and myotubes. Myoblast migration and proliferation were assessed using Wound Healing and MTT assays. Our results show that miR-155 interacts with the 3' UTR Ogn region and decrease the levels of Ogn in myotubes. The overexpression of miR-155 increased MyoG expression, decreased myoblasts wound closure rate, and decreased Myh2 expression in myotubes. Moreover, Ogn knockdown reduced the expression levels of MyoD, MyoG, and Myh2 in myotubes. These results reveal a novel pathway in which miR-155 inhibits Ogn expression to regulate proliferation and differentiation of C2C12 myoblast cells.
C1 [Freire, Paula Paccielli; Cury, Sarah Santiloni; de Oliveira, Grasieli; Fernandez, Geysson Javier; Moraes, Leonardo Nazario; da Silva Duran, Bruno Oliveira; Ferreira, Juarez Henrique; Dal-Pai-Silva, Maeli; Carvalho, Robson Francisco] Sao Paulo State Univ, Inst Biosci, Dept Morphol, Sao Paulo, Brazil.
   [Fuziwara, Cesar Seigi; Kimura, Edna Teruko] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
RP Carvalho, RF (reprint author), Sao Paulo State Univ, Inst Biosci, Dept Morphol, Sao Paulo, Brazil.
EM rcarvalho@ibb.unesp.br
RI Fernandez, geysson javier/O-2783-2017; Fuziwara, Cesar S/G-6149-2011;
   Carvalho, Robson Francisco/E-1161-2012; Freire, Paula
   Paccielli/D-6504-2018; Kimura, Edna/D-7334-2012
OI Fernandez, geysson javier/0000-0002-7982-9940; Fuziwara, Cesar
   S/0000-0002-0567-5432; Carvalho, Robson Francisco/0000-0002-4901-7714;
   Freire, Paula Paccielli/0000-0003-0649-8279; Kimura,
   Edna/0000-0001-8403-4459; Moraes, Leonardo/0000-0003-4515-4137
FU Sao Paulo Research Foundation [2012/13961-6]; MSc. FAPESP fellowship
   [2014/13783-6]
FX This study was supported by Sao Paulo Research Foundation (grant
   #2012/13961-6 to RFC). PPF was funded by a MSc. FAPESP fellowship #
   2014/13783-6. The funder had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Agarwal P, 2013, BBA-MOL BASIS DIS, V1832, P1294, DOI 10.1016/j.bbadis.2013.03.021
   Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Antoniou A, 2014, J BIOL CHEM, V289, P3923, DOI 10.1074/jbc.M113.507343
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bentzinger CF, 2012, COLD SPRING HARB PER, V4
   Betel D, 2008, NUCLEIC ACIDS RES, P36
   Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90
   Bizzarro V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048246
   Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178
   Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008
   Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242
   Chan CYX, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004804
   Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725
   Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036
   Cui XN, 2008, ACTA BIOCH BIOPH SIN, V40, P349, DOI 10.1111/j.1745-7270.2008.00392.x
   Dimchev GA, 2013, J MUSCLE RES CELL M, V34, P125, DOI 10.1007/s10974-013-9340-2
   Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404
   Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104
   Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013
   Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089
   Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710
   Grzelkowska-Kowalczyk K, 2015, J INTERF CYTOK RES, V35, P89, DOI 10.1089/jir.2014.0018
   Hamajima S, 2003, LASER MED SCI, V18, P78, DOI 10.1007/s10103-003-0255-9
   Harfouche R, 2006, AM J PHYSIOL-HEART C, V291, pH1635, DOI 10.1152/ajpheart.01318.2005
   Hitachi K, 2014, INT J BIOCHEM CELL B, V47, P93, DOI 10.1016/j.biocel.2013.12.003
   Hu SM, 2005, J CLIN ENDOCR METAB, V90, P6657, DOI 10.1210/jc.2005-0322
   Huang C, 2013, ONCOL REP, V30, P1223, DOI 10.3892/or.2013.2576
   Jazbutyte V, 2013, AGE, V35, P747, DOI 10.1007/s11357-012-9407-9
   Liu J, 2012, J CELL MOL MED, V16, P2379, DOI 10.1111/j.1582-4934.2012.01551.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MADISEN L, 1990, DNA CELL BIOL, V9, P303, DOI 10.1089/dna.1990.9.303
   McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006
   McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007
   McCarthy JJ, 2009, PHYSIOL GENOMICS, V39, P219, DOI 10.1152/physiolgenomics.00042.2009
   Meyer SU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135284
   Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031
   Nie M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.165
   Owens DJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE1019, DOI 10.1152/ajpendo.00375.2015
   Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162
   Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1021/rna.5248604
   Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x
   Seok HY, 2011, J BIOL CHEM, V286, P35339, DOI 10.1074/jbc.M111.273276
   Shen H, 2013, MOL CELL BIOCHEM, V381, P105, DOI 10.1007/s11010-013-1692-9
   Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845
   Tanaka K, 2012, J BIOL CHEM, V287, P11616, DOI 10.1074/jbc.M111.292193
   Tasheva ES, 2002, MOL VIS, V8, P407
   Tasheva ES, 2000, CYTOGENET CELL GENET, V88, P326, DOI 10.1159/000015521
   Van Aelst LNL, 2015, CIRC RES, V116, P425, DOI 10.1161/CIRCRESAHA.116.304599
   van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563
   Wang LJ, 2012, MOL THER, V20, P1222, DOI 10.1038/mt.2012.35
NR 52
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 21
PY 2017
VL 12
IS 11
AR e0188464
DI 10.1371/journal.pone.0188464
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FN4OQ
UT WOS:000415987000061
PM 29161332
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Cilek, EE
   Ozturk, H
   Dedeoglu, BG
AF Cilek, Emine Ezel
   Ozturk, Hakime
   Dedeoglu, Bala Gur
TI Construction of miRNA-miRNA networks revealing the complexity of
   miRNA-mediated mechanisms in trastuzumab treated breast cancer cell
   lines
SO PLOS ONE
LA English
DT Article
ID MICRORNA TARGET PREDICTION; METASTASIS; BIOGENESIS; ACTIVATION;
   WEBGESTALT; RESISTANCE; PATHWAY; DISEASE; SETS
AB Trastuzumab is a monoclonal antibody frequently used to prevent the progression of HER2+ breast cancers, which constitute approximately 20% of invasive breast cancers. microRNAs (miRNAs) are small, non-coding RNA molecules that are known to be involved in gene regulation. With their emerging roles in cancer, they are recently promoted as potential candidates to mediate therapeutic actions by targeting genes associated with drug response. In this study we explored miRNA-mediated regulation of trastuzumab mechanisms by identifying the important miRNAs responsible for the drug response via homogenous network analysis. Our network model enabled us to simplify the complexity of miRNA interactions by connecting them through their common pathways. We outlined the functionally relevant miRNAs by constructing pathway-based miRNA-miRNA networks in SKBR3 and BT474 cells, respectively. Identification of the most targeted genes revealed that trastuzumab responsive miRNAs favourably regulate the repression of targets with longer 3'UTR than average considered to be key elements, while the miRNA-miRNA networks highlighted central miRNAs such as hsa-miR-3976 and hsa-miR-3671 that showed strong interactions with the remaining members of the network. Furthermore, the clusters of the miRNA-miRNA networks showed that trastuzumab response was mostly established through cancer related and metabolic pathways. hsa-miR-216b was found to be the part of the most powerful interactions of metabolic pathways, which was defined in the largest clusters in both cell lines. The network based representation of miRNA-miRNA interactions through their shared pathways provided a better understanding of miRNA-mediated drug response and could be suggested for further characterization of miRNA functions.
C1 [Cilek, Emine Ezel; Dedeoglu, Bala Gur] Ankara Univ, Biotechnol Inst, Ankara, Turkey.
   [Ozturk, Hakime] Bogazici Univ, Dept Comp Engn, Istanbul, Turkey.
RP Dedeoglu, BG (reprint author), Ankara Univ, Biotechnol Inst, Ankara, Turkey.
EM bdedeoglu@ankara.edu.tr
RI Gur Dedeoglu, Bala/O-1604-2014; Ozturk, Hakime/J-6103-2018
OI Gur Dedeoglu, Bala/0000-0002-4320-5685; Cilek, Emine
   Ezel/0000-0002-4829-4891
FU Ankara University BAP [14L0415001]; L'Oreal-UNESCO Women in Science
   Programme; TUBITAK [BIDEB 2211]
FX This study was funded by Ankara University BAP (Award no:14L0415001)
   (http://bap.ankara.edu.tr/); L'Oreal-UNESCO Women in Science Programme
   (http://www.forwomeninscience.com/en/) and it was supported by
   TUBITAK-BIDEB 2211 Scholarship Programme
   (https://www.tubitak.gov.tr/tr/burslar/).
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656
   Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134
   Cao YZ, 2015, BIOMED RES INT, DOI 10.1155/2015/724715
   Cheng C, 2009, BMC GENOMICS, V10, P6
   Christmas R., 2005, CYTOSCAPE SOFTWARE E, P12
   Chu HW, 2014, HUM MOL GENET, V23, P355, DOI 10.1093/hmg/ddt426
   Creixell P, 2015, NAT METHODS, V12, P615, DOI [10.1038/NMETH.3440, 10.1038/nmeth.3440]
   De Mattos-Arruda L, 2015, ONCOTARGET, P4
   Gligorijevic V, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0571
   Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559
   Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010
   Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422
   Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783
   Jauffret-Charafe E, 2004, GENE EXPRESSION PROF, P2273
   Jung EJ, 2012, CANCER-AM CANCER SOC, V118, P2603, DOI 10.1002/cncr.26565
   Kao J., 2009, MOL PROFILING BREAST
   Kataoka Y, 2009, ASS GAIN OF FUNCTION, P255
   Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412
   Le XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041170
   Li J., 2016, NANO RES, P1
   Lopez-Romero Pedro, 2010, BMC Res Notes, V3, P18, DOI 10.1186/1756-0500-3-18
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Ma T, 2015, ONCOL REP, V33, P1215, DOI 10.3892/or.2015.3713
   Margeli M, 2014, LONG HER STUDY CLIN
   Mari G, 2017, DRUG SCREENING GENOM
   Min H, 2010, EXP MOL MED, V42, P233, DOI 10.3858/emm.2010.42.4.032
   Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436
   Muller V, 2014, BREAST CANCER RES TR, V147, P61, DOI 10.1007/s10549-014-3079-3
   Nahta Rita, 2012, ISRN Oncol, V2012, P428062, DOI 10.5402/2012/428062
   Ozturk H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117874
   Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393
   Parrella P, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-142
   Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605
   Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768
   Saxena R, 2011, ERBB FAMILY RECEPTOR, P166
   Scaglione KM, 2013, UBIQUITIN CONJUGATIN, P18784
   Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013
   Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311
   Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100
   Tirona MT, 2010, CANCER INVEST, V28, P743, DOI 10.3109/07357907.2010.494321
   van Dongen S, 2012, METHODS MOL BIOL, V804, P281, DOI 10.1007/978-1-61779-361-5_15
   Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439
   Witkos TM, 2011, CURR MOL MED, V11, P93
   Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832
   Ye XM, 2014, BMB REP, V47, P268, DOI 10.5483/BMBRep.2014.47.5.165
   Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475
   Zhang JP, 2016, MOL BIOSYST, V12, P454, DOI 10.1039/c5mb00562k
   Zhou JD, 2013, ONCOL REP, V30, P1275, DOI 10.3892/or.2013.2592
NR 50
TC 11
Z9 11
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 5
PY 2017
VL 12
IS 10
AR e0185558
DI 10.1371/journal.pone.0185558
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FI9WM
UT WOS:000412360300044
PM 28981542
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Ong, J
   Timens, W
   Rajendran, V
   Algra, A
   Spira, A
   Lenburg, ME
   Campbell, JD
   van den Berge, M
   Postma, DS
   van den Berg, A
   Kluiver, J
   Brandsma, CA
AF Ong, Jennie
   Timens, Wim
   Rajendran, Vijay
   Algra, Arjan
   Spira, Avrum
   Lenburg, Marc E.
   Campbell, Joshua D.
   van den Berge, Maarten
   Postma, Dirkje S.
   van den Berg, Anke
   Kluiver, Joost
   Brandsma, Corry-Anke
TI Identification of transforming growth factorbeta-lregulated microRNAs
   and the microRNAtargetomes in primary lung fibroblasts
SO PLOS ONE
LA English
DT Article
ID OBSTRUCTIVE PULMONARY-DISEASE; GENE-EXPRESSION; INHIBITION; TARGETS;
   REPAIR; AIRWAY; COPD
AB Background
   Lung fibroblasts are involved in extracellular matrix homeostasis, which is mainly regulated by transforming growth factor-beta (TGF-beta), and are therefore crucial in lung tissue repair and remodeling. Abnormal repair and remodeling has been observed in lung diseases like COPD. As miRNA levels can be influenced by TGF-beta, we hypothesized that TGF-beta influences miRNA expression in lung fibroblasts, thereby affecting their function.
   Materials and methods
   We investigated TGF-beta 1-induced miRNA expression changes in 9 control primary parenchymal lung fibroblasts using miRNA arrays. TGF-beta 1-induced miRNA expression changes were validated and replicated in an independent set of lung fibroblasts composted of 10 controls and 15 COPD patients using qRT-PCR. Ago2-immunoprecipitation followed by mRNA expression profiling was used to identify the miRNA-targetomes of unstimulated and TGF-beta 1-stimulated primary lung fibroblasts (n = 2). The genes affected by TGF-beta 1-modulated miRNAs were identified by comparing the miRNA targetomes of unstimulated and TGF-beta 1stimulated fibroblasts.
   Results
   Twenty-nine miRNAs were significantly differentially expressed after TGF-beta 1 stimulation (FDR< 0.05). The TGF-beta 1-induced miR-455-3p and miR-21-3p expression changes were validated and replicated, with in addition, lower miR-455-3p levels in COPD (p< 0.05). We identified 964 and 945 genes in the miRNA-targetomes of unstimulated and TGF-beta 1-stimulated lung fibroblasts, respectively. The TGF-beta and Wnt pathways were significantly enriched among the Ago2-IP enriched and predicted targets of miR-455-3p and miR-21-3p. The miR-455-3p target genes HN1, NGF, STRADB, DLD and ANO3 and the miR-21-3p target genes HHEX, CHORDC1 and ZBTB49 were consistently more enriched after TGF-beta 1 stimulation.
   Conclusion
   Two miRNAs, miR-455-3p and miR-21-3p, were induced by TGF-beta 1 in lung fibroblasts. The significant Ago2-IP enrichment of targets of these miRNAs related to the TGF-beta and/or Wnt pathways ( NGF, DLD, HHEX) in TGF-beta 1-stimulated fibroblasts suggest a role for these miRNAs in lung diseases by affecting lung fibroblast function.
C1 [Ong, Jennie; Timens, Wim; Rajendran, Vijay; Algra, Arjan; van den Berg, Anke; Kluiver, Joost; Brandsma, Corry-Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.
   [Ong, Jennie; Timens, Wim; Rajendran, Vijay; van den Berge, Maarten; Postma, Dirkje S.; Brandsma, Corry-Anke] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands.
   [Spira, Avrum; Lenburg, Marc E.; Campbell, Joshua D.] Boston Univ, Sch Med, Dept Med, Sect Computat Biomed, Boston, MA USA.
   [van den Berge, Maarten; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands.
RP Brandsma, CA (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.; Brandsma, CA (reprint author), Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands.
EM c.a.brandsma@umcg.nl
RI Lenburg, Marc/B-8027-2008; van den Berg, Anke/H-1718-2011
OI Lenburg, Marc/0000-0002-5760-4708; van den Berg,
   Anke/0000-0002-8894-2638
FU  [3.2.12.044]
FX This work was supported by Grant number: 3.2.12.044,
   https://www.longfonds.nl/. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Baarsma HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025450
   Brandsma CA, 2015, THORAX, V70, P21, DOI 10.1136/thoraxjnl-2014-205091
   Brandsma CA, 2013, AM J PHYSIOL-LUNG C, V305, pL582, DOI 10.1152/ajplung.00152.2013
   Butz H, 2012, TRENDS PHARMACOL SCI, V33, P382, DOI 10.1016/j.tips.2012.04.003
   Cao MR, 2012, INT J ONCOL, V41, P869, DOI 10.3892/ijo.2012.1535
   Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291
   Cui HC, 2016, AM J RESP CELL MOL, V54, P843, DOI 10.1165/rcmb.2015-0205OC
   Das S, 2014, AM J RESP CELL MOL, V50, P882, DOI 10.1165/rcmb.2013-0195OC
   Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096
   Eickelberg O, 1999, AM J PHYSIOL-LUNG C, V276, pL814
   Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089
   Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173
   Fernandes Lynette B, 2007, Ther Adv Respir Dis, V1, P25, DOI 10.1177/1753465807080740
   Ferretti R, 2010, DEV CELL, V18, P486, DOI 10.1016/j.devcel.2009.12.020
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2
   Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580
   Jeon BN, 2014, NUCLEIC ACIDS RES, V42, P11447, DOI 10.1093/nar/gku857
   Kluiver Joost, 2013, Methods Mol Biol, V971, P265, DOI 10.1007/978-1-62703-269-8_15
   Kohyama T, 2002, J LAB CLIN MED, V140, P329, DOI 10.1067/mlc.2002.128347
   Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898
   Milosevic J, 2012, AM J RESP CELL MOL, V47, P879, DOI 10.1165/rcmb.2011-0377OC
   Noordhoek JA, 2003, EXP LUNG RES, V29, P291, DOI 10.1080/01902140390196636
   Noordhoek Jacobien A, 2005, COPD, V2, P17
   Osei ET, 2015, EUR RESPIR J, V46, P807, DOI 10.1183/13993003.02139-2014
   Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC
   Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15
   Renzoni EA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-24
   Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC
   Slezak-Prochazka I, 2016, ONCOTARGET, V7, P2391, DOI 10.18632/oncotarget.6165
   Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Swingler TE, 2012, ARTHRITIS RHEUM-US, V64, P1909, DOI 10.1002/art.34314
   Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135
   Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715
   Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-9290C
   Wang MY, 2016, CLIN RESPIR J, V10, P104, DOI 10.1111/crj.12194
   Wen YC, 2015, ONCOTARGET, V6, P21120, DOI 10.18632/oncotarget.4229
   Zandvoort A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-83
   Zhang WJ, 2002, J BIOL CHEM, V277, P45435, DOI 10.1074/jbc.M208056200
NR 41
TC 8
Z9 8
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 14
PY 2017
VL 12
IS 9
AR e0183815
DI 10.1371/journal.pone.0183815
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FH0VR
UT WOS:000410859200018
PM 28910321
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Li, Q
   Hegge, R
   Bridges, PJ
   Matthews, JC
AF Li, Qing
   Hegge, Raquel
   Bridges, Phillip J.
   Matthews, James C.
TI Pituitary genomic expression profiles of steers are altered by grazing
   of high vs. low endophyte-infected tall fescue forages
SO PLOS ONE
LA English
DT Article
ID VASOACTIVE INTESTINAL POLYPEPTIDE; GROWTH-HORMONE; TRANSCRIPTION FACTOR;
   PROLACTIN SECRETION; GENE-EXPRESSION; PROOPIOMELANOCORTIN GENE;
   PLASMA-CONCENTRATIONS; ORGANIC FORMS; ACTIVATION; BINDING
AB Consumption of ergot alkaloid-containing tall fescue grass impairs several metabolic, vascular, growth, and reproductive processes in cattle, collectively producing a clinical condition known as "fescue toxicosis." Despite the apparent association between pituitary function and these physiological parameters, including depressed serum prolactin; no reports describe the effect of fescue toxicosis on pituitary genomic expression profiles. To identify candidate regulatory mechanisms, we compared the global and selected targeted mRNA expression patterns of pituitaries collected from beef steers that had been randomly assigned to undergo summer-long grazing (89 to 105 d) of a high-toxic endophyte-infected tall fescue pasture (HE; 0.746 mu g/g ergot alkaloids; 5.7 ha; n = 10; BW = 267 +/- 14.5 kg) or a low-toxic endophyte tall fescue-mixed pasture (LE; 0.023 mu g/g ergot alkaloids; 5.7 ha; n = 9; BW = 266 +/- 10.9 kg). As previously reported, in the HE steers, serum prolactin and body weights decreased and a potential for hepatic gluconeogenesis from amino acid-derived carbons increased. In this manuscript, we report that the pituitaries of HE steers had 542 differentially expressed genes (P < 0.001, false discovery rate <= 4.8%), and the pattern of altered gene expression was dependent (P < 0.001) on treatment. Integrated Pathway Analysis revealed that canonical pathways central to prolactin production, secretion, or signaling were affected, in addition to those related to corticotropin-releasing hormone signaling, melanocyte development, and pigmentation signaling. Targeted RT-PCR analysis corroborated these findings, including decreased (P < 0.05) expression of DRD2, PRL, POU1F1, GAL, and VIP and that of POMC and PCSK1, respectively. Canonical pathway analysis identified HE-dependent alteration in signaling of additional pituitary-derived hormones, including growth hormone and GnRH. We conclude that consumption of endophyte-infected tall fescue alters the pituitary transcriptome profiles of steers in a manner consistent with their negatively affected physiological parameters.
C1 [Li, Qing; Hegge, Raquel; Bridges, Phillip J.; Matthews, James C.] Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40506 USA.
RP Matthews, JC (reprint author), Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40506 USA.
EM jmatthew@uky.edu
FU United States Department of Agriculture-Agricultural Research Service
   Cooperative Agreement (JCM); National Institute of Food and Agriculture,
   U.S. Department of Agriculture [KY007095]
FX This work is supported by a United States Department of
   Agriculture-Agricultural Research Service Cooperative Agreement (JCM)
   and by the National Institute of Food and Agriculture, U.S. Department
   of Agriculture, Hatch project No. KY007095 (JCM, PB). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Aiken GE, 2013, J ANIM SCI, V91, P2369, DOI 10.2527/jas.2012-5948
   ALDRICH CG, 1993, J ANIM SCI, V71, P164, DOI 10.2527/1993.711164x
   Beardwell C, 1981, PITUITARY
   Ben-Jonathan N, 2006, TRENDS ENDOCRIN MET, V17, P110, DOI 10.1016/j.tem.2006.02.005
   BJORO T, 1987, MOL CELL ENDOCRINOL, V49, P119, DOI 10.1016/0303-7207(87)90205-X
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   BREDOW S, 1994, BRAIN RES, V660, P301, DOI 10.1016/0006-8993(94)91303-X
   Bridges PJ, 2012, ENDOCRINOLOGY, V153, P1925, DOI 10.1210/en.2011-1900
   Brown KR, 2009, J ANIM SCI, V87, P748, DOI 10.2527/jas.2008-1108
   Browning R, 1997, J ANIM SCI, V75, P796
   Browning R, 1998, J ANIM SCI, V76, P1644
   DROUIN J, 1993, EMBO J, V12, P145, DOI 10.1002/j.1460-2075.1993.tb05640.x
   Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909
   Ezzat S, 2005, MOL ENDOCRINOL, V19, P1004, DOI 10.1210/me.2004-0432
   Fitzgerald Peter, 2008, J Psychopharmacol, V22, P12, DOI 10.1177/0269216307087148
   Fliss MS, 1999, MOL ENDOCRINOL, V13, P644, DOI 10.1210/me.13.4.644
   FOX SR, 1990, MOL ENDOCRINOL, V4, P1069, DOI 10.1210/mend-4-7-1069
   FRAWLEY LS, 1981, NEUROENDOCRINOLOGY, V33, P79, DOI 10.1159/000123206
   Freeman ME, 2000, PHYSIOL REV, V80, P1523
   GOURDJI D, 1979, FEBS LETT, V104, P165, DOI 10.1016/0014-5793(79)81107-2
   Holsboer F, 1999, J PSYCHIATR RES, V33, P181, DOI 10.1016/S0022-3956(98)90056-5
   HURLEY WL, 1980, J ANIM SCI, V51, P374
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Jackson Joshua J, 2015, Front Vet Sci, V2, P77, DOI 10.3389/fvets.2015.00077
   KOSHIYAMA H, 1987, NEUROSCI LETT, V75, P49, DOI 10.1016/0304-3940(87)90073-5
   LAMBERTS SWJ, 1990, PHYSIOL REV, V70, P279
   Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284
   Larson BT, 1999, J ANIM SCI, V77, P942
   Latchman DS, 1997, INT J BIOCHEM CELL B, V29, P1305, DOI 10.1016/S1357-2725(97)00085-X
   Liao SF, 2015, J ANIM SCI, V93, P5659, DOI 10.2527/jas.2015-9193
   LIPHAM LB, 1989, J ANIM SCI, V67, P1090
   Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Looper ML, 2010, J ANIM SCI, V88, P4133, DOI 10.2527/jas.2010-3192
   Luo Y, 2007, EXP NEUROL, V203, P221, DOI 10.1016/j.expneurol.2006.08.005
   MACNAMEE MC, 1986, GEN COMP ENDOCR, V62, P470, DOI 10.1016/0016-6480(86)90057-2
   MANGALAM HJ, 1989, GENE DEV, V3, P946, DOI 10.1101/gad.3.7.946
   Matthews JC, 2014, ANIM PROD SCI, V54, P1594, DOI 10.1071/AN14274
   Matthews JC, 2014, BIOL TRACE ELEM RES, V160, P321, DOI 10.1007/s12011-014-0050-4
   Millington GWM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-18
   MURDOCH GH, 1982, NATURE, V300, P192, DOI 10.1038/300192a0
   Naef L, 2007, ENDOCRINOLOGY, V148, P5977, DOI 10.1210/en.2007-0442
   NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625
   Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673
   SAMSON WK, 1980, PEPTIDES, V1, P325, DOI 10.1016/0196-9781(80)90010-8
   Schuenemann Gustavo M, 2005, Reprod Biol, V5, P137
   Siegel MR, 1994, BIOTECHNOLOGY ENDOPH
   STEINFELDER HJ, 1991, P NATL ACAD SCI USA, V88, P3130, DOI 10.1073/pnas.88.8.3130
   Strickland JR, 2011, J ANIM SCI, V89, P1603, DOI 10.2527/jas.2010-3478
   Thompson IM, 2011, J ANIM SCI, V89, P1338, DOI 10.2527/jas.2010-3559
   Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460
   WATERMAN ML, 1988, MOL ENDOCRINOL, V2, P14, DOI 10.1210/mend-2-1-14
   Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683
   Wynick D, 1998, P NATL ACAD SCI USA, V95, P12671, DOI 10.1073/pnas.95.21.12671
NR 55
TC 2
Z9 2
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 13
PY 2017
VL 12
IS 9
AR e0184612
DI 10.1371/journal.pone.0184612
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FG8GZ
UT WOS:000410669200049
PM 28902910
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Palatnik, A
   Ye, S
   Kendziorski, C
   Iden, M
   Zigman, JS
   Hessner, MJ
   Rader, JS
AF Palatnik, Anna
   Ye, Shuyun
   Kendziorski, Christina
   Iden, Marissa
   Zigman, Jessica S.
   Hessner, Martin J.
   Rader, Janet S.
TI Identification of a serum-induced transcriptional signature associated
   with metastatic cervical cancer
SO PLOS ONE
LA English
DT Article
ID IMMUNOGLOBULIN-G; CELLS; EXPRESSION; CARCINOGENESIS; DISEASE; BLOOD
AB Objective
   Tumor cells that escape local tissue control can convert inflammatory cells from tumor suppressors to tumor promoters. Moreover, soluble immune-modulating factors secreted from the tumor environment can be difficult to identify in patient serum due to their low abundance. We used an alternative strategy to infer a metastatic signature induced by sera of cervical cancer patients.
   Methods
   Sera from patients with local and metastatic cervical cancer were used to induce a disease-specific transcriptional signature in cultured, healthy peripheral blood mononuclear cells (PBMCs). An empirical Bayesian method, EBarrays, was used to identify differentially expressed (DE) genes with a target false discovery rate of <5%. Ingenuity Pathway Analysis (IPA) software was used to detect the top molecular and cellular functions associated with the DE genes. IPA and in silco analysis was used to pinpoint candidate upstream regulators, including cancer-related microRNAs (miRNAs).
   Results
   We identified enriched pathways in the metastatic cervical group related to immune surveillance functions, such as downregulation of engulfment, accumulation, and phagocytosis of hematopoietic cells. The predicted top upstream genes were IL-10 and immunoglobulins. In silco analysis identified miRNAs predicted to drive the transcriptional signature. Two of the 4 miRNAs (miR-23a-3p and miR-944) were validated in a cohort of women with local and metastatic cervical cancer.
   Conclusions
   This study supports the use of a cell-based assay that uses PBMC "reporters" to predict biologically relevant factors in patient serum. Further, disease-specific transcriptional signatures induced by patient sera have the potential to differentiate patients with local versus metastatic disease.
C1 [Palatnik, Anna; Iden, Marissa; Zigman, Jessica S.; Rader, Janet S.] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA.
   [Ye, Shuyun; Kendziorski, Christina] UW Madison, Dept Biostat & Med Informat, Madison, WI USA.
   [Hessner, Martin J.] Med Coll Wisconsin, Childrens Hosp Wisconsin, Max McGee Natl Res Ctr Juvenile Diabet, Dept Pediat,Childrens Res Inst, Milwaukee, WI 53226 USA.
RP Palatnik, A (reprint author), Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA.
EM apalatnik@mcw.edu
OI palatnik, anna/0000-0001-6568-0201
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171
   Cabrera SM, 2016, DIABETOLOGIA, V59, P414, DOI 10.1007/s00125-015-3843-x
   Chen D, 2014, HUM MOL GENET, V23, P6047, DOI 10.1093/hmg/ddu304
   Chopra V, 1998, CANCER INVEST, V16, P152, DOI 10.3109/07357909809050029
   Daniel D, 2003, J EXP MED, V197, P1017, DOI 10.1084/jem.20021047
   Gening TP, 2014, B EXP BIOL MED+, V157, P776, DOI 10.1007/s10517-014-2665-z
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Grasedieck S, 2012, LEUKEMIA, V26, P2414, DOI 10.1038/leu.2012.106
   Grigsby PW, 2004, J CLIN ONCOL, V22, P2167, DOI 10.1200/JCO.2004.09.035
   Gurram B, 2016, CLIN EXP IMMUNOL, V184, P36, DOI 10.1111/cei.12753
   Honegger A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004712
   Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618
   Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548
   Kobayashi A, 2008, MUCOSAL IMMUNOL, V1, P412, DOI 10.1038/mi.2008.33
   Lan HY, 2015, BIOMED RES INT, DOI 10.1155/2015/125094
   Levy H, 2012, GENES IMMUN, V13, P593, DOI 10.1038/gene.2012.41
   Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248
   Liao QY, 2015, ONCOTARGET, V6, P40081, DOI 10.18632/oncotarget.5542
   Mohme M, 2016, NAT REV CLIN ONCOL
   Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104
   Ortiz-Quintero B, 2016, CELL PROLIFERAT, V49, P281, DOI 10.1111/cpr.12262
   R Development Core Team, 2013, R LANG ENV STAT COMP
   Tanikawa T, 2012, CANCER RES, V72, P420, DOI 10.1158/0008-5472.CAN-10-4627
   Viswanathan V, 2014, J MOL MED, V92, P1129, DOI 10.1007/s00109-014-1208-4
   Wang JP, 2014, ONCOTARGET, V5, P9727, DOI 10.18632/oncotarget.2359
   Wang Y, 2016, CANCER DISCOV, V6, P1022, DOI 10.1158/2159-8290.CD-15-1412
   Xie H, 2015, INT J CANCER, V136, pE230, DOI 10.1002/ijc.29160
   Zhang QW, 2005, J CLIN INVEST, V115, P2855, DOI 10.1172/JCI25429
NR 31
TC 6
Z9 6
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 30
PY 2017
VL 12
IS 8
AR e0181242
DI 10.1371/journal.pone.0181242
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FF1XX
UT WOS:000408693600005
PM 28854209
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Lee, S
   Jiang, X
AF Lee, Sanghoon
   Jiang, Xia
TI Modeling miRNA-mRNA interactions that cause phenotypic abnormality in
   breast cancer patients
SO PLOS ONE
LA English
DT Article
ID REGULATORY MODULES; MESENCHYMAL TRANSITION; TRANSLATION INITIATION;
   MICRORNA-21 TARGETS; PROTEIN-SYNTHESIS; EXPRESSION; MIR-21; INVASION;
   DEREGULATION; METASTASIS
AB Background
   The dysregulation of microRNAs (miRNAs) alters expression level of pro-oncogenic or tumor suppressive mRNAs in breast cancer, and in the long run, causes multiple biological abnormalities. Identification of such interactions of miRNA-mRNA requires integrative analysis of miRNA-mRNA expression profile data. However, current approaches have limitations to consider the regulatory relationship between miRNAs and mRNAs and to implicate the relationship with phenotypic abnormality and cancer pathogenesis.
   Methodology/Findings
   We modeled causal relationships between genomic expression and clinical data using a Bayesian Network (BN), with the goal of discovering miRNA-mRNA interactions that are associated with cancer pathogenesis. The Multiple Beam Search (MBS) algorithm learned interactions from data and discovered that hsa-miR-21, hsa-miR-10b, hsa-miR-448, and hsa-miR-96 interact with oncogenes, such as, CCND2, ESR1, MET, NOTCH1, TGFBR2 and TGFB1 that promote tumor metastasis, invasion, and cell proliferation. We also calculated Bayesian network posterior probability (BNPP) for the models discovered by the MBS algorithm to validate true models with high likelihood.
   Conclusion/Significance
   The MBS algorithm successfully learned miRNA and mRNA expression profile data using a BN, and identified miRNA-mRNA interactions that probabilistically affect breast cancer pathogenesis. The MBS algorithm is a potentially useful tool for identifying interacting gene pairs implicated by the deregulation of expression.
C1 [Lee, Sanghoon; Jiang, Xia] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA.
RP Jiang, X (reprint author), Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA.
EM xij6@pitt.edu
FU National Library of Medicine of the National Institutes of Health
   [R01LM011663]; CURE - Pennsylvania Department of Health [PA DOH
   4100070287]
FX Research reported in this paper was supported by grant R01LM011663
   awarded by the National Library of Medicine of the National Institutes
   of Health, and by a CURE grant awarded by the Pennsylvania Department of
   Health (PA DOH 4100070287). The content is solely the responsibility of
   the authors and does not necessarily represent the official views of the
   National Institutes of Health.; Research reported in this paper was
   supported by grant R01LM011663 awarded by the National Library of
   Medicine of the National Institutes of Health, and by a CURE grant
   awarded by the Pennsylvania Department of Health (PA DOH 4100070287).
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health. The National Institutes of Health had no role in study design,
   analysis, decision to publish, or preparation of the manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144
   Andorfer CA, 2011, TRENDS MOL MED, V17, P313, DOI 10.1016/j.molmed.2011.01.006
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783
   Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995
   Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997
   Cantini L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9878
   Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242
   Cloonan N, 2015, BIOESSAYS, V37, P379, DOI 10.1002/bies.201400191
   COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110
   Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005
   Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509
   Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103
   Fishelson M, 2004, J COMPUT BIOL, V11, P263, DOI 10.1089/1066527041410409
   Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200
   Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961
   Fu JH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-68
   Gevaert O, 2006, BIOINFORMATICS, V22, pE184, DOI 10.1093/bioinformatics/btl230
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427
   Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238
   Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002
   Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130
   Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102
   Huret J-L, 2006, ATLAS GENETICS CYTOG
   Ikeda K, 2006, J IMMUNOL METHODS, V317, P38, DOI 10.1016/j.jim.2006.09.010
   Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783
   Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714
   Jiang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143247
   Jiang X, 2015, GENET EPIDEMIOL, V39, P173, DOI 10.1002/gepi.21889
   Jiang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022075
   Jiang Xia, 2010, AMIA Annu Symp Proc, V2010, P341
   Karim SMM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2300-z
   Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181
   Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692
   Li QQ, 2011, CELL DEATH DIFFER, V18, P16, DOI 10.1038/cdd.2010.103
   Li Y, 2013, NUCLEIC ACIDS RES
   Liang Y-J, 2012, CARCINOGENESIS
   Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797
   Liu B., 2009, BMC BIOINFORMATICS, V10, P1
   Liu B, 2010, BIOINFORMATICS, V26, P3105, DOI 10.1093/bioinformatics/btq576
   Liu B, 2009, J BIOMED INFORM, V42, P685, DOI 10.1016/j.jbi.2009.01.005
   Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003
   Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105
   Luqmani YA, 2015, MICRORNA BREAST CANC
   Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174
   Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718
   Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067
   Meyer P. E, 2008, THESIS
   Neapolitan RE, 2004, LEARNING BAYESIAN NE
   Neapolitan R, 2014, CANCER INFORM, V13, P77, DOI 10.4137/CIN.S13578
   Nease RF, 1997, MED DECIS MAKING, V17, P263, DOI 10.1177/0272989X9701700302
   Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011
   O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484
   Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523
   Schwarzenbacher D, 2013, INT J MOL SCI, V14, P14712, DOI 10.3390/ijms140714712
   Segal E, 2005, J MACH LEARN RES, V6, P557
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083
   Spizzo R, 2009, EXPT THERAPEUTICS CA
   Stingo FC, 2010, ANN APPL STAT, V4, P2024, DOI 10.1214/10-AOAS360
   Tchatchou S, 2009, CARCINOGENESIS, V30, P59, DOI 10.1093/carcin/bgn253
   Team RC, 2013, R LANG ENV STAT COMP
   van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y
   van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a
   Vetter G, 2010, ONCOGENE, V29, P4436, DOI 10.1038/onc.2010.181
   Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103
   Walter BA, 2011, J CANCER, V2, P67, DOI 10.7150/jca.2.67
   WANG K, 2010, NUCLEIC ACIDS RES, V38, DOI DOI 10.1093/NAR/GKQ622
   WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
   Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103
   Wu ZS, 2011, CANCER-AM CANCER SOC, V117, P2842, DOI 10.1002/cncr.25860
   Xie B, 2013, BIOINFORMATICS
   Xiong Y, 2014, LIFE SCI, V106, P19, DOI 10.1016/j.lfs.2014.04.017
   Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808
   Yoon SR, 2005, BIOINFORMATICS, V21, P93, DOI 10.1093/bioinformatics/bti1116
   Yu ZR, 2010, AM J PATHOL, V176, P1058, DOI 10.2353/ajpath.2010.090664
   Yuan XL, 2015, J CHEM-NY, DOI 10.1155/2015/853105
   Zenz T, 2009, BLOOD, V113, P3801, DOI 10.1182/blood-2008-08-172254
   Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028
   Zhang ZJ, 2012, ONCOL REP, V27, P903, DOI 10.3892/or.2011.1611
   Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24
   Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200
   Zou Q, 2014, COMPUT BIOL MED, V45, P157, DOI 10.1016/j.compbiomed.2013.12.007
NR 85
TC 6
Z9 7
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 9
PY 2017
VL 12
IS 8
AR e0182666
DI 10.1371/journal.pone.0182666
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC9YJ
UT WOS:000407196700057
PM 28793339
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Wu, WS
   Tu, BW
   Chen, TT
   Hou, SW
   Tseng, JT
AF Wu, Wei-Sheng
   Tu, Bor-Wen
   Chen, Tsung-Te
   Hou, Shang-Wei
   Tseng, Joseph T.
TI CSmiRTar: Condition-Specific microRNA targets database
SO PLOS ONE
LA English
DT Article
ID IN-VIVO; EXPRESSION; RESOURCE; MIRNA; CANCER; GENE; RNAS; GENOMICS;
   SIRNAS; ATLAS
AB MicroRNAs (miRNAs) are functional RNA molecules which play important roles in the post transcriptional regulation. miRNAs regulate their target genes by repressing translation or inducing degradation of the target genes' mRNAs. Many databases have been constructed to provide computationally predicted miRNA targets. However, they cannot provide the miRNA targets expressed in a specific tissue and related to a specific disease at the same time. Moreover, they cannot provide the common targets of multiple miRNAs and the common miRNAs of multiple genes at the same time. To solve these two problems, we construct a database called CSmiRTar (Condition-Specific miRNA Targets). CSmiRTar collects computationally predicted targets of 2588 human miRNAs and 1945 mouse miRNAs from four most widely used miRNA target prediction databases (miRDB, TargetScan, microRNA. org and DIANA-microT) and implements functional filters which allows users to search (i) a miRNA's targets expressed in a specific tissue or/and related to a specific disease, (ii) multiple miRNAs' common targets expressed in a specific tissue or/and related to a specific disease, (iii) a gene's miRNAs related to a specific disease, and (iv) multiple genes' common miRNAs related to a specific disease. We believe that CSmiRTar will be a useful database for biologists to study the molecular mechanisms of post-transcriptional regulation in human or mouse.
C1 [Wu, Wei-Sheng; Tu, Bor-Wen; Chen, Tsung-Te; Hou, Shang-Wei] Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan.
   [Tseng, Joseph T.] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan.
RP Wu, WS (reprint author), Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan.; Tseng, JT (reprint author), Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan.
EM wessonwu@gmail.com; tctseng@mail.ncku.edu.tw
RI Wu, Wei-Sheng/P-5367-2019; Tseng, Joseph Ta-Chien/I-2850-2018
OI Tseng, Joseph Ta-Chien/0000-0002-3304-6086
FU National Cheng Kung University and Ministry of Science and Technology of
   Taiwan [MOST-105-2221-E-006-203-MY2]
FX This work was supported by National Cheng Kung University and Ministry
   of Science and Technology of Taiwan [MOST-105-2221-E-006-203-MY2].
   Funding for open access charge: National Cheng Kung University and
   Ministry of Science and Technology of Taiwan. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995
   Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406
   Cho S, 2013, NUCLEIC ACIDS RES, V41, pD252, DOI 10.1093/nar/gks1168
   Deu-Pons J, 2015, DATABASE
   Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485
   Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079
   Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006
   Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266
   Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936
   Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032
   Kim SY, 2012, BIOCHEM BIOPH RES CO, V429, P173, DOI 10.1016/j.bbrc.2012.10.117
   Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248
   Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390
   Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393
   Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270
   Preusse M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151771
   Qi XL, 2015, J MED GENET, V52, P710, DOI 10.1136/jmedgenet-2015-103334
   Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6
   Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423
   Shirdel EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017429
   Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030
   Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347
   Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029
   Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215
   Wada R, 2010, INT J CANCER, V127, P1106, DOI 10.1002/ijc.25126
   Wang DF, 2014, BIOINFORMATICS, V30, P2237, DOI 10.1093/bioinformatics/btu155
   Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104
   Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851
   Zhang XN, 2010, CANCER RES, V70, P7176, DOI 10.1158/0008-5472.CAN-10-0697
NR 35
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 13
PY 2017
VL 12
IS 7
AR e0181231
DI 10.1371/journal.pone.0181231
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA7TL
UT WOS:000405649700111
PM 28704505
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Ebeid, M
   Sripal, P
   Pecka, J
   Beisel, KW
   Kwan, K
   Soukup, GA
AF Ebeid, Michael
   Sripal, Prashanth
   Pecka, Jason
   Beisel, Kirk W.
   Kwan, Kelvin
   Soukup, Garrett A.
TI Transcriptome-wide comparison of the impact of Atoh1 and miR-183 family
   on pluripotent stem cells and multipotent otic progenitor cells
SO PLOS ONE
LA English
DT Article
ID MOUSE INNER-EAR; NOTCH SIGNALING PATHWAY; HAIR-CELLS; MAMMALIAN COCHLEA;
   GENE-EXPRESSION; IN-VIVO; DIRECT TARGETS; MATH1; DIFFERENTIATION;
   IDENTIFICATION
AB Over 5% of the global population suffers from disabling hearing loss caused by multiple factors including aging, noise exposure, genetic predisposition, or use of ototoxic drugs. Sensorineural hearing loss is often caused by the loss of sensory hair cells (HCs) of the inner ear. A barrier to hearing restoration after HC loss is the limited ability of mammalian auditory HCs to spontaneously regenerate. Understanding the molecular mechanisms orchestrating HC development is expected to facilitate cell replacement therapies. Multiple events are known to be essential for proper HC development including the expression of Atoh1 transcription factor and the miR-183 family. We have developed a series of vectors expressing the miR-183 family and/or Atoh1 that was used to transfect two different developmental cell models: pluripotent mouse embryonic stem cells (mESCs) and immortalized multipotent otic progenitor (iMOP) cells representing an advanced developmental stage. Transcriptome profiling of transfected cells show that the impact of Atoh1 is contextually dependent with more HC-specific effects on iMOP cells. miR-183 family expression in combination with Atoh1 not only appears to fine tune gene expression in favor of HC fate, but is also required for the expression of some HC-specific genes. Overall, the work provides novel insight into the combined role of Atoh1 and the miR-183 family during HC development that may ultimately inform strategies to promote HC regeneration or maintenance.
C1 [Ebeid, Michael; Sripal, Prashanth; Pecka, Jason; Beisel, Kirk W.; Soukup, Garrett A.] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA.
   [Kwan, Kelvin] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Dept Cell Biol & Neurosci, Piscataway, NJ USA.
RP Soukup, GA (reprint author), Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA.
EM garrettsoukup@creighton.edu
OI Kwan, Kelvin/0000-0002-8617-5543
FU Bellucci DePaoli Family Foundation; Nebraska Stem Cell Research Act
   [LB606]; Nebraska Health Care Funding Act [LB692]; National Institute of
   General Medical Sciences [P20GM103471]; National Institute on Deafness
   and Other Communication Disorders [R01DC009025]
FX Support for this work was provided by the Bellucci DePaoli Family
   Foundation (GAS), Nebraska Stem Cell Research Act LB606 (GAS and KWB),
   Nebraska Health Care Funding Act LB692 (GAS and KWB), National Institute
   of General Medical Sciences P20GM103471 (GAS), and National Institute on
   Deafness and Other Communication Disorders R01DC009025 (GAS). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   BenArie N, 1997, NATURE, V390, P169
   Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837
   Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1
   Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015
   Chellappa R, 2008, MOL CELL BIOL, V28, P1905, DOI 10.1128/MCB.01454-07
   Costa A, 2015, DEVELOPMENT, V142, P1948, DOI 10.1242/dev.119149
   Edge ASB, 2008, CURR OPIN NEUROBIOL, V18, P377, DOI 10.1016/j.conb.2008.10.001
   Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021
   Felfly H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02277
   Funke B, 2001, HUM MOL GENET, V10, P2549, DOI 10.1093/hmg/10.22.2549
   Furthauer M, 2001, DEVELOPMENT, V128, P2175
   Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621
   Gazit R, 2004, DEVELOPMENT, V131, P903, DOI 10.1242/dev.00982
   Gu CH, 2013, TOXICOL IN VITRO, V27, P486, DOI 10.1016/j.tiv.2012.07.008
   Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265
   Hartman BH, 2007, DEV DYNAM, V236, P2875, DOI 10.1002/dvdy.21307
   Hertzano R, 2004, HUM MOL GENET, V13, P2143, DOI 10.1093/hmg/ddh218
   Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838
   Hua H, 2006, J BIOL CHEM, V281, P13574, DOI 10.1074/jbc.M600526200
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Jones JM, 2006, J NEUROSCI, V26, P550, DOI 10.1523/JNEUROSCI.3859-05.2006
   KELLY MC, 2012, THE JOURNAL OF NEURO, V32, P6699, DOI DOI 10.1523/JNEUROSCI.5420-11.2012
   Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002
   Kim TH, 2014, NATURE, V506, P511, DOI 10.1038/nature12903
   Klisch TJ, 2011, P NATL ACAD SCI USA, V108, P3288, DOI 10.1073/pnas.1100230108
   Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200
   Kraaijenga VJC, 2016, CLIN OTOLARYNGOL, V41, P585, DOI 10.1111/coa.12571
   Kruger M, 2006, EUR J NEUROSCI, V24, P1581, DOI 10.1111/j.1460-9568.2006.05051.x
   Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108
   Kwan KY, 2015, STEM CELL REP, V4, P47, DOI 10.1016/j.stemcr.2014.11.001
   Lai HC, 2011, J NEUROSCI, V31, P10859, DOI 10.1523/JNEUROSCI.0445-11.2011
   Lanford PJ, 1999, NAT GENET, V21, P289
   Li HQ, 2010, J NEUROSCI, V30, P3254, DOI 10.1523/JNEUROSCI.4948-09.2010
   Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200
   Masuda M, 2011, NEUROSCIENCE, V197, P48, DOI 10.1016/j.neuroscience.2011.09.033
   Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355
   Morrison A, 1999, MECH DEVELOP, V84, P169, DOI 10.1016/S0925-4773(99)00066-0
   Mulvaney J, 2012, JARO-J ASSOC RES OTO, V13, P281, DOI 10.1007/s10162-012-0317-4
   Nakatani T, 2007, DEVELOPMENT, V134, P2783, DOI 10.1242/dev.02870
   Pierce ML, 2008, EVOL DEV, V10, P106, DOI 10.1111/j.1525-142X.2007.00217.x
   Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015
   Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905
   Vitelli F, 2003, HUM MOL GENET, V12, P2041, DOI 10.1093/hmg/ddg216
   Wang XR, 2012, HEARING RES, V286, P55, DOI 10.1016/j.heares.2012.02.005
   Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006
   Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591
   WHO, DEAFN HEAR LOSS
   Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349
   Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718
   Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005
   Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090
   Zheng JL, 2000, NAT NEUROSCI, V3, P580
NR 55
TC 2
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 7
PY 2017
VL 12
IS 7
AR E0180855
DI 10.1371/journal.pone.0180855
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA5DZ
UT WOS:000405464100115
PM 28686713
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Song, J
   Hu, YJ
   Li, JQ
   Zheng, HW
   Wang, JJ
   Guo, L
   Ning, RT
   Li, HZ
   Yang, ZN
   Fan, HT
   Liu, LD
AF Song, Jie
   Hu, Yajie
   Li, Jiaqi
   Zheng, Huiwen
   Wang, Jingjing
   Guo, Lei
   Ning, Ruotong
   Li, Hongzhe
   Yang, Zening
   Fan, Haitao
   Liu, Longding
TI Different microRNA profiles reveal the diverse outcomes induced by EV71
   and CA16 infection in human umbilical vein endothelial cells using
   high-throughput sequencing
SO PLOS ONE
LA English
DT Article
ID INACTIVATED ENTEROVIRUS 71; EPIDEMIOLOGY; VACCINE; EXPRESSION; IMMUNITY;
   THERAPEUTICS; BIOGENESIS; MIR-1246; DISEASES
AB Enterovirus 71 (EV71) and Coxsackievirus A16 (CA16) remain the predominant pathogens in hand, foot, and mouth disease (HFMD), but the factors underlying the pathogenesis of EV71 and CA16 infections have not been elucidated. Recently, the functions of microRNAs (miRNAs) in pathogen-host interactions have been highlighted. In the present study, we performed comprehensive miRNA profiling in EV71- and CA16-infected human umbilical vein endothelial cells (HUVECs) at multiple time points using high-throughput sequencing. The results showed that 135 known miRNAs exhibited remarkable differences in expression. Of these, 30 differentially expressed miRNAs presented opposite trends in EV71- and CA16-infected samples. Subsequently, we mainly focused on the 30 key differentially expressed miRNAs through further screening to predict targets. Gene ontology (GO) and pathway analysis of the predicted targets showed the enrichment of 14 biological processes, 9 molecular functions, 8 cellular components, and 85 pathways. The regulatory networks of these miRNAs with predicted targets, GOs, pathways, and co-expression genes were determined, suggesting that miRNAs display intricate regulatory mechanisms during the infection phase. Consequently, we specifically analyzed the hierarchical GO categories of the predicted targets involved in biological adhesion. The results indicated that the distinct changes induced by EV71 and CA16 infection may be partly linked to the function of the blood-brain barrier. Taken together, this is the first report describing miRNA expression profiles in HUVECs with EV71 and CA16 infections using high-throughput sequencing. Our data provide useful insights that may help to elucidate the different host-pathogen interactions following EV71 and CA16 infection and offer novel therapeutic targets for these infections.
C1 [Liu, Longding] Chinese Acad Med Sci, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China.
   Peking Union Med Coll, Kunming, Peoples R China.
RP Liu, LD (reprint author), Chinese Acad Med Sci, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China.
EM longdingl@gmail.com
FU CAMS Innovation Fund for Medical Sciences [2016-I2M-1-014,
   2016-I2M-1-019]; National Natural Sciences Foundations of China
   [81373142]
FX This work was supported CAMS Innovation Fund for Medical Sciences
   (2016-12M1-014 and 2016-12M-1-019) (http://www.ac. cn/) and National
   Natural Sciences Foundations of China (81373142)
   (http://www.nsfc.gov.cn/). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.; This work was supported CAMS Innovation Fund for Medical
   Sciences (2016-I2M-1-014 and 2016-I2M-1-019) and National Natural
   Sciences Foundations of China (81373142). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Auvinen E, 2017, MOL DIAGN THER, V21, P45, DOI 10.1007/s40291-016-0236-x
   Bakre A, 2012, J GEN VIROL, V93, P2346, DOI 10.1099/vir.0.044255-0
   Blanchette M, 2015, MECH DEVELOP, V138, P8, DOI 10.1016/j.mod.2015.07.007
   Brown BA, 1999, J VIROL, V73, P9969
   Cai YC, 2014, VACCINE, V32, P2406, DOI 10.1016/j.vaccine.2014.03.012
   Chai S, 2016, HEPATOLOGY, V64, P2062, DOI 10.1002/hep.28821
   Chang CY, 2015, GLIA
   Chen G, 2011, SCI CHINA LIFE SCI, V54, P1121, DOI 10.1007/s11427-011-4255-x
   Chen Xiaojing, 2016, Zhejiang Da Xue Xue Bao Yi Xue Ban, V45, P342
   Cui LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027071
   Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838
   Hu YJ, 2017, VIRUS RES, V228, P90, DOI 10.1016/j.virusres.2016.11.024
   Hui YJ, 2016, INT J BIOCHEM CELL B, V81, P20, DOI 10.1016/j.biocel.2016.10.011
   Koh WM, 2016, PEDIATR INFECT DIS J, V35, pE285, DOI 10.1097/INF.0000000000001242
   Lee JJ, 2011, J PROTEOMICS, V74, P2018, DOI 10.1016/j.jprot.2011.05.022
   Li JX, 2014, EXPERT REV VACCINES, V13, P609, DOI 10.1586/14760584.2014.897617
   Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224
   Louten J, 2015, BIOMARK INSIGHTS, V10, P25, DOI 10.4137/BMI.S29512
   Lugo D, 2016, CURR OPIN PEDIATR, V28, P107, DOI 10.1097/MOP.0000000000000303
   Lui YLE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102997
   Mao QY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.73
   Mao QY, 2014, HUM VACC IMMUNOTHER, V10, P360, DOI 10.4161/hv.27087
   Meliopoulos VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037169
   Monastyrskaya K, 2013, AM J PATHOL, V182, P431, DOI 10.1016/j.ajpath.2012.10.020
   Ng QY, 2015, VIRUSES-BASEL, V7, P6441, DOI 10.3390/v7122949
   O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708
   Ong KC, 2015, BRAIN PATHOL, V25, P614, DOI 10.1111/bpa.12279
   Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619
   Pathinayake PS, 2015, VIRUSES-BASEL, V7, P6613, DOI 10.3390/v7122961
   Piva R, 2013, INT J ONCOL, V43, P985, DOI 10.3892/ijo.2013.2059
   Pons-Salort M, 2015, CURR OPIN INFECT DIS, V28, P479, DOI 10.1097/QCO.0000000000000187
   Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71
   Roe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102598
   Sakha S, 2016, SCI REP-UK, V6, DOI 10.1038/srep38750
   Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8
   Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005
   Tahamtan A, 2016, REV MED VIROL, V26, P389, DOI 10.1002/rmv.1894
   Trobaugh DW, 2017, TRENDS MOL MED, V23, P80, DOI 10.1016/j.molmed.2016.11.003
   Velandia-Romero ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157786
   Wang CY, 2015, J GEN VIROL, V96, P3010, DOI 10.1099/jgv.0.000235
   Wang JJ, 2017, VIROLOGY, V500, P198, DOI 10.1016/j.virol.2016.10.031
   Wang RYL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24149
   Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228
   Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104
   Xu F, 2014, CLIN TRANSL ONCOL, V16, P980, DOI 10.1007/s12094-014-1183-9
   Xu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095272
   Xun M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0288-2
   Yuan DX, 2016, ONCOTARGET, V7, P32707, DOI 10.18632/oncotarget.9017
   Zhang WC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11702
   Zhu Z, 2016, BIOMED RES INT, V2016
NR 51
TC 7
Z9 8
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 22
PY 2017
VL 12
IS 5
AR e0177657
DI 10.1371/journal.pone.0177657
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV8UA
UT WOS:000402058400021
PM 28531227
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Sadeghi, M
   Ranjbar, B
   Ganjalikhany, MR
   Khan, FM
   Schmitz, U
   Wolkenhauer, O
   Gupta, SK
AF Sadeghi, Mehdi
   Ranjbar, Bijan
   Ganjalikhany, Mohamad Reza
   Khan, Faiz M.
   Schmitz, Ulf
   Wolkenhauer, Olaf
   Gupta, Shailendra K.
TI MicroRNA and Transcription Factor Gene Regulatory Network Analysis
   Reveals Key Regulatory Elements Associated with Prostate Cancer
   Progression
SO PLOS ONE
LA English
DT Article
ID PROGESTERONE-RECEPTOR EXPRESSION; TUMOR-SUPPRESSOR; BIOLOGICAL NETWORKS;
   BREAST-CANCER; TARGET GENES; CELLS; STAT3; AP-1; OVEREXPRESSION;
   CARCINOGENESIS
AB Technological and methodological advances in multi-omics data generation and integration approaches help elucidate genetic features of complex biological traits and diseases such as prostate cancer. Due to its heterogeneity, the identification of key functional components involved in the regulation and progression of prostate cancer is a methodological challenge. In this study, we identified key regulatory interactions responsible for primary to metastasis transitions in prostate cancer using network inference approaches by integrating patient derived transcriptomic and miRomics data into gene/miRNA/transcription factor regulatory networks. One such network was derived for each of the clinical states of prostate cancer based on differentially expressed and significantly correlated gene, miRNA and TF pairs from the patient data. We identified key elements of each network using a network analysis approach and validated our results using patient survival analysis. We observed that HOXD10, BCL2 and PGR are the most important factors affected in primary prostate samples, whereas, in the metastatic state, STAT3, JUN and JUNB are playing a central role. Benefiting integrative networks our analysis suggests that some of these molecules were targeted by several overexpressed miRNAs which may have a major effect on the dysregulation of these molecules. For example, in the metastatic tumors five miRNAs (miR-671-5p, miR-665, miR-663, miR-512-3p and miR-371-5p) are mainly responsible for the dysregulation of STAT3 and hence can provide an opportunity for early detection of metastasis and development of alternative therapeutic approaches. Our findings deliver new details on key functional components in prostate cancer progression and provide opportunities for the development of alternative therapeutic approaches.
C1 [Sadeghi, Mehdi; Ranjbar, Bijan] Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Tehran, Iran.
   [Ganjalikhany, Mohamad Reza] Univ Isfahan, Dept Biol, Fac Sci, Esfahan, Iran.
   [Khan, Faiz M.; Wolkenhauer, Olaf; Gupta, Shailendra K.] Univ Rostock, Dept Syst Biol & Bioinformat, Rostock, Germany.
   [Schmitz, Ulf] Univ Sydney, Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW, Australia.
   [Schmitz, Ulf] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia.
   [Wolkenhauer, Olaf] Univ Stellenbosch, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS, Stellenbosch, South Africa.
   [Gupta, Shailendra K.] CSIR, Indian Inst Toxicol Res, Dept Bioinformat, Lucknow, Uttar Pradesh, India.
RP Ranjbar, B (reprint author), Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Tehran, Iran.
EM ranjbarb@modares.ac.ir
RI sadeghi, mehdi/M-8507-2017
OI sadeghi, mehdi/0000-0001-6704-4591; Ganjalikhany, Mohamad
   Reza/0000-0002-6865-0814; Schmitz, Ulf/0000-0001-5806-4662; Gupta,
   Shailendra/0000-0002-3470-3260
FU German Federal Ministry of Education and Research (BMBF) [eBio: SysMet
   [0316171], eBio:MelEVIR [031L0073A]]; Council of Scientific and
   Industrial Research (CSIR) [BSC0121, BSC0111]
FX We acknowledge Vice Chancellor for Research and Technology of the
   Tarbiat Modares University. OW, FMK and SKG acknowledge the German
   Federal Ministry of Education and Research (BMBF) as part of the
   projects eBio: SysMet [0316171] and eBio:MelEVIR [031L0073A]. SKG
   acknowledges the Council of Scientific and Industrial Research (CSIR)
   network projects GENESIS [BSC0121] and INDEPTH [BSC0111].
CR Abell K, 2005, CELL CYCLE, V4, P897, DOI 10.4161/cc.4.7.1837
   Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554
   Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Bakkar A, 2016, MOL BIOL REP, V43, P229, DOI 10.1007/s11033-016-3948-4
   Banerjee K, 2016, INT J CANCER, V138, P2570, DOI 10.1002/ijc.29923
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918
   Barton BE, 2004, MOL CANCER THER, V3, P11
   Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90
   Birner P, 2015, CELL DEATH DIFFER, V22, P522, DOI 10.1038/cdd.2014.232
   Blando JM, 2011, NEOPLASIA, V13, P254, DOI 10.1593/neo.101388
   Bonkhoff H, 2001, PROSTATE, V48, P285, DOI 10.1002/pros.1108
   Cai Yimei, 2009, Genomics Proteomics & Bioinformatics, V7, P147, DOI 10.1016/S1672-0229(08)60044-3
   Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897
   Cha YJ, 2016, PROSTATE, V76, P937, DOI 10.1002/pros.23183
   Chou CH, 2015, NUCL ACIDS RES
   Culig Z., 2016, EUROPEAN UROLOGY
   Dasgupta Subhamoy, 2012, J Carcinog, V11, P4, DOI 10.4103/1477-3163.93001
   Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677
   Don-Doncow N, 2016, EUR UROL
   Esber N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140795
   Esposito S, 2015, ONCOTARGET, V6
   Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67
   Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032
   Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111
   Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31
   Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200
   Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8
   Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209
   Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14
   Jiao L, 2014, J CELL PHYSIOL, V229, P834, DOI 10.1002/jcp.24510
   Jin Y, 2015, INT J ONCOL, V47, P1594, DOI 10.3892/ijo.2015.3114
   Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389
   Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206
   Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3
   Kavlashvili T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148912
   Kawamura N, 2015, ONCOTARGET, V6, P22361, DOI 10.18632/oncotarget.4293
   Kim YR, 2016, ONCOL REP, V35, P2011, DOI 10.3892/or.2016.4563
   Knox SS, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-11
   Konishi N, 2008, CLIN CANCER RES, V14, P4408, DOI 10.1158/1078-0432.CCR-07-4120
   Lai X, 2012, NUCLEIC ACIDS RES, V40, P8818, DOI 10.1093/nar/gks657
   Li ML, 2016, ONCOL LETT, V11, P817, DOI 10.3892/ol.2015.3924
   Lin YT, 2007, CELL RES, V17, P531, DOI 10.1038/cr.2007.12
   Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425
   Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157
   Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937
   Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551
   Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608
   Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108
   Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513
   Nair S, 2010, ACTA PHARMACOL SIN, V31, P1223, DOI 10.1038/aps.2010.147
   Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746
   Nowak DG, 2015, CANCER DISCOV, V5, P636, DOI 10.1158/2159-8290.CD-14-1113
   Nunez YO, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-725
   Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055
   Palladinetti P, 2008, ATLAS GENET CYTOGENE, P367
   Pencik J, 2015, STAT3 REGULATED ARF, V6
   RAFFO AJ, 1995, CANCER RES, V55, P4438
   Ramachandran S, 2005, ONCOGENE, V24, P188, DOI 10.1038/sj.onc.1207906
   Ravani P, 2010, CLIN J AM SOC NEPHRO, V5, P1243, DOI 10.2215/CJN.06190809
   Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Roca H, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-29
   Schmelz M, 2002, NEOPLASIA, V4, P243, DOI 10.1038/sj/neo/7900223
   Schuringa JJ, 2001, CYTOKINE, V14, P78, DOI 10.1006/cyto.2001.0856
   Senapati S, 2009, ATLAS GENET CYTOGENE, P204
   Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254
   Taylor BS, 2011, INTEGRATIVE GENOMIC, V18, P11
   Thomsen MK, 2015, CELL DEATH DIFFER, V22, P574, DOI 10.1038/cdd.2014.213
   Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133
   Tsang J, 2015, MOL CELL ELSEVIER, V26, P753
   Tu WH, 2003, NEOPLASIA, V5, P267, DOI 10.1016/S1476-5586(03)80058-1
   Vanhara P, 2012, PROSTATE CANCER P D, V15, P320, DOI 10.1038/pcan.2012.6
   Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075
   Vera J, 2013, CANCER RES, V73, P3511, DOI 10.1158/0008-5472.CAN-12-4095
   Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200
   Wang LJ, 2012, MOL MED, V18, P389, DOI 10.2119/molmed.2011.00172
   Xiong AL, 2014, CANCERS, V6, P926, DOI 10.3390/cancers6020926
   Yin P, 2007, J CLIN ENDOCR METAB, V92, P4459, DOI 10.1210/jc.2007-0725
   Yu Y, 2015, PROSTATE, V75, P1043, DOI 10.1002/pros.22988
   Yu Y, 2013, J CLIN ENDOCR METAB, V98, P2887, DOI 10.1210/jc.2012-4000
   Zhang DT, 2014, TUMOR BIOL, V35, P3333, DOI 10.1007/s13277-013-1439-y
NR 86
TC 17
Z9 17
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 22
PY 2016
VL 11
IS 12
AR e0168760
DI 10.1371/journal.pone.0168760
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI9QH
UT WOS:000392843200091
PM 28005952
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Cottrell, KA
   Djuranovic, S
AF Cottrell, Kyle A.
   Djuranovic, Sergej
TI Urb-RIP - An Adaptable and Efficient Approach for Immunoprecipitation of
   RNAs and Associated RNAs/Proteins
SO PLOS ONE
LA English
DT Article
ID AFFINITY PURIFICATION; POLY(A)-BINDING PROTEIN; BINDING PROTEIN; BC200
   RNA; IDENTIFICATION; COMPLEXES; MICRORNAS; INTERACT; SEQUENCE; PLATFORM
AB Post-transcriptional regulation of gene expression is an important process that is mediated by interactions between mRNAs and RNA binding proteins (RBP), non-coding RNAs (ncRNA) or ribonucleoproteins (RNP). Key to the study of post-transcriptional regulation of mRNAs and the function of ncRNAs such as long non-coding RNAs (lncRNAs) is an understanding of what factors are interacting with these transcripts. While several techniques exist for the enrichment of a transcript whether it is an mRNA or an ncRNA, many of these techniques are cumbersome or limited in their application. Here we present a novel method for the immunoprecipitation of mRNAs and ncRNAs, Urb-RNA immunoprecipitation (Urb-RIP). This method employs the RRM1 domain of the "resurrected" snRNA-binding protein Urb to enrich messages containing a stem-loop tag. Unlike techniques which employ the MS2 protein, which require large repeats of the MS2 binding element, Urb-RIP requires only one stem-loop. This method routinely provides over similar to 100-fold enrichment of tagged messages. Using this technique we have shown enrichment of tagged mRNAs and lncRNAs as well as miRNAs and RNA-binding proteins bound to those messages. We have confirmed, using Urb-RIP, interaction between RNA PolIII transcribed lncRNA BC200 and polyA binding protein.
C1 [Cottrell, Kyle A.; Djuranovic, Sergej] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.
RP Djuranovic, S (reprint author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.
EM sergej.djuranovic@wustl.edu
OI Djuranovic, Sergej/0000-0002-9417-0822
FU NIH [T32 GM007067, RO1 GM112824]
FX This work was supported by an NIH training grant T32 GM007067 to KAC and
   NIH Grant RO1 GM112824 to SD.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Braun J, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku127
   Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Chu C, 2012, JOVE-J VIS EXP, DOI 10.3791/3912
   Chu L, 2012, J CLIN INVEST, V122, P2793, DOI 10.1172/JCI63051
   Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069
   Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31
   Davis CP, 2015, METHODS MOL BIOL, V1262, P167, DOI 10.1007/978-1-4939-2253-6_10
   Delaney KJ, 2014, RNA, V20, P1035, DOI 10.1261/rna.044255.114
   Dong YC, 2015, INT J MOL SCI, V16, P22456, DOI 10.3390/ijms160922456
   Engreitz J, 2015, METHODS MOL BIOL, V1262, P183, DOI 10.1007/978-1-4939-2253-6_11
   Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024
   Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088
   Gong CG, 2015, METHODS MOL BIOL, V1206, P81, DOI 10.1007/978-1-4939-1369-5_7
   Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Hamzeiy H, 2014, METHODS MOL BIOL, V1107, P207, DOI 10.1007/978-1-62703-748-8_12
   Hershey JW, 2012, COLD SPRING HARB PER, V4
   Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207
   Iioka H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1316
   Khanam Tasneem, 2006, RNA Biol, V3, P170
   Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049
   Law MJ, 2006, RNA, V12, P1168, DOI 10.1261/rna.75206
   Lechertier T, 2009, EXP CELL RES, V315, P928, DOI 10.1016/j.yexcr.2009.01.016
   LECUYER KA, 1995, BIOCHEMISTRY-US, V34, P10600, DOI 10.1021/bi00033a035
   Lee HY, 2013, P NATL ACAD SCI USA, V110, P5416, DOI 10.1073/pnas.1302807110
   Leppek K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt956
   Liu S, 2015, APPL BIOCH BIOTECHNO
   Marin-Bejar O, 2015, METHODS MOL BIOL, V1206, P87, DOI 10.1007/978-1-4939-1369-5_8
   MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563
   Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1
   Mullin C, 2004, FEBS LETT, V576, P437, DOI 10.1016/j.febslet.2004.09.054
   Muppirala UK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-489
   Olanich ME, 2011, ONCOGENE, V30, P77, DOI 10.1038/onc.2010.404
   PICKETT GG, 1993, NUCLEIC ACIDS RES, V21, P4621, DOI 10.1093/nar/21.19.4621
   Said N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp719
   Slobodin B, 2010, RNA, V16, P2277, DOI 10.1261/rna.2091710
   Suresh V, 2015, NUCLEIC ACIDS RES, V43, P1370, DOI 10.1093/nar/gkv020
   Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095
   Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408
   Wang XW, 2009, RNA, V15, P716, DOI 10.1261/rna.1460509
   Wei K, 2014, INT J MOL SCI, V15, P14753, DOI 10.3390/ijms150814753
   Williams SG, 2013, J MOL BIOL, V425, P3846, DOI 10.1016/j.jmb.2013.05.031
   Yoon JH, 2012, METHODS, V58, P81, DOI 10.1016/j.ymeth.2012.07.004
   Yue D, 2009, CURR GENOMICS, V10, P478, DOI 10.2174/138920209789208219
NR 46
TC 4
Z9 4
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 8
PY 2016
VL 11
IS 12
AR e0167877
DI 10.1371/journal.pone.0167877
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE4OA
UT WOS:000389580900055
PM 27930710
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Mentzel, CMJ
   Alkan, F
   Keinicke, H
   Jacobsen, MJ
   Gorodkin, J
   Fredholm, M
   Cirera, S
AF Mentzel, Caroline M. Junker
   Alkan, Ferhat
   Keinicke, Helle
   Jacobsen, Mette J.
   Gorodkin, Jan
   Fredholm, Merete
   Cirera, Susanna
TI Joint Profiling of miRNAs and mRNAs Reveals miRNA Mediated Gene
   Regulation in the Gottingen Minipig Obesity Model
SO PLOS ONE
LA English
DT Article
ID DIET-INDUCED OBESITY; INDUCED INSULIN-RESISTANCE; HUMAN ADIPOSE-TISSUE;
   HIGH-FAT-DIET; METABOLIC SYNDROME; NONALCOHOLIC STEATOHEPATITIS;
   LIPID-METABOLISM; EXPRESSION; MICE; PROTEIN
AB Obesity and its comorbidities are an increasing challenge for both affected individuals and health care systems, worldwide. In obese individuals, perturbation of expression of both protein-coding genes and microRNAs (miRNA) are seen in obesity-relevant tissues (i.e. adipose tissue, liver and skeletal muscle). miRNAs are small non-coding RNA molecules which have important regulatory roles in a wide range of biological processes, including obesity. Rodents are widely used animal models for human diseases including obesity. However, not all research is applicable for human health or diseases. In contrast, pigs are emerging as an excellent animal model for obesity studies, due to their similarities in their metabolism, their digestive tract and their genetics, when compared to humans. The Gottingen minipig is a small sized easy-to-handle pig breed which has been extensively used for modeling human obesity, due to its capacity to develop severe obesity when fed ad libitum. The aim of this study was to identify differentially expressed of protein-coding genes and miRNAs in a Gottingen minipig obesity model. Liver, skeletal muscle and abdominal adipose tissue were sampled from 7 lean and 7 obese minipigs. Differential gene expression was investigated using high-throughput quantitative real-time PCR (qPCR) on 90 mRNAs and 72 miRNAs. The results revealed de-regulation of several obesity and inflammation-relevant protein-coding genes and miRNAs in all tissues examined. Many genes that are known to be de-regulated in obese humans were confirmed in the obese minipigs and several of these genes have target sites for miRNAs expressed in the opposing direction of the gene, confirming miRNA-mediated regulation in obesity. These results confirm the translational value of the pig for human obesity studies.
C1 [Mentzel, Caroline M. Junker; Keinicke, Helle; Jacobsen, Mette J.; Fredholm, Merete; Cirera, Susanna] Univ Copenhagen, Dept Vet Clin & Anim Sci, Anim Genet, Fac Hlth Sci, Frederiksberg, Denmark.
   [Mentzel, Caroline M. Junker; Alkan, Ferhat; Gorodkin, Jan; Fredholm, Merete] Univ Copenhagen, Dept Vet Clin & Anim Sci, Ctr Noncoding RNA Technol & Hlth, Computat Biol & Bioinformat,Fac Hlth Sci, Frederiksberg, Denmark.
RP Cirera, S (reprint author), Univ Copenhagen, Dept Vet Clin & Anim Sci, Anim Genet, Fac Hlth Sci, Frederiksberg, Denmark.
EM scs@sund.ku.dk
RI Cirera, Susanna/K-8540-2017
OI Cirera, Susanna/0000-0001-8105-1579; Gorodkin, Jan/0000-0001-5823-4000;
   Mentzel, Caroline/0000-0003-4688-7367; Alkan, Ferhat/0000-0001-6709-9605
FU Danish Independent Research Council [DFF-1335-00127]; Innovation Fund
   Denmark; Danish Center for Scientific Computing (DCSC, DeIC); SHARE
   foundation; Danielsen's Foundation
FX The project was funded by the Danish Independent Research Council
   (DFF-1335-00127), Innovation Fund Denmark, Danish Center for Scientific
   Computing (DCSC, DeIC). The lean minipigs were funded by the SHARE
   foundation and Danielsen's Foundation. The obese minipigs were donated
   by Novo Nordisk A/S. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496
   Anty R, 2006, AM J GASTROENTEROL, V101, P1824, DOI 10.1111/j.1572-0241.2006.00724.x
   Auguet T, 2013, EXP CLIN ENDOCR DIAB, V121, P119, DOI 10.1055/s-0032-1331696
   Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70
   Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje
   Boonen HCM, 2014, PFLUG ARCH EUR J PHY, V466, P2167, DOI 10.1007/s00424-014-1486-2
   Busk PK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-29
   Celikbilek M, 2014, WORLD J HEPATOL, V6, P613, DOI 10.4254/wjh.v6.i8.613
   Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872
   Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258
   Cirera S, 2014, ANIM GENET, V45, P59, DOI 10.1111/age.12082
   Cirera S, 2014, METHODS MOL BIOL, V1182, P73, DOI 10.1007/978-1-4939-1062-5_7
   Diawara MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091375
   Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1
   Ersen BOC, 2007, COMPARATIVE MED, V57, P493
   Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7
   Felipe F, 2003, INT J OBESITY, V27, P60, DOI 10.1038/sj.ijo.0802188
   Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109
   Goossens GH, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00055
   Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622
   Guess MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118229
   Heneghan HM, 2011, J CLIN ENDOCR METAB, V96, pE846, DOI 10.1210/jc.2010-2701
   Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2
   Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890
   Huynh FK, 2013, HEPATOLOGY, V57, P543, DOI 10.1002/hep.26043
   Jacobsen MJ, 2016, J DIABETES RES, DOI 10.1155/2016/8539057
   Johansen T, 2001, COMPARATIVE MED, V51, P150
   Jones BH, 1996, AM J PHYSIOL-ENDOC M, V271, pE44
   Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0
   Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181
   Lee B, 2014, AM J PHYSIOL-ENDOC M, V306, pE1144, DOI 10.1152/ajpendo.00002.2014
   Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248
   Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070390
   Liu YM, 2004, J CLIN ENDOCR METAB, V89, P2684, DOI 10.1210/jc.2003-031978
   Lu J, 2014, CARCINOGENESIS, V35, P554, DOI 10.1093/carcin/bgt354
   Madeira MS, 2013, BRIT J NUTR, V110, P216, DOI 10.1017/S0007114512004916
   Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662
   Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932
   Mentzel Caroline M J, 2014, Microrna, V3, P174
   Mentzel CMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131650
   Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64
   Mika A, 2015, EUR J LIPID SCI TECH, V117, P926, DOI 10.1002/ejlt.201400372
   Musa CV, 2012, INT J OBESITY, V36, P207, DOI 10.1038/ijo.2011.81
   Oliver P, 2012, INT J OBESITY, V36, P225, DOI 10.1038/ijo.2011.92
   Padilla J, 2013, PHYSIOL GENOMICS, V45, P434, DOI 10.1152/physiolgenomics.00038.2013
   Pant SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137356
   Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007
   Rennie W, 2014, NUCLEIC ACIDS RES, V42, pW114, DOI 10.1093/nar/gku376
   Rodgaard T, 2014, ANIM GENET, V45, P67, DOI 10.1111/age.12090
   Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015
   Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898
   Spurlock ME, 2008, J NUTR, V138, P397
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365
   Traini M, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.612341
   Troseid M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-11
   Trujillo ME, 2004, J CLIN ENDOCR METAB, V89, P5577, DOI 10.1210/jc.2004-0603
   Vienberg S, 2016, ACTA PHYSL OXF
   Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215
   Wenzel A, 2012, BIOINFORMATICS, V28, P2738, DOI 10.1093/bioinformatics/bts519
   World Health Organization, 2015, OB OV
   Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299
   Yao LB, 2014, FASEB J, V28, P4534, DOI 10.1096/fj.14-249797
   Yates A., 2015, NUCLEIC ACIDS RES
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
   Zhang J, 2012, J BIOL CHEM, V287, P21093, DOI 10.1074/jbc.M111.330381
   Zhu HM, 2015, DIABETOLOGIA, V58, P900, DOI 10.1007/s00125-015-3510-2
NR 70
TC 4
Z9 4
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 30
PY 2016
VL 11
IS 11
AR e0167285
DI 10.1371/journal.pone.0167285
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE3FV
UT WOS:000389474100067
PM 27902747
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Port, M
   Herodin, F
   Valente, M
   Drouet, M
   Ullmann, R
   Douche-Senf, S
   Lamkowski, A
   Majewski, M
   Abend, M
AF Port, Matthias
   Herodin, Francis
   Valente, Marco
   Drouet, Michel
   Ullmann, Reinhard
   Douche-Senf, Sven
   Lamkowski, Andreas
   Majewski, Matthaeus
   Abend, Michael
TI MicroRNA Expression for Early Prediction of Late Occurring Hematologic
   Acute Radiation Syndrome in Baboons
SO PLOS ONE
LA English
DT Article
ID NUCLEAR-POWER-PLANT; CHROMOSOME-ABERRATIONS; CHERNOBYL ACCIDENT;
   THYROID-CANCER; SIGNATURES; RESIDENTS; EXPOSURE; UNCERTAINTIES;
   IRRADIATION; PREFECTURE
AB For effective medical management of radiation-exposed persons after a radiological/nuclear event, blood-based screening measures in the first few days that could predict hematologic acute radiation syndrome (HARS) are needed. For HARS severity prediction, we used microRNA (miRNA) expression changes measured on days one and two after irradiation in a baboon model. Eighteen baboons underwent different patterns of partial or total body irradiation, corresponding to an equivalent dose of 2.5 or 5 Gy. According to changes in blood cell counts (BCC) the surviving baboons (n = 17) exhibited mild (H1-2, n = 4) or more severe (H2-3, n = 13) HARS. In a two Stage study design we screened 667 miRNAs using a quantitative real-time polymerase chain reaction (qRT-PCR) platform. In Stage II we validated candidates where miRNAs had to show a similar regulation (up- or down-regulated) and a significant 2-fold miRNA expression difference over H0. Seventy-two candidate miRNAs (42 for H1-2 and 30 for H2-3) were forwarded for validation. Forty-two of the H1-2 miRNA candidates from the screening phase entered the validation step and 20 of them showed a statistically significant 2-4 fold up-regulation relative to the unexposed reference (H0). Fifteen of the 30 H2-3 miRNAs were validated in Stage II. All miRNAs appeared 2-3 fold down-regulated over H0 and allowed an almost complete separation of HARS categories; the strongest candidate, miR-342-3p, showed a sustained and 10-fold down-regulation on both days 1 and 2. In summary, our data support the medical decision making of the HARS even within the first two days after exposure where diagnostic tools for early medical decision are required but so far missing. The miRNA species identified and in particular miR-342-3p add to the previously identified mRNAs and complete the portfolio of identified mRNA and miRNA transcripts for HARS prediction and medical management.
C1 [Port, Matthias; Ullmann, Reinhard; Douche-Senf, Sven; Lamkowski, Andreas; Majewski, Matthaeus; Abend, Michael] Bundeswehr Inst Radiobiol, Munich, Germany.
   [Herodin, Francis; Valente, Marco; Drouet, Michel] Inst Rech Biomed Armees, Bretigny Sur Orge, France.
RP Abend, M (reprint author), Bundeswehr Inst Radiobiol, Munich, Germany.
EM michaelabend@bundeswehr.org
RI Valente, Marco/A-8833-2018
FU French Ministry of Defense; German Ministry of Defense
FX This work was supported by both the French and the German Ministry of
   Defense.
CR Aavik E, 2004, FASEB J, V18, P130, DOI 10.1096/fj.04-2225fje
   Abend M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039103
   Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Akiba S, 2012, J RADIOL PROT, V32, P1, DOI 10.1088/0952-4746/32/1/1
   Beinke C, 2013, RADIAT RES, V180, P129, DOI 10.1667/RR3235.1
   Boldt S, 2012, INT J RADIAT BIOL, V88, P267, DOI 10.3109/09553002.2012.638358
   Bouville A, 2006, RADIAT RES, V166, P158, DOI 10.1667/RR3370.1
   Chaudhry MA, 2008, J BIOMED SCI, V15, P557, DOI 10.1007/s11373-008-9253-z
   Cullings HM, 2006, RADIAT RES, V166, P219, DOI 10.1667/RR3546.1
   Drozdovitch V, 2007, RADIAT PROT DOSIM, V127, P540, DOI 10.1093/rpd/ncm360
   Friesecke I, 2001, BRIT J RADIOL, V74, P121, DOI 10.1259/bjr.74.878.740121
   Iaea, 2001, TECH REP SER, V138
   Kamada N, 2012, J ENVIRON RADIOACTIV, V110, P84, DOI 10.1016/j.jenvrad.2012.02.007
   Koizumi Akio, 2012, Environmental Health and Preventive Medicine, V17, P292, DOI 10.1007/s12199-011-0251-9
   Kopecky KJ, 2006, RADIAT RES, V166, P367, DOI 10.1667/RR3596.1
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Meadows SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011535
   Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912
   Natarajan AT, 1998, MUTAT RES-FUND MOL M, V400, P299, DOI 10.1016/S0027-5107(98)00021-9
   Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043
   Paul S, 2011, INT J RADIAT BIOL, V87, P791, DOI 10.3109/09553002.2011.568574
   Port M, 2016, 1 GENERATION GENE EX, P39, DOI [10.1667/RR14318.1, DOI 10.1667/RR14318.1]
   Ramalho AT, 1998, MUTAT RES-FUND MOL M, V404, P97, DOI 10.1016/S0027-5107(98)00099-2
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sherwin JRA, 2010, ENDOCRINOLOGY, V151, P4982, DOI 10.1210/en.2010-0275
   Shi Q, 2010, CLIN EXP PHARMACOL P, V37, P178, DOI 10.1111/j.1440-1681.2009.05260.x
   Singh VK, 2012, RADIAT RES, V177, P781, DOI 10.1667/RR2894.1
   Singh VK, 2012, CYTOKINE, V58, P406, DOI 10.1016/j.cyto.2012.03.011
   Valente M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132194
NR 29
TC 8
Z9 8
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 15
PY 2016
VL 11
IS 11
AR e0165307
DI 10.1371/journal.pone.0165307
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EC0MG
UT WOS:000387794600011
PM 27846229
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Vassilev, B
   Louhimo, R
   Ikonen, E
   Hautaniemi, S
AF Vassilev, Boris
   Louhimo, Riku
   Ikonen, Elina
   Hautaniemi, Sampsa
TI Language-Agnostic Reproducible Data Analysis Using Literate Programming
SO PLOS ONE
LA English
DT Article
ID BREAST-CANCER; EXPRESSION ANALYSES; TARGET INTERACTIONS; LAPTM4B;
   INTEGRATION; PREDICTOR; MICRORNAS; RESOURCE; GENES; CELLS
AB A modern biomedical research project can easily contain hundreds of analysis steps and lack of reproducibility of the analyses has been recognized as a severe issue. While thorough documentation enables reproducibility, the number of analysis programs used can be so large that in reality reproducibility cannot be easily achieved. Literate programming is an approach to present computer programs to human readers. The code is rearranged to follow the logic of the program, and to explain that logic in a natural language. The code executed by the computer is extracted from the literate source code. As such, literate programming is an ideal formalism for systematizing analysis steps in biomedical research. We have developed the reproducible computing tool Lir (literate, reproducible computing) that allows a tool-agnostic approach to biomedical data analysis. We demonstrate the utility of Lir by applying it to a case study. Our aim was to investigate the role of endosomal trafficking regulators to the progression of breast cancer. In this analysis, a variety of tools were combined to interpret the available data: a relational database, standard command-line tools, and a statistical computing environment. The analysis revealed that the lipid transport related genes LAPTM4B and NDRG1 are coamplified in breast cancer patients, and identified genes potentially cooperating with LAPTM4B in breast cancer progression. Our case study demonstrates that with Lir, an array of tools can be combined in the same data analysis to improve efficiency, reproducibility, and ease of understanding. Lir is an open-source software available at github. com/borisvassilev/lir.
C1 [Vassilev, Boris; Ikonen, Elina] Univ Helsinki, Fac Med, Dept Anat, Helsinki, Finland.
   [Louhimo, Riku; Hautaniemi, Sampsa] Univ Helsinki, Genome Scale Biol, Res Programs Unit, Helsinki, Finland.
   [Ikonen, Elina] Minerva Fdn, Inst Med Res, Helsinki, Finland.
RP Vassilev, B (reprint author), Univ Helsinki, Fac Med, Dept Anat, Helsinki, Finland.
EM boris.vassilev@heisinki.fi
RI Hautaniemi, Sampsa/A-3122-2009; Vassilev, Boris/F-6065-2019
OI Hautaniemi, Sampsa/0000-0002-7749-2694; Vassilev,
   Boris/0000-0003-3727-4331; Ikonen, Elina/0000-0001-8382-1135
FU Finnish Society of Science and Letters; Biomedicum Helsinki Foundation;
   Paulon Saatio; K. Albin Johanssons Stiftelse; Ida Montinin Saatio;
   Academy of Finland [282192]; Biocentrum Helsinki
FX BV received personal grants by the Finnish Society of Science and
   Letters (http://www.scientiarum.fi/eng/); the Biomedicum Helsinki
   Foundation (http://www.biomedicum.com/index.php?page=112& The Paulon
   Saatio (http://www.paulo.fi/); the K. Albin Johanssons Stiftelse
   (http://www.foundationweb.net/johansson/); and the Ida Montinin Saatio
   (www.idamontininsaatio.fi/). RL received no specific funding for this
   work. El received grant 282192 by the Academy of Finland (www.aka.fi).
   SH received funding by Biocentrum Helsinki
   (http://www.helsinki.fi/biocentrum/). The funders had no role in the
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Baggerly K, 2010, NATURE, V467, P401, DOI 10.1038/467401b
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995
   Blom T, 2015, NAT CHEM BIOL, V11, P799, DOI [10.1038/NCHEMBIO.1889, 10.1038/nchembio.1889]
   Bornigen D, 2015, PEERJ, V3, DOI 10.7717/peerj.791
   Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042
   Chan HJ, 2015, ONCOTARGET, V6, P25815, DOI 10.18632/oncotarget.4441
   Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138
   Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485
   Fang BA, 2014, BBA-REV CANCER, V1845, P1, DOI 10.1016/j.bbcan.2013.11.002
   He XH, 2016, ONCOGENE
   Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295
   John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363
   Kauraniemi P, 2006, ENDOCR-RELAT CANCER, V13, P39, DOI 10.1677/erc.1.01147
   Kitchin JR, 2015, ACS CATAL, V5, P3894, DOI 10.1021/acscatal.5b00538
   KNUTH DE, 1984, COMPUT J, V27, P97, DOI 10.1093/comjnl/27.2.97
   Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412
   Leisch F, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P575
   Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090
   Luo EC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05908
   McConnell S., 2004, CODE COMPLETE
   Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031
   Noble WS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000424
   Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008
   Ovaska K, 2010, GENOME MED, V2, DOI 10.1186/gm186
   Parris TZ, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.8
   Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847
   Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53
   Pietiainen V, 2013, J CELL SCI, V126, P3961, DOI 10.1242/jcs.128132
   Prechelt L, 2000, COMPUTER, V33, P23, DOI 10.1109/2.876288
   R. Core Team, 2014, R A LANGUAGE AND ENV
   RAMSEY N, 1994, IEEE SOFTWARE, V11, P97, DOI 10.1109/52.311070
   Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285
   Shade A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002303
   Shen H, 2014, NATURE, V515, P151, DOI 10.1038/515151a
   Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73
   Song JK, 2007, PROTEIN SCI, V16, P807, DOI 10.1110/ps.072752407
   Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568
   Therneau T M, 2014, A PACKAGE FOR SURVIV
   Therneau Terry M, 2000, MODELING SURVIVAL DA
   Vassilev B, 2015, AM J PATHOL, V185, P987, DOI 10.1016/j.ajpath.2014.12.018
   Wielemaker J, 2012, THEOR PRACT LOG PROG, V12, P67, DOI 10.1017/S1471068411000494
   Wilson G, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001745
   Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104
   Xie Y., 2014, IMPLEMENTING REPRODU, V1, P1
   Zhang HT, 2015, ONCOTARGET, V6, P6092, DOI 10.18632/oncotarget.3341
NR 48
TC 0
Z9 0
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 6
PY 2016
VL 11
IS 10
AR e0164023
DI 10.1371/journal.pone.0164023
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DZ2UR
UT WOS:000385697600064
PM 27711123
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Tkatchenko, AV
   Luo, XY
   Tkatchenko, TV
   Vaz, C
   Tanavde, VM
   Maurer-Stroh, S
   Zauscher, S
   Gonzalez, P
   Young, TL
AF Tkatchenko, Andrei V.
   Luo, Xiaoyan
   Tkatchenko, Tatiana V.
   Vaz, Candida
   Tanavde, Vivek M.
   Maurer-Stroh, Sebastian
   Zauscher, Stefan
   Gonzalez, Pedro
   Young, Terri L.
TI Large-Scale microRNA Expression Profiling Identifies Putative Retinal
   miRNA-mRNA Signaling Pathways Underlying Form-Deprivation Myopia in Mice
SO PLOS ONE
LA English
DT Article
ID EMBRYONIC STEM-CELLS; TREE SHREW SCLERA; EPITHELIAL-MESENCHYMAL
   TRANSITION; EYE GROWTH-REGULATION; GENE-EXPRESSION; MICROARRAY ANALYSIS;
   NONCODING RNAS; MOUSE RETINA; LINEAGE DIFFERENTIATION; PROTEIN
   EXPRESSION
AB Development of myopia is associated with large-scale changes in ocular tissue gene expression. Although differential expression of coding genes underlying development of myopia has been a subject of intense investigation, the role of non-coding genes such as microRNAs in the development of myopia is largely unknown. In this study, we explored myopia-associated miRNA expression profiles in the retina and sclera of C57Bl/6J mice with experimentally induced myopia using microarray technology. We found a total of 53 differentially expressed miRNAs in the retina and no differences in miRNA expression in the sclera of C57BL/6J mice after 10 days of visual form deprivation, which induced -6.93 +/- 2.44 D (p < 0.000001, n = 12) of myopia. We also identified their putative mRNA targets among mRNAs found to be differentially expressed in myopic retina and potential signaling pathways involved in the development of form-deprivation myopia using miRNA-mRNA interaction network analysis. Analysis of myopia-associated signaling pathways revealed that myopic response to visual form deprivation in the retina is regulated by a small number of highly integrated signaling pathways. Our findings highlighted that changes in microRNA expression are involved in the regulation of refractive eye development and predicted how they may be involved in the development of myopia by regulating retinal gene expression.
C1 [Tkatchenko, Andrei V.; Tkatchenko, Tatiana V.] Columbia Univ, Dept Ophthalmol, Coll Phys & Surg, New York, NY 10027 USA.
   [Tkatchenko, Andrei V.] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA.
   [Luo, Xiaoyan; Gonzalez, Pedro] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC USA.
   [Luo, Xiaoyan] Duke Univ, Sch Med, Ctr Human Genet, Durham, NC USA.
   [Vaz, Candida; Tanavde, Vivek M.; Maurer-Stroh, Sebastian] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore.
   [Tanavde, Vivek M.] ASTAR, Inst Med Biol, Singapore, Singapore.
   [Zauscher, Stefan] Duke Univ, Dept Mech Engn & Mat Sci, Pratt Sch Engn, Durham, NC 27706 USA.
   [Young, Terri L.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA.
RP Tkatchenko, AV (reprint author), Columbia Univ, Dept Ophthalmol, Coll Phys & Surg, New York, NY 10027 USA.; Tkatchenko, AV (reprint author), Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA.; Young, TL (reprint author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA.
EM avt2130@cumc.columbia.edu; tyoung6@wisc.edu
RI Tanavde, Vivek/N-6564-2019; Maurer-Stroh, Sebastian/Q-9476-2019
OI Tanavde, Vivek/0000-0001-7404-5568; Maurer-Stroh,
   Sebastian/0000-0003-0813-9640
FU National Institutes of Health/National Eye Institute grant
   [R01EY023839]; National Institutes of Health/National Eye Institute
   [R01EY023287, R01EY016228, R01EY014685, P30EY019007]; Duke Eye Center
   Exploring Grant; Research to Prevent Blindness (New York, NY);
   Department of Ophthalmology and Visual Sciences, University of
   Wisconsin-Madison; Acquavella Family Foundation; University of Wisconsin
   Centennial Scholar Fund
FX This project was supported by National Institutes of Health/National Eye
   Institute grant R01EY023839, (www.nih.gov) (to AVT), National Institutes
   of Health/National Eye Institute grants R01EY023287 and R01EY016228,
   (www.nih.gov) (to PG), National Institutes of Health/National Eye
   Institute grant R01EY014685, (www.nih.gov) (to TLY), National Institutes
   of Health/National Eye Institute grant P30EY019007 (Core Support for
   Vision Research) (to AVT), Duke Eye Center Exploring Grant and
   unrestricted funds from Research to Prevent Blindness (New York, NY) to
   the Department of Ophthalmology, Columbia University and the Department
   of Ophthalmology and Visual Sciences, University of Wisconsin-Madison.
   These research was funded with support from the Acquavella Family
   Foundation, Joseph C. Connors, and the University of Wisconsin
   Centennial Scholar Fund.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Alexander LJ, 1994, PRIMARY CARE POSTERI
   Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262
   Arora A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-1
   Ashby R, 2010, MOL VIS, V16, P639
   Ashby RS, 2010, INVEST OPHTH VIS SCI, V51, P3726, DOI 10.1167/iovs.09-4615
   Augustin R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-35
   Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108
   Banerjee P, 2015, STEM CELLS
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bracken CP, 2014, EMBO J, V33, P2040, DOI 10.15252/embj.201488641
   Brand C, 2007, MOL VIS, V13, P920
   Calissano M, 2010, MOL CELL NEUROSCI, V45, P317, DOI 10.1016/j.mcn.2010.06.015
   Chase HB, 1942, GENETICS, V27, P0339
   Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076
   Chen JC, 2006, VISION RES, V46, P4096, DOI 10.1016/j.visres.2006.07.033
   Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040849
   Chen KC, 2012, INVEST OPHTH VIS SCI, V53, P2732, DOI 10.1167/iovs.11-9272
   Chivukula RR, 2009, CELL, V137, P606, DOI 10.1016/j.cell.2009.04.059
   Conte I, 2013, CELL MOL LIFE SCI, V70, P4141, DOI 10.1007/s00018-013-1335-z
   Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195
   Curtin BJ, 1985, MYOPIAS BASIC SCI CL
   de Sousa E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056908
   Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106
   Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847
   Di Bernardini E, 2014, J BIOL CHEM, V289, P3383, DOI 10.1074/jbc.M113.495531
   Diaz-Martin J, 2014, J PATHOL, V232, P319, DOI 10.1002/path.4289
   Engelsvold DH, 2013, EXP EYE RES, V115, P189, DOI 10.1016/j.exer.2013.07.003
   Feldkaemper MP, 2009, INVEST OPHTH VIS SCI, V50, P13, DOI 10.1167/iovs.08-1702
   Feldkaemper MP, 2002, VISUAL NEUROSCI, V19, P755, DOI 10.1017/S0952523802196064
   Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167
   Fischer AJ, 1997, CAN J OPHTHALMOL, V32, P373
   Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004
   Frost MR, 2012, INVEST OPHTH VIS SCI, V53, P322, DOI 10.1167/iovs.11-8354
   Gao H, 2011, MOL VIS, V17, P903
   Genini S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-172
   Gonzalez P, 2014, J OCUL PHARMACOL TH, V30, P128, DOI 10.1089/jop.2013.0191
   Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722
   Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022
   Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007
   Hackler L, 2010, INVEST OPHTH VIS SCI, V51, P1823, DOI 10.1167/iovs.09-4657
   Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014
   Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071
   Hwang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046521
   Iliff BW, 2012, INVEST OPHTH VIS SCI, V53, P348, DOI 10.1167/iovs.11-8783
   Ishida W, 2011, INVEST OPHTH VIS SCI, V52, P611, DOI 10.1167/iovs.10-6115
   Jin ZB, 2009, MOL VIS, V15, P523
   KALTER H, 1968, TERATOLOGY, V1, P193, DOI 10.1002/tera.1420010208
   Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715
   Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235
   Koch FLP, 1939, ARCH PATHOL, V28, P171
   Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879
   Kushwaha R, 2014, STEM CELLS DEV, V23, P1149, DOI 10.1089/scd.2013.0262
   La Torre A, 2013, P NATL ACAD SCI USA, V110, pE2362, DOI 10.1073/pnas.1301837110
   Lam CSY, 2004, OPTOMETRY VISION SCI, V81, P317, DOI 10.1097/01.opx.0000134905.98403.18
   Lee SKW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021249
   Li DD, 2015, GENE, V572, P198, DOI 10.1016/j.gene.2015.07.010
   Li ZY, 2015, HUM REPROD, V30, P507, DOI 10.1093/humrep/dev001
   Liang CL, 2011, INVEST OPHTH VIS SCI, V52, P3500, DOI 10.1167/iovs.10-5859
   Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254
   Lin LL, 2004, ANN ACAD MED SINGAP, V33, P27
   Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248
   Lu TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059397
   Lumayag S, 2013, P NATL ACAD SCI USA, V110, pE507, DOI 10.1073/pnas.1212655110
   Maiorano NA, 2012, INT J MOL SCI, V13, P558, DOI 10.3390/ijms13010558
   Mathis U, 2007, GRAEF ARCH CLIN EXP, V245, P267, DOI 10.1007/s00417-006-0282-x
   Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662
   McGarvey KM, 2015, MAMM GENOME, V26, P379, DOI 10.1007/s00335-015-9585-8
   McGlinn AM, 2007, INVEST OPHTH VIS SCI, V48, P3430, DOI 10.1167/iovs.06-1538
   Mei Y, 2013, J CELL BIOCHEM, V114, P1374, DOI 10.1002/jcb.24479
   Metlapally R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078984
   Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005
   Morgan Ian G, 2003, Clin Exp Optom, V86, P276
   NGUYENLEGROS J, 1994, INVEST OPHTH VIS SCI, V35, P2906
   Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002
   Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108
   O'Leary Nuala A, 2016, Nucleic Acids Res, V44, pD733, DOI 10.1093/nar/gkv1189
   Oyster CW, 1999, HUMAN EYE STRUCTURE
   Pandi SPS, 2013, INVEST OPHTH VIS SCI, V54, P8140, DOI 10.1167/iovs.13-12631
   Papadopoulos EI, 2015, GENE, V554, P174, DOI 10.1016/j.gene.2014.10.043
   Pararajasegaram R, 1999, AM J OPHTHALMOL, V128, P359
   Paschou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046189
   Pattanayak Debasis, 2005, Indian Journal of Experimental Biology, V43, P7
   Qi J, 2013, HUM GENET, V132, P1395, DOI 10.1007/s00439-013-1346-8
   Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234
   Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009
   Rada JAS, 2009, MOL VIS, V15, P778
   Ryan D, 2006, MOL VIS, V12, P1175
   Rymer J, 2005, VISUAL NEUROSCI, V22, P251, DOI 10.1017/S0952523805223015
   Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136
   Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x
   Schippert R, 2008, MOL VIS, V14, P1589
   SELTNER RLP, 1995, VISION RES, V35, P1265
   Shelton L, 2008, MOL VIS, V14, P1465
   Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104
   Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015
   Siegwart JT, 2002, INVEST OPHTH VIS SCI, V43, P2067
   Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863
   Singh SK, 2015, STEM CELL RES, V15, P305, DOI 10.1016/j.scr.2015.05.003
   Sinha M, 2011, RNA BIOL, V8, P1005, DOI 10.4161/rna.8.6.16035
   STONE RA, 1988, P NATL ACAD SCI USA, V85, P257, DOI 10.1073/pnas.85.1.257
   Sun KL, 2013, NAT REV GENET, V14, P535, DOI 10.1038/nrg3471
   Tkatchenko AV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005432
   Tkatchenko AV, 2006, P NATL ACAD SCI USA, V103, P4681, DOI 10.1073/pnas.0600589103
   Tkatchenko TV, 2010, INVEST OPHTH VIS SCI, V51, P1297, DOI 10.1167/iovs.09-4153
   Tkatchenko TV, 2010, INVEST OPHTH VIS SCI, V51, P21, DOI 10.1167/iovs.08-2767
   Trumbach D, 2015, CELL TISSUE RES, V359, P161, DOI 10.1007/s00441-014-1911-z
   Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073
   Vallejo DM, 2011, EMBO J, V30, P756, DOI 10.1038/emboj.2010.358
   Vessey KA, 2005, INVEST OPHTH VIS SCI, V46, P3922, DOI 10.1167/iovs.04-1026
   Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111
   Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110
   Wang HC, 2014, CANCER INFORM, V13, P25, DOI 10.4137/CIN.S14074
   Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091199
   Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744
   Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708
   Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038
   Xu SB, 2009, PROG RETIN EYE RES, V28, P87, DOI 10.1016/j.preteyeres.2008.11.003
   Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679
   Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106
   Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067
   Zhong XW, 2004, INVEST OPHTH VIS SCI, V45, P2065, DOI 10.1167/iovs.03-1046
NR 122
TC 12
Z9 12
U1 3
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 13
PY 2016
VL 11
IS 9
AR e0162541
DI 10.1371/journal.pone.0162541
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DW5JR
UT WOS:000383681000038
PM 27622715
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Muroya, S
   Shibata, M
   Hayashi, M
   Oe, M
   Ojima, K
AF Muroya, Susumu
   Shibata, Masahiro
   Hayashi, Masayuki
   Oe, Mika
   Ojima, Koichi
TI Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu
   Cattle Are Associated with Altered Expression of Intramuscular microRNA,
   the Potential Target PTEN, and Lipogenic Genes
SO PLOS ONE
LA English
DT Article
ID MUSCLE-FIBER CHARACTERISTICS; SLOW-TYPE MUSCLES; HIGH-FAT DIET;
   SKELETAL-MUSCLE; MEAT QUALITY; ADIPOSE-TISSUE; JAPANESE-BLACK;
   IDENTIFICATION; STEERS; PERFORMANCE
AB We aimed to understand the roles of miRNAs in the muscle tissue maturation and those of circulating microRNAs (c-miRNAs) in beef production of Japanese Black (JB) cattle (Wagyu), a breed with genetically background of superior intermuscular fat depot, by comparing different feeding conditions (indoor grain-feeding vs. grazing on pasture). The cattle at 18 months old were assigned to pasture feeding or conventional indoor grain feeding conditions for 5 months. Microarray analysis of c-miRNAs from the plasma extracellular vesicles led to the detection of a total of 202 bovine miRNAs in the plasma, including 15 miRNAs that differed between the feeding conditions. Validation of the microarray results by qPCR showed that the circulating miR-10b level in the grazing cattle was upregulated compared to that of the grain-fed cattle. In contrast, the levels of miR-17-5p, miR-19b, miR-29b, miR-30b-5p, miR-98, miR-142-5p, miR-301a, miR-374b, miR-425-5p, and miR-652 were lower in the grazing cattle than in the grain-fed cattle. Bioinformatic analysis indicated that the predicted target genes of those c-miRNAs were enriched in gene ontology terms associated with blood vessel morphogenesis, plasma membrane, focal adhesion, endocytosis, collagen, ECM-receptor interaction, and phosphorylation. In the grazing cattle, the elevation of miR-10b expression in the plasma was coincident with its elevation in the longissimus lumborum (LL) muscle. Expression of bovine-specific miR-2478, the most plasma-enriched miRNA, tended to be also upregulated in the muscle but not in the plasma. Furthermore, grazing caused the downregulated mRNA expression of predicted miR-10b and/or miR-2478 target genes, such as DNAJB2, PTEN, and SCD1. Thus, the feeding system used for JB cattle affected the c-miRNAs that could be indicators of grain feeding. Among these, miR-10b expression was especially associated with feeding-induced changes and with the expression of the potential target genes responsible for glucose homeo-stasis and intramuscular fat depot in the LL muscle of JB cattle.
C1 [Muroya, Susumu; Oe, Mika; Ojima, Koichi] NARO Inst Livestock & Grassland Sci, Anim Prod Res Div, Tsukuba, Ibaraki, Japan.
   [Shibata, Masahiro] NARO Western Reg Agr Ctr, Livestock Prod & Wildlife Management Res Div, Ohda, Shimane, Japan.
   [Hayashi, Masayuki] NARO Inst Livestock & Grassland Sci, Anim Physiol & Nutr Res Div, Tsukuba, Ibaraki, Japan.
RP Muroya, S (reprint author), NARO Inst Livestock & Grassland Sci, Anim Prod Res Div, Tsukuba, Ibaraki, Japan.
EM muros@affrc.go.jp
RI MUROYA, Susumu/H-9604-2019
OI MUROYA, Susumu/0000-0002-2376-9352; Ojima, Koichi/0000-0002-5973-1073
FU Japan Society for the Promotion of Science [JP15K07775, JP15K14849]
FX This work was supported by the Japan Society for the Promotion of
   Science (https://www.jsps.go.jp/; JSPS KAKENHI JP15K07775 to SM and
   JP15K14849 to MH). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. There was no additional external funding received for this
   study.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Bai WL, 2014, EXP MOL PATHOL, V96, P426, DOI 10.1016/j.yexmp.2014.04.011
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872
   Choi YM, 2009, LIVEST SCI, V122, P105, DOI 10.1016/j.livsci.2008.08.015
   Chung KY, 2007, J ANIM SCI, V85, P380, DOI 10.2527/jas.2006-087
   Claeys KG, 2010, AM J PATHOL, V176, P2901, DOI 10.2353/ajpath.2010.090663
   Das T, 2009, J CELL PHYSL, V218, P436, DOI [10.1002/jcp.21618, 10. 1002/ jcp. 21618 PMID:18937284, DOI 10.1002/JCP.21618PMID:18937284]
   Endo K, 2013, BIOMED RES-TOKYO, V34, P289, DOI 10.2220/biomedres.34.289
   Farrell D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134310
   Horikawa A, 2015, ANIMAL SCI IN PRESS
   Hu ZY, 2010, DIABETES, V59, P1312, DOI 10.2337/db09-1155
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Ioannidis J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2529-1
   Jeng SF, 2009, J NEUROTRAUM, V26, P2345, DOI 10.1089/neu.2009.0960
   Kim JM, 2015, ANIM GENET, V46, P73, DOI 10.1111/age.12255
   Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831
   LAMBRECHTS A, 1995, EUR J BIOCHEM, V230, P281, DOI 10.1111/j.1432-1033.1995.0281i.x
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Li HY, 2012, ANIM GENET, V43, P704, DOI 10.1111/j.1365-2052.2012.02332.x
   Liu JY, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.122788
   Liu YK, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-7
   Mahoney DJ, 2008, AM J PHYSIOL-REG I, V294, pR1901, DOI 10.1152/ajpregu.00847.2007
   Mandl A, 2007, MOL CELL BIOL, V27, P8098, DOI 10.1128/MCB.00756-07
   Meale SJ, 2014, J ANIM SCI, V92, P3328, DOI [10.2527/jas.2014-7710, 10.2527/jas2014-7710]
   Moisa SJ, 2014, GENE REGUL SYST BIO, V8, P17, DOI 10.4137/GRSB.S11782
   Muroya S, 2013, J ANIM SCI, V91, P90, DOI 10.2527/jas.2012-5371
   Muroya S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136475
   Muroya S, 2014, MEAT SCI, V98, P726, DOI 10.1016/j.meatsci.2014.07.018
   Mussnich P, 2013, MOL ONCOL, V7, P531, DOI 10.1016/j.molonc.2013.01.002
   Nakashima N, 2000, J BIOL CHEM, V275, P12889, DOI 10.1074/jbc.275.17.12889
   Ortega FJ, 2015, J NUTR BIOCHEM, V26, P1095, DOI 10.1016/j.jnutbio.2015.05.001
   Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005
   Pernier J, 2016, DEV CELL, V36, P201, DOI 10.1016/j.devcel.2015.12.024
   Ponsuksili S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-533
   Romao JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-137
   Romao JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040605
   Ryu YC, 2005, MEAT SCI, V71, P351, DOI 10.1016/j.meatsci.2005.04.015
   Sharples AP, 2013, GROWTH HORM IGF RES, V23, P53, DOI 10.1016/j.ghir.2013.03.004
   Shen LY, 2016, MEAT SCI, V116, P201, DOI 10.1016/j.meatsci.2016.02.023
   Shibata M, 2009, J ANIM SCI, V87, P2700, DOI 10.2527/jas.2008-1486
   Shibata M, 2016, ANIM SCI J, V87, P929, DOI 10.1111/asj.12519
   Shibata M, 2011, MEAT SCI, V89, P451, DOI 10.1016/j.meatsci.2011.05.006
   Shibata MMK, 2014, SCI RES, V4, P297, DOI DOI 10.4236/0JAS.2014.45038
   Sun JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099299
   Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013
   Waters SM, 2009, J ANIM SCI, V87, P244, DOI 10.2527/jas.2008-1005
   Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005
   Yamada T, 2012, MEAT SCI, V90, P807, DOI 10.1016/j.meatsci.2011.11.019
   ZEMBAYASHI M, 1995, MEAT SCI, V40, P211, DOI 10.1016/0309-1740(94)00046-A
   Zheng Y, 2014, CELL STRESS CHAPERON, V19, P973, DOI 10.1007/s12192-014-0521-8
NR 53
TC 3
Z9 3
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 9
PY 2016
VL 11
IS 9
AR e0162496
DI 10.1371/journal.pone.0162496
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV9JE
UT WOS:000383255900115
PM 27611783
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Stutika, C
   Mietzsch, M
   Gogol-Doring, A
   Weger, S
   Sohn, M
   Chen, W
   Heilbronn, R
AF Stutika, Catrin
   Mietzsch, Mario
   Gogol-Doering, Andreas
   Weger, Stefan
   Sohn, Madlen
   Chen, Wei
   Heilbronn, Regine
TI Comprehensive Small RNA-Seq of Adeno-Associated Virus (AAV)-Infected
   Human Cells Detects Patterns of Novel, Non-Coding AAV RNAs in the
   Absence of Cellular miRNA Regulation
SO PLOS ONE
LA English
DT Article
ID INVERTED TERMINAL REPEATS; GENE-EXPRESSION; DNA-REPLICATION; ADENOVIRUS
   REPLICATION; HUMAN PARVOVIRUS; SEQUENCING DATA; MICRORNAS; TYPE-2;
   TRANSCRIPTION; INFECTION
AB Most DNA viruses express small regulatory RNAs, which interfere with viral or cellular gene expression. For adeno-associated virus (AAV), a small ssDNA virus with a complex biphasic life cycle miRNAs or other small regulatory RNAs have not yet been described. This is the first comprehensive Illumina-based RNA-Seq analysis of small RNAs expressed by AAV alone or upon co-infection with helper adenovirus or HSV. Several hotspots of AAV-specific small RNAs were detected mostly close to or within the AAV-ITR and apparently transcribed from the newly identified anti-p5 promoter. An additional small RNA hotspot was located downstream of the p40 promoter, from where transcription of non-coding RNAs associated with the inhibition of adenovirus replication were recently described. Parallel detection of known Ad and HSV miRNAs indirectly validated the newly identified small AAV RNA species. The predominant small RNAs were analyzed on Northern blots and by human argonaute protein-mediated co-immunoprecipitation. None of the small AAV RNAs showed characteristics of bona fide miRNAs, but characteristics of alternative RNA processing indicative of differentially regulated AAV promoter-associated small RNAs. Furthermore, the AAV-induced regulation of cellular miRNA levels was analyzed at different time points post infection. In contrast to other virus groups AAV infection had virtually no effect on the expression of cellular miRNA, which underscores the long-established concept that wild-type AAV infection is apathogenic.
C1 [Stutika, Catrin; Mietzsch, Mario; Weger, Stefan; Heilbronn, Regine] Charite, Inst Virol, Campus Benjamin Franklin, Berlin, Germany.
   [Gogol-Doering, Andreas] Tech Hsch Mittelhessen, Giessen, Germany.
   [Sohn, Madlen; Chen, Wei] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab Funct Genom & Syst Biol, Berlin, Germany.
   [Mietzsch, Mario] Univ Florida, Dept Biochem & Mol Biol, Struct Biol Ctr, McKnight Brain Inst, Gainesville, FL 32610 USA.
RP Heilbronn, R (reprint author), Charite, Inst Virol, Campus Benjamin Franklin, Berlin, Germany.
EM regine.heilbronn@charite.de
FU Sonnenfeld-Stiftung, Berlin; Charite Universitatsmedizin Berlin
FX RH received funding by the Sonnenfeld-Stiftung, Berlin;
   http://www.sonnenfeld-stiftung.de/. CS received a Ph.D. scholarship from
   Charite Universitatsmedizin Berlin.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005
   Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006
   Aparicio O, 2010, NUCLEIC ACIDS RES, V38, P750, DOI 10.1093/nar/gkp1028
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bellutti F, 2015, J VIROL, V89, P1608, DOI 10.1128/JVI.02336-14
   BLACKLOW NR, 1967, P NATL ACAD SCI USA, V58, P1410, DOI 10.1073/pnas.58.4.1410
   Brister JR, 2000, J VIROL, V74, P7762, DOI 10.1128/JVI.74.17.7762-7771.2000
   Brister JR, 1999, J VIROL, V73, P9325
   BULLER RML, 1981, J VIROL, V40, P241
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Damm K, 2015, METHODS MOL BIOL, V1296, P41, DOI 10.1007/978-1-4939-2547-6_5
   Ferrari FK, 1996, J VIROL, V70, P3227
   Flores O, 2013, J VIROL, V87, P6589, DOI 10.1128/JVI.00504-13
   FLOTTE TR, 1993, J BIOL CHEM, V268, P3781
   Furuse Y, 2013, VIROLOGY, V447, P140, DOI 10.1016/j.virol.2013.08.024
   GEORGFRIES B, 1984, VIROLOGY, V134, P64, DOI 10.1016/0042-6822(84)90272-1
   Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129
   Haberman RP, 2000, J VIROL, V74, P8732, DOI 10.1128/JVI.74.18.8732-8739.2000
   Harris CJ, 2015, NUCLEIC ACIDS RES, V43, P7590, DOI 10.1093/nar/gkv604
   HAUSWIRTH WW, 1977, VIROLOGY, V78, P488, DOI 10.1016/0042-6822(77)90125-8
   He SM, 2008, CRIT REV MICROBIOL, V34, P175, DOI 10.1080/10408410802482008 
   HEILBRONN R, 1990, J VIROL, V64, P3012
   Huser D, 2014, J VIROL, V88, P11253, DOI 10.1128/JVI.01356-14
   Jing XJ, 2001, VIROLOGY, V291, P140, DOI 10.1006/viro.2001.1192
   Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09
   Keam Simon P., 2015, Life-Basel, V5, P1638, DOI 10.3390/life5041638
   Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235
   Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644
   Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018
   King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282
   KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211
   Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181
   Langenberger D, 2009, BIOINFORMATICS, V25, P2298, DOI 10.1093/bioinformatics/btp419
   Langmead B., 2010, CURR PROTOC BIOINFOR, V11, P7, DOI DOI 10.1002/0471250953.BI1107S32
   Lin YT, 2010, RNA, V16, P1540, DOI 10.1261/rna.1967910
   MCPHERSON RA, 1985, VIROLOGY, V147, P217, DOI 10.1016/0042-6822(85)90243-0
   Meshesha Mesfin K, 2012, Open Virol J, V6, P38, DOI 10.2174/1874357901206010038
   Mietzsch M, 2014, J VIROL, V88, P2991, DOI 10.1128/JVI.03371-13
   Munson DJ, 2012, ARCH VIROL, V157, P1677, DOI 10.1007/s00705-012-1345-4
   Pereira DJ, 1997, J VIROL, V71, P1079
   Qiu JM, 2002, J VIROL, V76, P12435, DOI 10.1128/JVI.76.24.12435-12447.2002
   Rother S, 2011, BIOCHIMIE, V93, P1905, DOI 10.1016/j.biochi.2011.07.032
   Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253
   Son KN, 2015, J VIROL, V89, P9383, DOI 10.1128/JVI.01299-15
   Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107
   SRIVASTAVA A, 1983, J VIROL, V45, P555
   Stilwell JL, 2004, MOL THER, V9, P337, DOI 10.1016/j.ymthe.2003.11.007
   Stutika C, 2016, J VIROL, V90, P1278, DOI 10.1128/JVI.02750-15
   Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312
   THOMSON BJ, 1994, VIROLOGY, V204, P304, DOI 10.1006/viro.1994.1535
   Timpe JA, 2006, J VIROL, V80, P7807, DOI 10.1128/JVI.00198-06
   Tuddenham L, 2012, J VIROL, V86, P1638, DOI 10.1128/JVI.05911-11
   Tycowski KT, 2015, GENE DEV, V29, P567, DOI 10.1101/gad.259077.115
   Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103
   Wang LN, 2015, J GEN VIROL, V96, P2780, DOI 10.1099/jgv.0.000229
   Wang XS, 1997, J VIROL, V71, P3077
   Wang XS, 1996, J VIROL, V70, P1668
   Weger S, 2016, J VIROL, V90, P3981, DOI 10.1128/JVI.03120-15
   WEINDLER FW, 1991, J VIROL, V65, P2476
   Winter K, 2012, J VIROL, V86, P5099, DOI 10.1128/JVI.06991-11
   Yan BX, 2012, CELL MOL LIFE SCI, V69, P2833, DOI 10.1007/s00018-012-0953-1
   Yang JS, 1999, J VIROL, V73, P9468
   Zhao HX, 2015, VIROLOGY, V478, P99, DOI 10.1016/j.virol.2015.01.033
NR 65
TC 2
Z9 2
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 9
PY 2016
VL 11
IS 9
AR e0161454
DI 10.1371/journal.pone.0161454
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV9JE
UT WOS:000383255900017
PM 27611072
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Zhang, W
   Zhong, L
   Wang, J
   Han, JY
AF Zhang, Wei
   Zhong, Liang
   Wang, Jing
   Han, Jianyong
TI Distinct MicroRNA Expression Signatures of Porcine Induced Pluripotent
   Stem Cells under Mouse and Human ESC Culture Conditions
SO PLOS ONE
LA English
DT Article
ID DLK1-DIO3 REGION; SELF-RENEWAL; DIFFERENTIATION; IDENTIFICATION;
   TARGETS; TRANSITION; CLUSTER; MIR-302; PATHWAY; KINASE
AB It is well known that microRNAs play a very important role in regulating reprogramming, pluripotency and cell fate decisions. Porcine induced pluripotent stem cells (piPSCs) are now available for studying the pluripotent regulation network in pigs. Two types of piPSCs have been derived from human and mouse embryonic stem cell (ESC) culture conditions: hpiPSCs and mpiPSCs, respectively. The hpiPSCs were morphologically similar to human ESCs, and the mpiPSCs resembled mouse ESCs. However, our current understanding of the role of microRNAs in the development of piPSCs is still very limited. Here, we performed small RNA sequencing to profile the miRNA expression in porcine fibroblasts (pEFs), hpiPSCs and mpiPSCs. There were 22 differential expressed (DE) miRNAs down-regulated in both types of piPSCs compared with pEFs, such as ssc-miR-145-5p and ssc-miR-98. There were 27 DE miRNAs up-regulated in both types of piPSCs compared with pEFs. Among these up-regulated DE miRNAs in piPSCs, ssc-miR-217, ssc-miR-216, ssc-miR-142-5p, ssc-miR-182, ssc-miR-183 and ssc-miR-96-5p have much higher expression levels in mpiPSCs, while ssc-miR-106a, ssc-miR-363, ssc-miR-146b, ssc-miR-195, ssc-miR-497, ssc-miR-935 and ssc-miR-20b highly expressed in hpiPSCs. Quantitative stem-loop RTPCR was performed to confirm selected DE miRNAs expression levels. The results were consistent with small RNA sequencing. Different expression patterns were observed for key miRNA clusters, such as the miR-17-92 cluster, the let-7 family, the miR-106a-363 cluster and the miR-182-183 cluster, in the mpiPSCs and hpiPSCs. Novel miRNAs were also predicted in this study, including a putative porcine miR-302 cluster: ssc_38503, ssc_38503 and ssc_38501 (which resemble human miR-302a and miR-302b) found in both types of piPSCs. The miR-106a-363 cluster and putative miR-302 cluster increased the reprogramming efficiency of pEFs. The study revealed significant differences in the miRNA signatures of hpiPSCs and mpiPSCs under different pluripotent states that were derived from different culture conditions. These differentially expressed miRNAs may play important roles in pluripotent regulation in pigs, and this information will facilitate the understanding of the mechanism of pluripotency in pigs.
C1 [Zhang, Wei; Zhong, Liang; Wang, Jing; Han, Jianyong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.
RP Han, JY (reprint author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.
EM hanjy@cau.edu.cn
RI zhang, wei/J-1685-2019
FU China National Key Research Program [SQ2016ZY05002032-02]; China
   National Basic Research Program [2011CBB01001]; Program for New Century
   Excellent Talents in University [NCET-11-0482]; State Key Laboratories
   for Agrobiotechnology, China Agricultural University [2015SKLAB1-4];
   National Thousand Talents Program of China
FX This study was supported by grants from China National Key Research
   Program (SQ2016ZY05002032-02), China National Basic Research Program
   (2011CBB01001), National Thousand Talents Program of China, Program for
   New Century Excellent Talents in University (NCET-11-0482), and by
   Research Programs from the State Key Laboratories for Agrobiotechnology,
   China Agricultural University (2015SKLAB1-4). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Aravalli RN, 2012, VET J, V194, P369, DOI [10.1016/j.tvjl.2012.05,013, 10.1016/j.tvjl.2012.05.013]
   Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308
   Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995
   Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08
   Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178
   Chen GF, 2014, CELL RES, V24, P1121, DOI 10.1038/cr.2014.112
   Cheng D, 2012, CELL REPROGRAM, V14, P312, DOI 10.1089/cell.2012.0025
   Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485
   Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002
   Furuta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060155
   Gao J, 2011, J CELL BIOCHEM, V112, P1844, DOI 10.1002/jcb.23106
   Greve TS, 2013, ANNU REV CELL DEV BI, V29, P213, DOI 10.1146/annurev-cellbio-101512-122343
   Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006
   Grunhagen J, 2015, J BONE MINER RES, V30, P796, DOI 10.1002/jbmr.2412
   Gu MX, 2012, CIRC RES, V111, P882, DOI 10.1161/CIRCRESAHA.112.269001
   He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552
   Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235
   Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2
   Jouneau A, 2012, RNA, V18, P253, DOI 10.1261/rna.028878.111
   Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897
   Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311
   Li L, 2015, CELL MOL BIOL LETT, V20, P385, DOI 10.1515/cmble-2015-0023
   Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014
   Li W, 2011, CELL RES, V21, P550, DOI 10.1038/cr.2011.25
   Li XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066688
   Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2
   Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960
   Lichner Z, 2011, DIFFERENTIATION, V81, P11, DOI 10.1016/j.diff.2010.08.002
   Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850
   Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211
   Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Ma KY, 2014, MOL CELL BIOCHEM, V389, P209, DOI 10.1007/s11010-013-1942-x
   Mackowiak Sebastian D, 2011, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1210s36
   Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031
   Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001
   Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299
   Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101
   Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20
   Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049079
   Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462
   Sladitschek HL, 2015, CELL SYST BIOL, P11
   Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426
   Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862
   Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009
   Tang XL, 2014, NUCLEIC ACIDS RES, V42, P2988, DOI 10.1093/nar/gkt1275
   Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299
   Tsai ZY, 2010, J CELL BIOCHEM, V109, P93, DOI 10.1002/jcb.22385
   Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110
   Wang YM, 2013, CELL REP, V4, P99, DOI 10.1016/j.celrep.2013.05.027
   Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250
   Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111
   Wei Q, 2015, THORAC CANCER, V6, P2, DOI 10.1111/1759-7714.12164
   Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104
   Xia HP, 2013, HEPATOLOGY, V58, P629, DOI 10.1002/hep.26369
   Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038
   Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761
   Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744
   Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200
   Zhang W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124562
   Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607
   Zhou L, 2011, STEM CELLS, V29, P972, DOI 10.1002/stem.637
NR 64
TC 3
Z9 5
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 6
PY 2016
VL 11
IS 7
AR e0158655
DI 10.1371/journal.pone.0158655
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DR3NH
UT WOS:000379809400073
PM 27384321
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Potenza, N
   Castiello, F
   Panella, M
   Colonna, G
   Ciliberto, G
   Russo, A
   Costantini, S
AF Potenza, Nicoletta
   Castiello, Filomena
   Panella, Marta
   Colonna, Giovanni
   Ciliberto, Gennaro
   Russo, Aniello
   Costantini, Susan
TI Human MiR-544a Modulates SELK Expression in Hepatocarcinoma Cell Lines
SO PLOS ONE
LA English
DT Article
ID HEPATOCELLULAR-CARCINOMA; CANCER-CELLS; REGULATES EXPRESSION;
   LIVER-CANCER; IN-VITRO; SELENOPROTEINS; MICRORNAS; PROMOTES; ETIOLOGY;
   TARGETS
AB Hepatocellular carcinoma (HCC) is a multi-factorial cancer with a very poor prognosis; therefore, there are several investigations aimed at the comprehension of the molecular mechanisms leading to development and progression of HCC and at the definition of new therapeutic strategies. We have recently evaluated the expression of selenoproteins in HCC cell lines in comparison with normal hepatocytes. Recent results have shown that some of them are down- and others up-regulated, including the selenoprotein K (SELK), whose expression was also induced by sodium selenite treatment on cells. However, so far very few studies have been dedicated to a possible effect of microRNAs on the expression of selenoproteins and their implication in HCC. In this study, the analysis of SELK 3'UTR by bioinformatics tools led to the identification of eight sites potentially targeted by human microRNAs. They were then subjected to a validation test based on luciferase reporter constructs transfected in HCC cell lines. In this functional screening, miR-544a was able to interact with SELK 3'UTR suppressing the reporter activity. Transfection of a miR-544a mimic or inhibitor was then shown to decrease or increase, respectively, the translation of the endogenous SELK mRNA. Intriguingly, miR-544a expression was found to be modulated by selenium treatment, suggesting a possible role in SELK induction by selenium.
C1 [Potenza, Nicoletta; Castiello, Filomena; Panella, Marta; Russo, Aniello] Univ Naples 2, Dipartimento Sci & Tecnol Ambientali, Biol & Farmaceut, Caserta, Italy.
   [Colonna, Giovanni] Univ Naples 2, Azienda Osped Univ, Serv Informat Med, Naples, Italy.
   [Ciliberto, Gennaro] Ist Nazl Tumori Fdn G Pascale IRCCS, Direttore Sci, Naples, Italy.
   [Costantini, Susan] Ist Nazl Tumori Fdn G Pascale IRCCS, CROM, Naples, Italy.
RP Potenza, N (reprint author), Univ Naples 2, Dipartimento Sci & Tecnol Ambientali, Biol & Farmaceut, Caserta, Italy.; Costantini, S (reprint author), Ist Nazl Tumori Fdn G Pascale IRCCS, CROM, Naples, Italy.
EM nicoletta.potenza@unina2.it; s.costantini@istitutotumori.na.it
RI Ciliberto, Gennaro/J-4131-2017; Costantini, Susan/J-9914-2018
OI Ciliberto, Gennaro/0000-0003-2851-8605; Costantini,
   Susan/0000-0002-7538-4657
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219
   Bronte F, 2016, CRIT REV ONCOL HEMAT, V97, P312, DOI 10.1016/j.critrevonc.2015.09.007
   Capone F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134594
   DAEMER RJ, 1980, INFECT IMMUN, V30, P607
   Davis-Dusenbery Brandi N, 2010, Genes Cancer, V1, P1100, DOI 10.1177/1947601910396213
   Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715
   Diamond AM, 2015, NUTRIENTS, V7, P3938, DOI 10.3390/nu7053938
   Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001
   Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607
   Guariniello S, 2015, ANAL CELL PATHOL AMS, V2015
   Haga CL, 2015, ACS CHEM BIOL, V10, P2267, DOI 10.1021/acschembio.5b00265
   He XX, 2016, TUMOR BIOL, V37, P807, DOI 10.1007/s13277-015-3857-5
   Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279
   John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264
   Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394
   Lee JH, 2015, J BIOL CHEM, V290, P29941, DOI 10.1074/jbc.M115.680215
   Liu J, 2014, FEBS LETT, V588, P3311, DOI 10.1016/j.febslet.2014.07.037
   Maciel-Dominguez A, 2013, MOL NUTR FOOD RES, V57, P2195, DOI 10.1002/mnfr.201300168
   Mao LY, 2015, AM J CANCER RES, V5, P1939
   Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022
   Meplan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048709
   Michael MZ, 2003, MOL CANCER RES, V1, P882
   Mo XM, 2014, ONCOL LETT, V8, P1731, DOI 10.3892/ol.2014.2387
   Mo XM, 2014, ONCOTARGETS THER, V7, P895, DOI 10.2147/OTT.S61695
   Morishita A, 2015, HEPATOL RES, V45, P128, DOI 10.1111/hepr.12386
   Mosca N, 2014, BIOCHEM BIOPH RES CO, V449, P141, DOI 10.1016/j.bbrc.2014.05.009
   Mukhopadhyay B, 2015, HEPATOLOGY, V61, P1615, DOI 10.1002/hep.27686
   Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283
   Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067
   Rusolo F, 2013, MOLECULES, V18, P2549, DOI 10.3390/molecules18032549
   Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14
   Stiuso P, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.8
   Sun J, 2013, SCI WORLD J, V2013, P14
   Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637
   Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158
   Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003
   Yanaka Y, 2015, CARCINOGENESIS, V36, P1363, DOI 10.1093/carcin/bgv106
   Yang YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149227
   Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444
NR 40
TC 7
Z9 7
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 8
PY 2016
VL 11
IS 6
AR e0156908
DI 10.1371/journal.pone.0156908
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO1TJ
UT WOS:000377561700048
PM 27275761
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU MacLean, JA
   King, ML
   Okuda, H
   Hayashi, K
AF MacLean, James A., II
   King, Mandy L.
   Okuda, Hiroshi
   Hayashi, Kanako
TI WNT7A Regulation by miR-15b in Ovarian Cancer
SO PLOS ONE
LA English
DT Article
ID TARGETING BCL2; CELLS; EXPRESSION; MICRORNAS; APOPTOSIS; GENES
AB WNT signaling is well known to play an important role in the regulation of development, cell proliferation and cell differentiation in a wide variety of normal and cancerous tissues. Despite the wealth of knowledge concerning when and where various WNT genes are expressed and downstream events under their control, there is surprisingly little published evidence of how they are regulated. We have recently reported that aberrant WNT7A is observed in serous ovarian carcinomas, and WNT7A is the sole ligand accelerating ovarian tumor progression through CTNNB1 (beta-catenin)/TCF signaling in the absence of CTNNB1 mutations. In the present study, we report that WNT7A is a direct target of miR-15b in ovarian cancer. We showed that a luciferase reporter containing the putative binding site of miR-15b in the WNT7A 3'-UTR was significantly repressed by miR-15b. Mutation of the putative binding site of miR-15b in the WNT7A 3'-UTR restored luciferase activity. Furthermore, miR-15b was able to repress increased levels of TOPFLASH activity by WNT7A, but not those induced by S33Y. Additionally, miR-15b dose-dependently decreased WNT7A expression. When we evaluated the prognostic impact of WNT7A and miR-15b expression using TCGA datasets, a significant inverse correlation in which high-expression of WNT7A and low-expression of miR-15b was associated with reduced survival rates of ovarian cancer patients. Treatment with decitabine dose-dependently increased miR-15b expression, and silencing of DNMT1 significantly increased miR-15b expression. These results suggest that WNT7A is post-transcriptionally regulated by miR-15b, which could be down-regulated by promoter hypermethylation, potentially via DNMT1, in ovarian cancer.
C1 [MacLean, James A., II; King, Mandy L.; Hayashi, Kanako] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.
   [Okuda, Hiroshi] Kyoto Univ, Grad Sch Med, Lab Malignancy Control Res, Kyoto, Japan.
RP Hayashi, K (reprint author), So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.
EM khayashi@siumed.edu
OI Hayashi, Kanako/0000-0002-5028-799X
FU National Institutes of Health [CA179214]
FX This work was funded by National Institutes of Health CA179214.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552
   Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880
   Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799
   Cheng JC, 2011, ONCOGENE, V30, P3930, DOI 10.1038/onc.2011.117
   Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102
   Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018
   Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715
   Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126
   Gu YF, 2013, ONCOL LETT, V5, P452, DOI 10.3892/o1.2012.1057
   Guglielmelli P, 2011, BLOOD, V117, P6923, DOI 10.1182/blood-2010-09-306506
   Hayashi K, 2009, BIOL REPROD, V80, P989, DOI 10.1095/biolreprod.108.075416
   King ML, 2015, ONCOGENE, V34, P3452, DOI 10.1038/onc.2014.277
   Lovat F, 2015, P NATL ACAD SCI USA, V112, P11636, DOI 10.1073/pnas.1514954112
   Pekarsky Y, 2015, CELL DEATH DIFFER, V22, P6, DOI 10.1038/cdd.2014.87
   Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052
   Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126
   Polytarchou C, 2012, P NATL ACAD SCI USA, V109, P14470, DOI 10.1073/pnas.1212811109
   Sanchez-Beato M, 2003, BLOOD, V101, P1220, DOI 10.1182/blood-2002-07-2009
   Satzger I, 2010, INT J CANCER, V126, P2553, DOI 10.1002/ijc.24960
   Sehgal V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140072
   Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263
   Suzuki HI, 2015, ONCOGENE, V34, P3085, DOI 10.1038/onc.2014.254
   Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501
   Yoshioka S, 2012, MOL CANCER RES, V10, P469, DOI 10.1158/1541-7786.MCR-11-0177
   YU DH, 1993, CANCER RES, V53, P891
   Yue JM, 2010, MAMM GENOME, V21, P88, DOI 10.1007/s00335-009-9240-3
NR 28
TC 14
Z9 15
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 19
PY 2016
VL 11
IS 5
AR e0156109
DI 10.1371/journal.pone.0156109
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM4BR
UT WOS:000376291100160
PM 27195958
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Lafzi, A
   Kazan, H
AF Lafzi, Atefeh
   Kazan, Hilal
TI Inferring RBP-Mediated Regulation in Lung Squamous Cell Carcinoma
SO PLOS ONE
LA English
DT Article
ID RNA-BINDING PROTEIN; DIFFERENTIAL EXPRESSION ANALYSIS; YIN YANG 1;
   NONCODING RNA; TARGET INTERACTIONS; CANCER PROGRESSION;
   COLORECTAL-CANCER; PAR-CLIP; HUR; METASTASIS
AB RNA-binding proteins (RBPs) play key roles in post-transcriptional regulation of mRNAs. Dysregulations in RBP-mediated mechanisms have been found to be associated with many steps of cancer initiation and progression. Despite this, previous studies of gene expression in cancer have ignored the effect of RBPs. To this end, we developed a lasso regression model that predicts gene expression in cancer by incorporating RBP-mediated regulation as well as the effects of other well-studied factors such as copy-number variation, DNA methylation, TFs and miRNAs. As a case study, we applied our model to Lung squamous cell carcinoma (LUSC) data as we found that there are several RBPs differentially expressed in LUSC. Including RBP-mediated regulatory effects in addition to the other features significantly increased the Spearman rank correlation between predicted and measured expression of held-out genes. Using a feature selection procedure that accounts for the adaptive search employed by lasso regularization, we identified the candidate regulators in LUSC. Remarkably, several of these candidate regulators are RBPs. Furthermore, majority of the candidate regulators have been previously found to be associated with lung cancer. To investigate the mechanisms that are controlled by these regulators, we predicted their target gene sets based on our model. We validated the target gene sets by comparing against experimentally verified targets. Our results suggest that the future studies of gene expression in cancer must consider the effect of RBP-mediated regulation.
C1 [Lafzi, Atefeh] Middle E Tech Univ, Dept Hlth Informat, TR-06531 Ankara, Turkey.
   [Kazan, Hilal] Antalya Int Univ, Dept Comp Engn, Antalya, Turkey.
RP Kazan, H (reprint author), Antalya Int Univ, Dept Comp Engn, Antalya, Turkey.
EM hilal.kazan@antalya.edu.tr
RI Lafzi, Atefeh/P-6687-2019
OI Lafzi, Atefeh/0000-0003-4237-4847
FU Scientific and Technological Research Council of Turkey [113E159];
   European Union Marie Curie Career Integration Grant [631986]
FX This work was supported by The Scientific and Technological Research
   Council of Turkey (113E159 to H.K.) and European Union Marie Curie
   Career Integration Grant (631986 to H.K.). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abdelmohsen K, 2011, WILEY INTERDISCIPLIN, V1, P214, DOI [10.1002/wrna.4, DOI 10.1002/WRNA.4]
   Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887
   Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099
   Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021
   Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z
   Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351
   Bielli P, 2011, ENDOCR-RELAT CANCER, V18, pR91, DOI 10.1530/ERC-11-0041
   Bolognani F, 2012, J NEURO-ONCOL, V106, P531, DOI 10.1007/s11060-011-0707-1
   Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314
   Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031
   Consortium EP, 2011, PLOS BIOL, V9, DOI DOI 10.1371/JOURNAL.PBIO.1001046
   Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069
   Davidson MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012560
   Friedersdorf MB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r2
   Friedman J, 2010, J STAT SOFTW, V33, P1
   Frisone P, 2015, BIOMED RES INT, DOI 10.1155/2015/528954
   Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064
   Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Ho JJD, 2014, WIRES RNA, V5, P69, DOI 10.1002/wrna.1197
   Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266
   Jacobsen A, 2013, NAT STRUCT MOL BIOL, V20, P1325, DOI 10.1038/nsmb.2678
   Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928
   Ji Q, 2014, BRIT J CANCER, V111, P736, DOI 10.1038/bjc.2014.383
   Jun-Hao L, 2013, NUCLEIC ACIDS RES, V42, P2380
   Kim GY, 2011, MODERN PATHOL, V24, P1336, DOI 10.1038/modpathol.2011.90
   Kim MY, 2009, BMB REP, V42, P125, DOI 10.5483/BMBRep.2009.42.3.125
   Kim M, 2015, METHODS, V83, P111, DOI 10.1016/j.ymeth.2015.04.011
   Li Y, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003908
   Liao WT, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-126
   Lockhart R, 2014, ANN STAT, V42, P413, DOI 10.1214/13-AOS1175
   Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530
   Mataki H, 2015, J HUM GENET, V53-61, P2120
   Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176
   Mukherjee N, 2011, MOL CELL, V43, P327, DOI [10.1016/j.molce1.2011.06.007, 10.1016/j.molcel.2011.06.007]
   Nam JW, 2014, MOL CELL, V53, P1031, DOI 10.1016/j.molcel.2014.02.013
   Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039
   Ponten F, 2011, J INTERN MED, V270, P428, DOI 10.1111/j.1365-2796.2011.02427.x
   Qian J, 2012, P NATL ACAD SCI USA, V106, P3469
   Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894
   Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37
   Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263
   Taylor J, 2015, P NATL ACAD SCI USA, V112, P7629, DOI 10.1073/pnas.1507583112
   The Cancer Genome Atlas Research Network, 2011, TCGA DAT PORT
   Wan MM, 2012, AM J PATHOL, V180, P2120, DOI 10.1016/j.ajpath.2012.01.037
   Wang J, 2013, INT J MOL SCI, V14, P10015, DOI 10.3390/ijms140510015
   Wang J, 2011, MED ONCOL, V28, pS577, DOI 10.1007/s12032-010-9734-6
   Wurth L, 2012, COMP FUNCT GENOM, V2012, DOI DOI 10.1155/2012/178525
   Xia Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6274
NR 52
TC 1
Z9 1
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 17
PY 2016
VL 11
IS 5
AR e0155354
DI 10.1371/journal.pone.0155354
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM3YJ
UT WOS:000376282300028
PM 27186987
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Penso-Dolfin, L
   Swofford, R
   Johnson, J
   Alfoldi, J
   Lindblad-Toh, K
   Swarbreck, D
   Moxon, S
   Di Palma, F
AF Penso-Dolfin, Luca
   Swofford, Ross
   Johnson, Jeremy
   Alfoldi, Jessica
   Lindblad-Toh, Kerstin
   Swarbreck, David
   Moxon, Simon
   Di Palma, Federica
TI An Improved microRNA Annotation of the Canine Genome
SO PLOS ONE
LA English
DT Article
ID CHRONIC LYMPHOCYTIC-LEUKEMIA; DEEP SEQUENCING DATA; SMALL RNAS; CELL
   LYMPHOMAS; HEART-FAILURE; EXPRESSION; BIOGENESIS; EVOLUTION; GENES;
   IDENTIFICATION
AB The domestic dog, Canis familiaris, is a valuable model for studying human diseases. The publication of the latest Canine genome build and annotation, CanFam3.1 provides an opportunity to enhance our understanding of gene regulation across tissues in the dog model system. In this study, we used the latest dog genome assembly and small RNA sequencing data from 9 different dog tissues to predict novel miRNAs in the dog genome, as well as to annotate conserved miRNAs from the miRBase database that were missing from the current dog annotation. We used both miRCat and miRDeep2 algorithms to computationally predict miRNA loci. The resulting, putative hairpin sequences were analysed in order to discard false positives, based on predicted secondary structures and patterns of small RNA read alignments. Results were further divided into high and low confidence miRNAs, using the same criteria. We generated tissue specific expression profiles for the resulting set of 811 loci: 720 conserved miRNAs, (207 of which had not been previously annotated in the dog genome) and 91 novel miRNA loci. Comparative analyses revealed 8 putative homologues of some novel miRNA in ferret, and one in microbat. All miRNAs were also classified into the genic and intergenic categories, based on the Ensembl RefSeq gene annotation for CanFam3.1. This additionally allowed us to identify four previously undescribed MiRtrons among our total set of miRNAs. We additionally annotated piRNAs, using proTRAC on the same input data. We thus identified 263 putative clusters, most of which (211 clusters) were found to be expressed in testis. Our results represent an important improvement of the dog genome annotation, paving the way to further research on the evolution of gene regulation, as well as on the contribution of post-transcriptional regulation to pathological conditions.
C1 [Penso-Dolfin, Luca; Di Palma, Federica] Genome Anal Ctr, Vertebrate & Hlth Genom, Norwich, Norfolk, England.
   [Swarbreck, David; Moxon, Simon] Genome Anal Ctr, Regulatory Genom, Norwich, Norfolk, England.
   [Swofford, Ross; Johnson, Jeremy; Alfoldi, Jessica; Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Vertebrate Genome Biol, Cambridge, MA USA.
   [Lindblad-Toh, Kerstin] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Uppsala, Sweden.
RP Di Palma, F (reprint author), Genome Anal Ctr, Vertebrate & Hlth Genom, Norwich, Norfolk, England.; Moxon, S (reprint author), Genome Anal Ctr, Regulatory Genom, Norwich, Norfolk, England.
EM Simon.Moxon@tgac.ac.uk; Federica.Di-Palma@tgac.ac.uk
OI Penso Dolfin, Luca/0000-0002-4893-2400; Moxon,
   Simon/0000-0003-4644-1816; Di-Palma, Federica/0000-0002-4394-0102;
   Swarbreck, David/0000-0002-5453-1013
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837
   Bannasch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009632
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040
   Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079
   Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193
   Brown Miguel, 2013, Frontiers in Genetics, V4, P145, DOI 10.3389/fgene.2013.00145
   Buza Teresia, 2014, BMC Res Notes, V7, P403, DOI 10.1186/1756-0500-7-403
   Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Chen YH, 2000, RNA, V6, P1277, DOI 10.1017/S1355838200000285
   Chen Y, 2014, J MOL CELL CARDIOL, V77, P113, DOI 10.1016/j.yjmcc.2014.10.001
   Dai Zhong-Hua, 2010, Yichuan, V32, P105, DOI 10.3724/SP.J.1005.2010.00105
   de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915
   Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452
   Dreger DL, 2013, J HERED, V104, P399, DOI 10.1093/jhered/est012
   Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102
   Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394
   Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688
   Genini S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-172
   Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504
   Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68
   Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191
   Guo JW, 2012, J BONE MINER RES, V27, P1607, DOI 10.1002/jbmr.1597
   Ha H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-545
   Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838
   Hoeppner MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091172
   Hofacker Ivo L, 2009, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1202s26
   Hoopes BC, 2012, MAMM GENOME, V23, P780, DOI 10.1007/s00335-012-9417-z
   Jain M, 2014, J EXP BOT, V65, P5945, DOI 10.1093/jxb/eru333
   Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014
   Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509
   Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632
   Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486
   Koppers-Lalic D, 2014, CELL REP, V8, P1649, DOI 10.1016/j.celrep.2014.08.027
   Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181
   Ladewig E, 2012, GENOME RES, V22, P1634, DOI 10.1101/gr.133553.111
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Lulli V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060436
   Maxwell EK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-714
   Melman YF, 2015, CIRCULATION, V131, P2202, DOI 10.1161/CIRCULATIONAHA.114.013220
   Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355
   Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112
   Michael MZ, 2003, MOL CANCER RES, V1, P882
   Mraz M, 2012, EXPERT REV HEMATOL, V5, P579, DOI [10.1586/EHM.12.54, 10.1586/ehm.12.54]
   Noguchi S, 2016, VET COMP ONCOL, V14, P384, DOI 10.1111/vco.12118
   Noguchi S, 2013, VET COMP ONCOL, V11, P113, DOI 10.1002/vco.306
   Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332
   Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195
   Pazzaglia L, 2015, RES VET SCI, V99, P112, DOI 10.1016/j.rvsc.2014.12.017
   Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223
   Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47
   Rosenkranz D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-5
   Seppala EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002194
   Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004
   Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089
   Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311
   Stroynowska-Czerwinska A, 2014, CELL MOL LIFE SCI, V71, P2253, DOI 10.1007/s00018-013-1551-6
   Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37
   Uhl E, 2011, GENE CHROMOSOME CANC, V50, P950, DOI 10.1002/gcc.20917
   Wang LS, 2015, BLOOD, V125, P1302, DOI 10.1182/blood-2014-06-581926
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525
   Zhao FR, 2014, INFECT GENET EVOL, V21, P367, DOI 10.1016/j.meegid.2013.11.019
NR 68
TC 4
Z9 4
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 27
PY 2016
VL 11
IS 4
AR e0153453
DI 10.1371/journal.pone.0153453
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DK5QZ
UT WOS:000374976200025
PM 27119849
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Le, TD
   Zhang, JP
   Liu, L
   Liu, HW
   Li, JY
AF Le, Thuc Duy
   Zhang, Junpeng
   Liu, Lin
   Liu, Huawen
   Li, Jiuyong
TI miRLAB: An R Based Dry Lab for Exploring miRNA-mRNA Regulatory
   Relationships
SO PLOS ONE
LA English
DT Article
ID INFERRING MICRORNA; PROTEIN; CANCER; REGULARIZATION; NETWORKS; RESOURCE;
   TARGETS; SYSTEMS; MODELS
AB microRNAs (miRNAs) are important gene regulators at post-transcriptional level, and inferring miRNA-mRNA regulatory relationships is a crucial problem. Consequently, several computational methods of predicting miRNA targets have been proposed using expression data with or without sequence based miRNA target information. A typical procedure for applying and evaluating such a method is i) collecting matched miRNA and mRNA expression profiles in a specific condition, e.g. a cancer dataset from The Cancer Genome Atlas (TCGA), ii) applying the new computational method to the selected dataset, iii) validating the predictions against knowledge from literature and third-party databases, and comparing the performance of the method with some existing methods. This procedure is time consuming given the time elapsed when collecting and processing data, repeating the work from existing methods, searching for knowledge from literature and third-party databases to validate the results, and comparing the results from different methods. The time consuming procedure prevents researchers from quickly testing new computational models, analysing new datasets, and selecting suitable methods for assisting with the experiment design. Here, we present an R package, miRLAB, for automating the procedure of inferring and validating miRNA-mRNA regulatory relationships. The package provides a complete set of pipelines for testing new methods and analysing new datasets. miRLAB includes a pipeline to obtain matched miRNA and mRNA expression datasets directly from TCGA, 12 benchmark computational methods for inferring miRNA-mRNA regulatory relationships, the functions for validating the predictions using experimentally validated miRNA target data and miRNA perturbation data, and the tools for comparing the results from different computational methods.
C1 [Le, Thuc Duy; Liu, Lin; Li, Jiuyong] Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia.
   [Zhang, Junpeng] Dali Univ, Fac Engn, Dali, Peoples R China.
   [Liu, Huawen] Zhejiang Normal Univ, Dept Comp Sci, Jinhua, Peoples R China.
RP Le, TD (reprint author), Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia.
EM thuc.le@unisa.edu.au; jiuyong.li@unisa.edu.au
RI Le, Thuc Duy/G-8444-2019; Li, Jiuyong/A-8134-2008; Zhang,
   Junpeng/E-4737-2013
OI Le, Thuc Duy/0000-0002-9732-4313; Li, Jiuyong/0000-0002-9023-1878;
   Zhang, Junpeng/0000-0001-6127-9701
FU Australian Research Council [DP130104090]; Applied Basic Research
   Foundation of Science and Technology of Yunnan Province [2013FD038]
FX This work has been partially supported by Australian Research Council
   Discovery Project DP130104090, (JL and LL), and the Applied Basic
   Research Foundation of Science and Technology of Yunnan Province, No.
   2013FD038 (JZ). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Cheng WY, 2013, ARXIV PREPRINT ARXIV
   Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31
   Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002
   Friedman J, 2010, J STAT SOFTW, V33, P1
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   HOEFFDING W, 1948, ANN MATH STAT, V19, P546, DOI 10.1214/aoms/1177730150
   Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266
   Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226
   Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141
   Le TD, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-92
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Li Y, 2013, BIOINFORMATICS
   Li Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku182
   Liu B, 2014, BRIEF BIOINFORM, V15, P1, DOI 10.1093/bib/bbs075
   Liu B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-408
   Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51
   Lopez-Paz D, 2013, ADV NEURAL INFORM PR, V26, P1
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Lu YM, 2011, BIOINFORMATICS, V27, P2406, DOI 10.1093/bioinformatics/btr410
   Maathuis MH, 2010, NAT METHODS, V7, P247, DOI 10.1038/nmeth0410-247
   Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685
   Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/NMETH.2016, 10.1038/nmeth.2016]
   MOON YI, 1995, PHYS REV E, V52, P2318, DOI 10.1103/PhysRevE.52.2318
   Muniategui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030766
   Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393
   Pearson K, 1920, BIOMETRIKA, V13, P25, DOI 10.1093/biomet/13.1.25
   Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202
   Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798
   Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605
   Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107
   Speed T, 2011, SCIENCE, V334, P1502, DOI 10.1126/science.1215894
   Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505
   Le TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131627
   Le TD, 2015, BRIEF BIOINFORM, V16, P475, DOI 10.1093/bib/bbu023
   Le TD, 2013, BIOINFORMATICS, V29, P765, DOI 10.1093/bioinformatics/btt048
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267
   Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787
   Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161
   Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851
   Yu K, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S17-S6
   Zhang JP, 2014, J BIOMED INFORM, V52, P438, DOI 10.1016/j.jbi.2014.08.005
   Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956
   Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x
NR 49
TC 6
Z9 6
U1 1
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 30
PY 2015
VL 10
IS 12
AR e0145386
DI 10.1371/journal.pone.0145386
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA0TN
UT WOS:000367510500034
PM 26716983
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

PT J
AU Simpson, MR
   Brede, G
   Johansen, J
   Johnsen, R
   Storro, O
   Saetrom, P
   Oien, T
AF Simpson, Melanie Rae
   Brede, Gaute
   Johansen, Jostein
   Johnsen, Roar
   Storro, Ola
   Saetrom, Pal
   Oien, Torbjorn
TI Human Breast Milk miRNA, Maternal Probiotic Supplementation and Atopic
   Dermatitis in Offspring
SO PLOS ONE
LA English
DT Article
ID LARGE GENE LISTS; EXTRACELLULAR VESICLES; SMALL-INTESTINE; MICRORNAS;
   EXPRESSION; RNA; MOUSE; EXOSOMES; DISEASE; INJURY
AB Background
   Perinatal probiotic ingestion has been shown to prevent atopic dermatitis (AD) in infancy in a number of randomised trials. The Probiotics in the Prevention of Allergy among Children in Trondheim (ProPACT) trial involved a probiotic supplementation regime given solely to mothers in the perinatal period and demonstrated a similar to 40% relative risk reduction in the cumulative incidence of AD at 2 years of age. However, the mechanisms behind this effect are incompletely understood. Micro-RNAs (miRNA) are abundant in mammalian milk and may influence the developing gastrointestinal and immune systems of newborn infants. The objectives of this study were to describe the miRNA profile of human breast milk, and to investigate breast milk miRNAs as possible mediators of the observed preventative effect of probiotics.
   Methods
   Small RNA sequencing was conducted on samples collected 3 months postpartum from 54 women participating in the ProPACT trial. Differential expression of miRNA was assessed for the probiotic vs placebo and AD vs non-AD groups. The results were further analysed using functional prediction techniques.
   Results
   Human breast milk samples contain a relatively stable core group of highly expressed miRNAs, including miR-148a-3p, miR-22-3p, miR-30d-5p, let-7b-5p and miR-200a-3p. Functional analysis of these miRNAs revealed enrichment in a broad range of biological processes and molecular functions. Although several miRNAs were found to be differentially expressed on comparison of the probiotic vs placebo and AD vs non-AD groups, none had an acceptable false discovery rate and their biological significance in the development of AD is not immediately apparent from their predicted functional consequences.
   Conclusion
   Whilst breast milk miRNAs have the potential to be active in a diverse range of tissues and biological process, individual miRNAs in breast milk 3 months postpartum are unlikely to play a major role in the prevention of atopic dermatitis in infancy by probiotics ingestion in the perinatal period.
C1 [Simpson, Melanie Rae; Johnsen, Roar; Storro, Ola; Oien, Torbjorn] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.
   [Brede, Gaute; Johansen, Jostein; Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.
   [Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Comp & Informat Sci, N-7034 Trondheim, Norway.
RP Simpson, MR (reprint author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.
EM melanie.simpson@ntnu.no
RI Simpson, Melanie Rae/H-6853-2019
OI Simpson, Melanie Rae/0000-0003-2763-6343; Saetrom,
   Pal/0000-0001-8142-7441
FU Norwegian University of Science and Technology; Norwegian Research
   Council; Nidarosfondet; Tine BA
FX This study was funded by the Norwegian University of Science and
   Technology, the Norwegian Research Council and Nidarosfondet. Tine BA
   sponsored the study through supply of study milk and logistics of its
   distribution. Siemens Medical Solutions Diagnostics AS provided reagents
   for the analysis of serum IgE. Employees from funding sources played no
   role in the study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Agarwal S, 2011, J HUM LACT, V27, P171, DOI 10.1177/0890334410395761
   Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Anderson RC, 2012, COLITIS
   [Anonymous], 2008, R LANG ENV STAT COMP
   Argov-Argaman N, 2010, J AGR FOOD CHEM, V58, P11234, DOI 10.1021/jf102495s
   Arroyo JD, 2011, PNAS, V108, P6
   Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994
   Chapkin RS, 2010, AM J PHYSIOL-GASTR L, V298, pG582, DOI 10.1152/ajpgi.00004.2010
   Chassin C, 2012, EMBO MOL MED, V4, P1308, DOI 10.1002/emmm.201201298
   Chen T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-100
   Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80
   Davis MK, 2001, PEDIATR CLIN N AM, V48, P125, DOI 10.1016/S0031-3955(05)70289-3
   Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dotterud CK, 2010, BRIT J DERMATOL, V163, P616, DOI 10.1111/j.1365-2133.2010.09889.x
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691
   Hu CH, 2013, J ANIM SCI, V91, P1094, DOI 10.2527/jas.2012-5796
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489
   Izumi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088843
   Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7
   Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Lu TX, 2013, J ALLERGY CLIN IMMUN, V132, P3, DOI 10.1016/j.jaci.2013.04.039
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Matheson MC, 2012, CLIN EXP ALLERGY, V42, P827, DOI 10.1111/j.1365-2222.2011.03925.x
   Modepalli V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1012
   Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564
   Nata T, 2013, J GENE MED, V15, P249, DOI 10.1002/jgm.2717
   Panduru M, 2015, J EUR ACAD DERMATOL, V29, P232, DOI 10.1111/jdv.12496
   Patelarou E, 2012, NUTR REV, V70, P509, DOI 10.1111/j.1753-4887.2012.00513.x
   Pelucchi C, 2012, EPIDEMIOLOGY, V23, P402, DOI 10.1097/EDE.0b013e31824d5da2
   Power ML, 2013, APPL TRANSL GENOM, V2, P55, DOI 10.1016/j.atg.2013.06.001
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027
   Van Deun J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24858
   Walker WA, 2015, PEDIATR RES, V77, P220, DOI 10.1038/pr.2014.160
   Wang JJ, 2008, J NUTR, V138, P1025
   Webber J, 2010, CLIN CHEM, V56, P9
   WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x
   Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118
   Zonneveld MI, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24215
NR 50
TC 8
Z9 8
U1 0
U2 29
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 14
PY 2015
VL 10
IS 12
AR e0143496
DI 10.1371/journal.pone.0143496
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CY9GR
UT WOS:000366715900011
PM 26657066
OA DOAJ Gold, Green Published
DA 2019-07-07
ER

EF